{"meta":{"query_hash":"4cfbdd9d7299","filters":{"venue":"American Journal of Clinical Dermatology"},"cohort_total":137,"direct_labels_cover":1,"predictions_cover":137,"exported":137,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4cfbdd9d7299","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Clinical+Dermatology"},"results":[{"id":"W119503694","doi":"10.2165/11593240-000000000-00000","title":"Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario HIV Treatment Network; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ontario HIV Treatment Network; Canadian Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Medicine; Cohort; Incidence (geometry); Erythema multiforme; Population; Retrospective cohort study; Pediatrics; Cohort study; Internal medicine; Dermatology; Environmental health","score_opus":0.05387720911183005,"score_gpt":0.3742420569830588,"score_spread":0.32036484787122876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W119503694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991903,0.00008978181,0.000036823545,0.000020180009,0.00000409275,0.000005317578,0.00020033022,0.0000028457841,0.00045036877],"genre_scores_gemma":[0.99952173,0.00008773053,0.000024238854,0.000015664862,0.0000070690344,0.0000039967213,0.00015424319,0.000001719188,0.00018365035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995191,0.000092707895,0.00004473648,0.00013578375,0.0000869209,0.00012085163],"domain_scores_gemma":[0.9989943,0.00014158219,0.00030507855,0.00010801558,0.0001381967,0.00031284505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041178646,0.00029041103,0.00033162368,0.0015331783,0.0010690708,0.0011013661,0.0004950195,0.0006316641,0.0029662282],"category_scores_gemma":[0.0018398033,0.00056843203,0.00048841524,0.0009891278,0.0003140931,0.0009330204,0.00057761144,0.0008714799,0.00039924754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063664615,0.000037794718,0.9990934,0.0000016194302,0.000028310771,0.00014457018,0.000054210974,0.000017138711,0.00011977073,0.00001271454,0.000039787446,0.00038703173],"study_design_scores_gemma":[0.0000045846173,0.000097145006,0.99816763,0.000002954966,0.00002494902,0.0008992318,0.00047709135,0.0001732352,0.000045671026,0.000018901548,0.00008342619,0.0000052320233],"about_ca_topic_score_codex":0.010587164,"about_ca_topic_score_gemma":0.0062627047,"teacher_disagreement_score":0.010587164,"about_ca_system_score_codex":0.00035436894,"about_ca_system_score_gemma":0.00039229245,"threshold_uncertainty_score":0.02105105},"labels":[],"label_agreement":null},{"id":"W1243598765","doi":"10.2165/11631880-000000000-00000","title":"Pharmacologic Interventions for Hidradenitis Suppurativa","year":2012,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"European Society for Dermatological Research","keywords":"Medicine; Hidradenitis suppurativa; Infliximab; Adalimumab; Randomized controlled trial; Adverse effect; MEDLINE; Psychological intervention; Discontinuation; Disease; Systematic review; Internal medicine; Physical therapy; Intensive care medicine","score_opus":0.36745854606808154,"score_gpt":0.5828050171403425,"score_spread":0.21534647107226096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1243598765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015728423,0.9992735,0.000046206038,0.00006988303,0.00006774576,0.000007113693,0.0000114977865,0.0000039182423,0.00036279176],"genre_scores_gemma":[0.0024945429,0.9965411,0.0002520896,0.00022828807,0.00015991792,0.0000145366275,0.000022392242,9.603007e-7,0.00028622517],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99977773,0.000045663106,0.000055820867,0.000034180062,0.000067428955,0.000019207373],"domain_scores_gemma":[0.9994086,0.00029554672,0.00019105876,0.000011904673,0.000059122252,0.000033796896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005267085,0.0007639395,0.0017320854,0.002365757,0.00026401272,0.00070464937,0.0006818232,0.00084517256,0.0050306832],"category_scores_gemma":[0.00093962107,0.00028225465,0.000864551,0.0014079342,0.00031675896,0.00078649784,0.00049158547,0.0012943236,0.0007441747],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021597807,0.00023186757,0.00033209322,0.05333475,0.00043226997,0.00025982258,0.0000466649,0.00010640302,0.0013098808,0.0006029766,0.012086663,0.93104064],"study_design_scores_gemma":[0.00079706224,0.0013183398,0.009872432,0.048774466,0.005445566,0.007391258,0.0003412454,0.00037172754,0.0025631571,0.0014493415,0.9215903,0.00008509005],"about_ca_topic_score_codex":0.0006604579,"about_ca_topic_score_gemma":0.0020553106,"teacher_disagreement_score":0.0050306832,"about_ca_system_score_codex":0.000315344,"about_ca_system_score_gemma":0.00064337254,"threshold_uncertainty_score":0.016829312},"labels":[],"label_agreement":null},{"id":"W160731419","doi":"10.2165/00128071-200910040-00002","title":"Dapsone 5% Gel","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Dapsone; Medicine; Acne; Dermatology; Adverse effect; Isotretinoin; Pharmacology","score_opus":0.10312371780429515,"score_gpt":0.5060478937611652,"score_spread":0.4029241759568701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W160731419","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067893695,0.996104,0.00020907435,0.00018990871,0.00020770487,0.000018170662,0.00005335681,0.000021364747,0.002517546],"genre_scores_gemma":[0.005339465,0.9910676,0.0003563735,0.0002953441,0.00017149588,0.00002029519,0.00008898327,0.0000024739861,0.00265795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998622,0.00001851687,0.000032953783,0.000022686869,0.000050299233,0.000013433182],"domain_scores_gemma":[0.99978966,0.00008380372,0.000074525764,0.0000054555867,0.000030664756,0.000015980666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025835892,0.0007699431,0.0012813873,0.0022490486,0.0001874434,0.00046712943,0.00051591784,0.00053970236,0.0061096707],"category_scores_gemma":[0.00041040088,0.00022497553,0.00038554097,0.0012566873,0.00023086215,0.0006585458,0.00044195887,0.0007156565,0.0017090889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016132243,0.000089095134,0.00018390159,0.017958771,0.000114697876,0.00027850847,0.000020609765,0.00008173926,0.002299305,0.00034476075,0.017244518,0.9612228],"study_design_scores_gemma":[0.00022023483,0.0005616427,0.004201013,0.0060921744,0.0010035153,0.0061235037,0.00008869756,0.00016801864,0.0031937687,0.00046940654,0.9778476,0.00003053891],"about_ca_topic_score_codex":0.0006404155,"about_ca_topic_score_gemma":0.0020357594,"teacher_disagreement_score":0.0061096707,"about_ca_system_score_codex":0.00027200833,"about_ca_system_score_gemma":0.00041226405,"threshold_uncertainty_score":0.02043891},"labels":[],"label_agreement":null},{"id":"W1793997425","doi":"10.1007/s40257-015-0158-0","title":"Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Pharmacotherapy; Erythroderma; Internal medicine","score_opus":0.1220413872710241,"score_gpt":0.47238018069650023,"score_spread":0.35033879342547614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1793997425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012910362,0.9989065,0.0000640823,0.00018234728,0.0003056309,0.000005110019,0.00002172515,0.000007385305,0.0003781126],"genre_scores_gemma":[0.00077620405,0.9975955,0.00022800888,0.00044453682,0.00059457216,0.0000053324425,0.000041091826,0.0000014718875,0.00031328984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995196,0.000070920076,0.00012617095,0.0000672827,0.00017746861,0.00003857535],"domain_scores_gemma":[0.9985232,0.000547755,0.00047266108,0.000033107808,0.00030658743,0.00011670699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085377187,0.0012068948,0.0019835,0.004563739,0.00029348923,0.0016101496,0.001083518,0.0014279473,0.0042573917],"category_scores_gemma":[0.0015987585,0.00039590546,0.0009501862,0.0035472482,0.00045850754,0.0022855077,0.0010527817,0.0016079358,0.0010839553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015198028,0.0001560327,0.0007598877,0.033760026,0.0002761501,0.0009190705,0.000072500305,0.0003154759,0.0013115082,0.0009359439,0.054942146,0.90639925],"study_design_scores_gemma":[0.000112202135,0.00024708128,0.0035821795,0.014471871,0.0012272827,0.009118607,0.00015498785,0.00023120249,0.00041085266,0.0011562947,0.96922183,0.00006568309],"about_ca_topic_score_codex":0.0012091474,"about_ca_topic_score_gemma":0.0036479968,"teacher_disagreement_score":0.004563739,"about_ca_system_score_codex":0.00049074343,"about_ca_system_score_gemma":0.0015444615,"threshold_uncertainty_score":0.014242351},"labels":[],"label_agreement":null},{"id":"W1972569644","doi":"10.2165/00128071-200203010-00004","title":"The Role of Fluoroquinolones in Skin and Skin Structure Infections","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Dermatology; Skin infection; Intensive care medicine; Internal medicine; Staphylococcus aureus","score_opus":0.0338893809488807,"score_gpt":0.4149426798164158,"score_spread":0.3810532988675351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972569644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014652566,0.99920887,0.000108240696,0.00010267226,0.0000715727,0.0000020464395,0.000007168619,0.000003480686,0.0003495141],"genre_scores_gemma":[0.0011594545,0.9980678,0.00024514663,0.00010267147,0.00015392234,0.0000027490357,0.0000133624935,8.609946e-7,0.00025408113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966764,0.000060605376,0.0000730072,0.000054875447,0.000123472,0.000020389742],"domain_scores_gemma":[0.99899775,0.0005291159,0.00018593326,0.000022309106,0.0002193158,0.0000455919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009215912,0.00082646357,0.0019173988,0.0027562694,0.00027990845,0.0010170179,0.000921287,0.0012089694,0.0021935417],"category_scores_gemma":[0.0012105556,0.00030138314,0.0005972249,0.0024560005,0.0004828329,0.0014021104,0.00042031668,0.0012941924,0.0010443287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013372707,0.000097369535,0.0004925513,0.013257231,0.0001134283,0.0005643685,0.000053530144,0.0003447452,0.0017919054,0.0009581066,0.008807518,0.9733855],"study_design_scores_gemma":[0.00007668928,0.00039648666,0.003996339,0.0050785076,0.0005289093,0.009110552,0.000122396,0.0002966853,0.0018103255,0.0012630981,0.97727716,0.000042867505],"about_ca_topic_score_codex":0.0015449447,"about_ca_topic_score_gemma":0.0027029663,"teacher_disagreement_score":0.0027562694,"about_ca_system_score_codex":0.00052460836,"about_ca_system_score_gemma":0.0010579817,"threshold_uncertainty_score":0.0073381066},"labels":[],"label_agreement":null},{"id":"W1975795171","doi":"10.2165/00128071-200607030-00004","title":"Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??)","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"","keywords":"Betamethasone dipropionate; Medicine; Dermatology; Psoriasis; Calcipotriol","score_opus":0.03893121790341279,"score_gpt":0.3272870268135607,"score_spread":0.2883558089101479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975795171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822254,0.0059125144,0.0008172419,0.0012377399,0.0003254776,0.0003165773,0.00019050359,0.000063259205,0.008911184],"genre_scores_gemma":[0.9956928,0.0009924177,0.00037807963,0.0005813734,0.00010146474,0.000023129922,0.00010831977,0.000007867594,0.0021146194],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997327,0.000048630598,0.000025727117,0.000034291814,0.00008721493,0.000071385206],"domain_scores_gemma":[0.9994642,0.00021810218,0.00010024308,0.000021814785,0.000059139194,0.00013656703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034131622,0.0002867365,0.0008229476,0.00050074235,0.0008291956,0.0002741014,0.0002660808,0.0009622405,0.0015790022],"category_scores_gemma":[0.0013193564,0.00013428998,0.0004670517,0.00028638952,0.00021616922,0.00022062256,0.00016367681,0.0010724876,0.00034927705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041621216,0.0079429485,0.23514389,0.0016674406,0.0005869195,0.23406881,0.0022310854,0.0006465449,0.14293076,0.0005260812,0.006769448,0.32586485],"study_design_scores_gemma":[0.0018600252,0.057958398,0.66828346,0.00029411787,0.00071363576,0.17076488,0.0009990623,0.002017126,0.0682875,0.00036413025,0.028339645,0.00011793343],"about_ca_topic_score_codex":0.0020495483,"about_ca_topic_score_gemma":0.0056240642,"teacher_disagreement_score":0.0020495483,"about_ca_system_score_codex":0.0004418247,"about_ca_system_score_gemma":0.0003429567,"threshold_uncertainty_score":0.0052823424},"labels":[],"label_agreement":null},{"id":"W1977267367","doi":"10.2165/00128071-200001040-00003","title":"Assessment and Clinical Implications of Absorption of Sunscreens Across Skin","year":2000,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cosmetics; Stratum corneum; Dermatology; Absorption (acoustics); Systemic circulation; Medicine; Skin barrier; Ultraviolet radiation; Chemistry; Materials science; Pathology","score_opus":0.12321574120501994,"score_gpt":0.5521958423288226,"score_spread":0.42898010112380264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977267367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003007674,0.9991073,0.00007997683,0.00012471687,0.000054455886,0.0000024292372,0.000006591749,0.0000018463855,0.00032193676],"genre_scores_gemma":[0.002202422,0.99715245,0.00020703864,0.0001078909,0.000098155615,0.0000034179686,0.000010236237,6.269892e-7,0.00021774885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938047,0.00011235241,0.000099504265,0.00011128083,0.00027307586,0.000023369259],"domain_scores_gemma":[0.99871314,0.0007653605,0.00021204259,0.000026770324,0.00025273787,0.000029936338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013532373,0.0009119796,0.0021359732,0.002316715,0.00022130516,0.0010310762,0.00094804575,0.0013854476,0.0015797375],"category_scores_gemma":[0.0018013408,0.00029086493,0.00082784524,0.0017248391,0.0005879309,0.0012594014,0.00043184016,0.0010715123,0.0006024451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018028104,0.000085785236,0.001250722,0.014730566,0.00018008206,0.00031112065,0.00007785593,0.00023522635,0.0016973658,0.0007504729,0.00450044,0.9759999],"study_design_scores_gemma":[0.00013041412,0.0011647197,0.027477244,0.01559112,0.0018177411,0.014562566,0.00070721883,0.00055889465,0.0066262074,0.0037169515,0.9275314,0.000115418705],"about_ca_topic_score_codex":0.0016995232,"about_ca_topic_score_gemma":0.0028948698,"teacher_disagreement_score":0.002316715,"about_ca_system_score_codex":0.00048341873,"about_ca_system_score_gemma":0.0009199941,"threshold_uncertainty_score":0.00715667},"labels":[],"label_agreement":null},{"id":"W1979209155","doi":"10.1007/s40257-015-0119-7","title":"Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Women's College Hospital; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Epidermolysis bullosa; Dermatology; Genotype; Mutation; Meta-analysis; Internal medicine; Epidermolysis bullosa simplex; Pathology; Genetics; Gene; Biology","score_opus":0.12387531509326755,"score_gpt":0.4291166032516235,"score_spread":0.30524128815835594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979209155","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004701715,0.9991799,0.00003846733,0.00009571683,0.00003768616,0.000010301977,0.00008981505,0.0000017557433,0.000076308694],"genre_scores_gemma":[0.0057922914,0.9933662,0.0002500396,0.00034711004,0.00005181996,0.000021606698,0.000117116564,0.0000016191706,0.00005221817],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986224,0.0002941674,0.0005450647,0.00023757492,0.00023599107,0.00006482647],"domain_scores_gemma":[0.9947509,0.0037645078,0.0010403857,0.00007322475,0.00028997404,0.00008111814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021745854,0.0010435455,0.0045754774,0.0047678314,0.00026106884,0.0014763796,0.0012680895,0.0012205115,0.0035410123],"category_scores_gemma":[0.0063155433,0.00052152545,0.003954887,0.00488367,0.0004920271,0.0014438385,0.0009833926,0.00088946585,0.0002358669],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006878395,0.00008962622,0.006415535,0.6445853,0.018377423,0.00091397477,0.0002447028,0.00031876098,0.0012311308,0.00076993427,0.009547826,0.3168179],"study_design_scores_gemma":[0.001309455,0.00060046127,0.045808777,0.5396365,0.19768807,0.008552163,0.00094483915,0.00027647,0.0009980056,0.0021121919,0.20184885,0.0002242151],"about_ca_topic_score_codex":0.0023960639,"about_ca_topic_score_gemma":0.007813267,"teacher_disagreement_score":0.0047678314,"about_ca_system_score_codex":0.0007313894,"about_ca_system_score_gemma":0.002350956,"threshold_uncertainty_score":0.011845887},"labels":[],"label_agreement":null},{"id":"W1983541360","doi":"10.2165/00128071-200304120-00005","title":"Cost of Medications in Patients Admitted to a Burn Center","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Burn Injury Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Formulary; Burn center; Toxic epidermal necrolysis; Emergency medicine; Medical record; Retrospective cohort study; Trauma center; Pediatrics; Surgery; Poison control; Family medicine","score_opus":0.04464836051780951,"score_gpt":0.409535332553763,"score_spread":0.3648869720359535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983541360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563354,0.0007258237,0.00003677557,0.0009772765,0.000050724684,0.000023493127,0.00041977456,0.0000036963384,0.0021289252],"genre_scores_gemma":[0.99890125,0.00030918216,0.000067852714,0.0001981653,0.000048539994,0.000009484461,0.00025571426,0.0000015304529,0.00020821983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993124,0.00017896129,0.0001150549,0.000042520005,0.00012606625,0.00022505206],"domain_scores_gemma":[0.998137,0.00036977284,0.0007193857,0.000024007151,0.00015341275,0.00059646077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002117886,0.0002915401,0.00046440226,0.00096646283,0.0009768757,0.0010981121,0.00039924314,0.0009831833,0.0055431733],"category_scores_gemma":[0.004006577,0.00030381745,0.0010311941,0.0010664206,0.00023902231,0.0007557094,0.0006821387,0.0012819311,0.000206823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075422507,0.00040675577,0.98787445,0.00006272171,0.00018223585,0.0017400712,0.000115482086,0.0004598322,0.0001448032,0.00019764467,0.0010793365,0.0069824136],"study_design_scores_gemma":[0.00006795767,0.00072939123,0.9919282,0.00008105877,0.00015357391,0.0025281042,0.0019339741,0.0017219578,0.0000817416,0.00021576458,0.0005370168,0.000021303264],"about_ca_topic_score_codex":0.017072406,"about_ca_topic_score_gemma":0.024111789,"teacher_disagreement_score":0.017072406,"about_ca_system_score_codex":0.0023647917,"about_ca_system_score_gemma":0.0014237841,"threshold_uncertainty_score":0.033946097},"labels":[],"label_agreement":null},{"id":"W1984062094","doi":"10.2165/00128071-200304030-00006","title":"Optimizing Treatment with Topical Tazarotene","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Allergan","keywords":"Tazarotene; Medicine; Dermatology; Adapalene; Mometasone furoate; Acne; Tolerability; Psoriasis; Combination therapy; Erythema; Adverse effect; Retinoid; Tretinoin; Irritation; Calcipotriol; Pharmacology; Corticosteroid; Surgery; Retinoic acid; Immunology; Benzoyl peroxide","score_opus":0.08788930886669413,"score_gpt":0.45090600086289373,"score_spread":0.36301669199619957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984062094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094892934,0.9972584,0.00027033704,0.00018714309,0.00015309085,0.000009094755,0.000016360835,0.000014957111,0.0011415499],"genre_scores_gemma":[0.007180257,0.990424,0.0005935966,0.00024901316,0.00026923846,0.000015274181,0.00004227408,0.000002791814,0.0012235731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997998,0.000034667406,0.000046556495,0.000034543384,0.00006805996,0.0000163217],"domain_scores_gemma":[0.999749,0.000099906065,0.000078313366,0.000007882637,0.00005150714,0.000013405007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038758825,0.000779261,0.0013950353,0.0013116796,0.00019428447,0.00056128314,0.00061988,0.0006624786,0.0021512285],"category_scores_gemma":[0.0005486983,0.00019058332,0.00046126847,0.00092163024,0.00020758797,0.00052446936,0.00019863578,0.0008380097,0.0009864842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003251231,0.00013913734,0.00045530967,0.009961204,0.00014887478,0.00036418939,0.000027850934,0.00015393463,0.0060603833,0.00033281953,0.007158199,0.97487295],"study_design_scores_gemma":[0.000565332,0.0013599065,0.013115226,0.004925147,0.0022277127,0.010170127,0.00014752771,0.00052847376,0.010814585,0.0010352433,0.9550576,0.00005307317],"about_ca_topic_score_codex":0.00096949603,"about_ca_topic_score_gemma":0.003006172,"teacher_disagreement_score":0.0021512285,"about_ca_system_score_codex":0.00028682945,"about_ca_system_score_gemma":0.0005175886,"threshold_uncertainty_score":0.0071965456},"labels":[],"label_agreement":null},{"id":"W1991330761","doi":"10.2165/00128071-200809050-00001","title":"Can We Define Acne as a Chronic Disease?","year":2008,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Acne; Medicine; Disease; Dermatology; Intensive care medicine; Clinical trial; Epidemiology; Acne treatment; Pathology","score_opus":0.07052480202714943,"score_gpt":0.45619216244835364,"score_spread":0.3856673604212042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991330761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010796608,0.99428326,0.00020927675,0.003108716,0.001390703,0.0000040020764,0.0000094613615,0.000006187598,0.00088039506],"genre_scores_gemma":[0.0020808815,0.9900349,0.00057470845,0.004030541,0.0024857551,0.00001508974,0.000025456717,0.0000031105901,0.0007496523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921334,0.0002014637,0.00018055507,0.00009646139,0.00024594791,0.000062191604],"domain_scores_gemma":[0.9979905,0.0010794599,0.0002728446,0.00006565517,0.00044059777,0.00015101141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018976163,0.0008991667,0.0030147429,0.0026063742,0.0006669324,0.0026310422,0.0010329669,0.0022590659,0.0025810392],"category_scores_gemma":[0.0036652826,0.00034667423,0.0007742458,0.0024116796,0.0027647861,0.005833486,0.0014161228,0.004248434,0.0015304587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001077507,0.00009915985,0.0013029122,0.020036642,0.00016350551,0.00049803563,0.000358388,0.00013633155,0.0008234262,0.015156201,0.088589266,0.8727284],"study_design_scores_gemma":[0.000053199026,0.000091594324,0.0027465462,0.011597411,0.00023417707,0.004146702,0.0006186032,0.000099439865,0.0001462918,0.009607374,0.97062194,0.000036704365],"about_ca_topic_score_codex":0.0029672128,"about_ca_topic_score_gemma":0.005056082,"teacher_disagreement_score":0.0030147429,"about_ca_system_score_codex":0.0010919892,"about_ca_system_score_gemma":0.0029247482,"threshold_uncertainty_score":0.010035694},"labels":[],"label_agreement":null},{"id":"W1995325931","doi":"10.2165/00128071-200809040-00004","title":"Ceftobiprole","year":2008,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Bacteroides fragilis; Microbiology; Cefepime; Cephalosporin; Enterococcus faecalis; Ceftazidime; Medicine; Antibiotics; Pharmacology; Biology; Pseudomonas aeruginosa; Staphylococcus aureus; Imipenem; Antibiotic resistance; Bacteria","score_opus":0.12093585059013945,"score_gpt":0.5077251777660386,"score_spread":0.3867893271758992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995325931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026365108,0.9982363,0.000116620395,0.0001910723,0.00016814058,0.000007821265,0.000019421059,0.000009231184,0.0009876847],"genre_scores_gemma":[0.0028792322,0.9951757,0.00026284275,0.00030392138,0.00017833643,0.000012425459,0.0000456081,0.0000016374875,0.0011401873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999767,0.000043248452,0.000049958293,0.000037218055,0.00008016523,0.000022345841],"domain_scores_gemma":[0.99962854,0.00014726103,0.00012051795,0.000010880079,0.00006428261,0.000028636552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003724944,0.00083399966,0.0015757693,0.00220708,0.00017796882,0.00066345354,0.00049180415,0.00069316005,0.0038658527],"category_scores_gemma":[0.00085404643,0.00022273086,0.00041216938,0.0014436191,0.0003340543,0.00073981856,0.0004849032,0.0011285514,0.0013717323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020548892,0.00008148257,0.00012621662,0.015643012,0.00009675232,0.00022402803,0.00001986813,0.00008811088,0.0021952728,0.00046936862,0.017208379,0.96364206],"study_design_scores_gemma":[0.00023629765,0.00049175206,0.0023728393,0.0070673428,0.0007841347,0.0053852075,0.00006067537,0.00017192906,0.0035717606,0.0004979679,0.97932726,0.00003281461],"about_ca_topic_score_codex":0.0011173504,"about_ca_topic_score_gemma":0.0027375007,"teacher_disagreement_score":0.0038658527,"about_ca_system_score_codex":0.0004185732,"about_ca_system_score_gemma":0.0009013063,"threshold_uncertainty_score":0.012932539},"labels":[],"label_agreement":null},{"id":"W1996532601","doi":"10.2165/00128071-200405040-00006","title":"Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; PharmIdeas (Canada); Health Sciences Centre; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Pimecrolimus; Tacrolimus; Medicine; Calcineurin; Atopic dermatitis; Placebo; Eczema Area and Severity Index; Randomized controlled trial; Dermatology; Internal medicine; Transplantation; Pathology","score_opus":0.06726534287392007,"score_gpt":0.44266883156699377,"score_spread":0.3754034886930737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996532601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016354464,0.9991309,0.00007032941,0.000068699635,0.0001228346,0.0000033886715,0.000008203585,0.0000045072434,0.00042764982],"genre_scores_gemma":[0.001071867,0.99813014,0.00015038764,0.00010709024,0.00016840544,0.0000033590643,0.000017576287,9.3303294e-7,0.0003502758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999816,0.000027374632,0.000035193767,0.00003285354,0.00007481515,0.00001377305],"domain_scores_gemma":[0.99959165,0.00021015423,0.00007667087,0.000009950683,0.000078183286,0.000033446377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047328035,0.00075870875,0.0018959318,0.0021545477,0.00023588109,0.0006459515,0.0009097527,0.0007720598,0.0028146906],"category_scores_gemma":[0.000655018,0.00025512776,0.00053979957,0.002243836,0.00034019107,0.0007429315,0.00037695217,0.00142819,0.0013024985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017074404,0.00010472371,0.0002598723,0.014857401,0.0001730687,0.00044785673,0.000031223946,0.00024088712,0.0015058153,0.00054806867,0.01620989,0.96545047],"study_design_scores_gemma":[0.00021669845,0.00046791736,0.004456939,0.0077165766,0.0013580223,0.008767261,0.00013426389,0.00032085812,0.0016714741,0.0011352682,0.97370934,0.000045373192],"about_ca_topic_score_codex":0.0015662146,"about_ca_topic_score_gemma":0.0041440213,"teacher_disagreement_score":0.0028146906,"about_ca_system_score_codex":0.0003381825,"about_ca_system_score_gemma":0.00063017197,"threshold_uncertainty_score":0.009416044},"labels":[],"label_agreement":null},{"id":"W1999541518","doi":"10.2165/00128071-200405060-00006","title":"Role of Antifungal Agents in the Treatment of Seborrheic Dermatitis","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Seborrheic dermatitis; Terbinafine; Malassezia; Pimecrolimus; Ketoconazole; Dermatology; Itraconazole; Medicine; Seborrhoeic dermatitis; Dermatomycosis; Tea tree oil; Antifungal; Shampoo; Tacrolimus; Biology; Essential oil; Surgery; Pathology; Botany","score_opus":0.08453442629024796,"score_gpt":0.4672681617179624,"score_spread":0.3827337354277145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999541518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011124059,0.99926203,0.000080956575,0.0000699758,0.00007576543,0.0000027495128,0.0000068492923,0.000004027505,0.0003864748],"genre_scores_gemma":[0.00091480376,0.9982468,0.0002592323,0.000118335636,0.00013596223,0.0000033297486,0.000017550301,0.0000010573864,0.00030301782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973017,0.00004355318,0.00005558151,0.000046944246,0.00010432622,0.000019457932],"domain_scores_gemma":[0.99932563,0.0003771656,0.000111456124,0.000018770234,0.00012409543,0.00004287123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071632146,0.0009430943,0.002062457,0.002989534,0.00030443707,0.0009802212,0.0011556597,0.0011029232,0.0030525867],"category_scores_gemma":[0.0008749828,0.00031795984,0.0006869694,0.002495156,0.0005287598,0.0010624238,0.0004973467,0.001985201,0.0015371068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013934226,0.0001400773,0.00024246296,0.011044155,0.00013991923,0.00038590463,0.000038483988,0.0002806152,0.0014741558,0.0008128087,0.009543547,0.97575855],"study_design_scores_gemma":[0.0001542774,0.0004393797,0.003594399,0.007191513,0.00075370894,0.007377883,0.00010966814,0.00032537786,0.0015400045,0.0014066575,0.97706044,0.000046667],"about_ca_topic_score_codex":0.0013651138,"about_ca_topic_score_gemma":0.0031109478,"teacher_disagreement_score":0.0030525867,"about_ca_system_score_codex":0.0004083217,"about_ca_system_score_gemma":0.0007413766,"threshold_uncertainty_score":0.010211945},"labels":[],"label_agreement":null},{"id":"W2000347666","doi":"10.2165/00128071-200506060-00003","title":"Monitoring Liver Function during Methotrexate Therapy for Psoriasis","year":2005,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Methotrexate; Medicine; Psoriasis; Liver biopsy; Biopsy; Pharmacotherapy; Liver function; Liver function tests; Internal medicine; Liver disease; Dermatology","score_opus":0.4229021072902276,"score_gpt":0.5805141046800265,"score_spread":0.15761199738979892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000347666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011380397,0.99763167,0.0003226991,0.00012726225,0.00008303057,0.0000067722967,0.000016676166,0.000010702017,0.0006631091],"genre_scores_gemma":[0.012265578,0.9856418,0.0008537264,0.00026488784,0.00027851303,0.000014250099,0.000050400875,0.0000028014308,0.00062815356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999736,0.00006419505,0.00005162361,0.000037061094,0.00009827066,0.000012822282],"domain_scores_gemma":[0.99928397,0.00037271166,0.00018003066,0.00001300649,0.00012248795,0.000027932309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006128271,0.0005652199,0.0014968081,0.0013934923,0.0001281352,0.0004935963,0.00054685056,0.00064692396,0.00072628126],"category_scores_gemma":[0.0010102359,0.00021693505,0.00046814998,0.00096621836,0.00022162168,0.00045119965,0.00024384889,0.00080625573,0.0006228025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022014875,0.00007671451,0.001822344,0.0056033153,0.0001640611,0.00053317193,0.00003050567,0.0001977617,0.002206693,0.00017019988,0.0042997072,0.9846752],"study_design_scores_gemma":[0.00054887385,0.0024635796,0.07316349,0.011386182,0.0031022513,0.03686754,0.00034596777,0.001619073,0.015185231,0.0020545088,0.8530871,0.00017623704],"about_ca_topic_score_codex":0.00077889534,"about_ca_topic_score_gemma":0.0021879901,"teacher_disagreement_score":0.0014968081,"about_ca_system_score_codex":0.0002487665,"about_ca_system_score_gemma":0.0004321107,"threshold_uncertainty_score":0.003240943},"labels":[],"label_agreement":null},{"id":"W2001132015","doi":"10.2165/00128071-200203020-00001","title":"Six Novel Antimycotics","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Dermatology; Tinea capitis; Bifonazole; Voriconazole; Antifungal; Seborrheic dermatitis; Pharmacology; Tinea versicolor; Clinical trial; Drug; Pathology","score_opus":0.16305742141623916,"score_gpt":0.4834526691126559,"score_spread":0.3203952476964167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001132015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052573695,0.99715567,0.00030507223,0.00025665414,0.00029911599,0.000016983868,0.0000300091,0.000021984919,0.0013887327],"genre_scores_gemma":[0.002807636,0.99333715,0.0008743417,0.0006015578,0.0003682478,0.000025249114,0.000090362366,0.000003844939,0.0018916333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997003,0.00004454439,0.00007006721,0.000057584177,0.000097808464,0.000029732562],"domain_scores_gemma":[0.99950576,0.00018112313,0.00012995246,0.000020961807,0.00010548942,0.000056768455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006601958,0.0011678176,0.0016288442,0.0032319836,0.0003533815,0.00095660426,0.0009184535,0.00089207233,0.0036746978],"category_scores_gemma":[0.0008417211,0.00030651942,0.0005365412,0.0022994592,0.00041744925,0.0011516968,0.0007886513,0.0014860394,0.0017060166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018539591,0.00015107609,0.00020025345,0.010646818,0.00009902361,0.00037815567,0.00005083565,0.0001562781,0.0033693193,0.0008499104,0.019451685,0.9644613],"study_design_scores_gemma":[0.00012139181,0.0004411023,0.0016315038,0.0027735895,0.0005131561,0.0032843011,0.00005406321,0.00014634142,0.0025931762,0.00049786817,0.9879189,0.000024663226],"about_ca_topic_score_codex":0.0005368832,"about_ca_topic_score_gemma":0.0019529336,"teacher_disagreement_score":0.0036746978,"about_ca_system_score_codex":0.00042421764,"about_ca_system_score_gemma":0.0008534579,"threshold_uncertainty_score":0.012293041},"labels":[],"label_agreement":null},{"id":"W2001264462","doi":"10.2165/00128071-200607020-00005","title":"Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pimecrolimus; Medicine; Tolerability; Atopic dermatitis; Discontinuation; Adverse effect; Dermatology; Regimen; Clinical trial; Calcineurin; Internal medicine; Transplantation","score_opus":0.022337140062407928,"score_gpt":0.3775678081110146,"score_spread":0.35523066804860665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001264462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98149544,0.0146291675,0.0005552849,0.0005087088,0.00010612777,0.00013101533,0.00008994467,0.00004200676,0.0024421706],"genre_scores_gemma":[0.9970601,0.0018652758,0.00035988638,0.00015451721,0.00021215688,0.000024818026,0.000051290044,0.0000052882065,0.00026656076],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983571,0.00087831577,0.00015991826,0.000102399325,0.0004334868,0.0000687156],"domain_scores_gemma":[0.9979407,0.0010439011,0.0005819296,0.00012132311,0.00014615615,0.00016582207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021552816,0.00031264263,0.00088033313,0.00043055485,0.0003044504,0.0003808874,0.00036598387,0.00073811406,0.00081483705],"category_scores_gemma":[0.0052318615,0.00016463663,0.0005568351,0.00025635352,0.00028410403,0.0003870831,0.00011827212,0.001017647,0.00025721212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13238686,0.010295786,0.044245206,0.0015446352,0.0009892352,0.0012149862,0.00045704027,0.001268299,0.06206392,0.00035736337,0.0016140098,0.74356276],"study_design_scores_gemma":[0.03279366,0.3562476,0.5385554,0.00045743724,0.0023989894,0.008839843,0.00037169846,0.0062319064,0.044423614,0.0006871663,0.008880127,0.00011254962],"about_ca_topic_score_codex":0.00023779075,"about_ca_topic_score_gemma":0.00043464315,"teacher_disagreement_score":0.0021552816,"about_ca_system_score_codex":0.00025832345,"about_ca_system_score_gemma":0.00025721898,"threshold_uncertainty_score":0.011398375},"labels":[],"label_agreement":null},{"id":"W2016198078","doi":"10.2165/00128071-200405010-00011","title":"Azelaic Acid","year":2004,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Essential Oils and Antimicrobial Activity","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Azelaic acid; Dermatology; Pharmacotherapy; Pharmacology; Internal medicine; Biochemistry; Chemistry","score_opus":0.031474940603011314,"score_gpt":0.3089048803974129,"score_spread":0.27742993979440156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016198078","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06448994,0.096257254,0.0049341694,0.36710024,0.042690564,0.00020532862,0.00037527212,0.0007581602,0.42318898],"genre_scores_gemma":[0.48787764,0.02369478,0.0033469195,0.1358006,0.011903643,0.00009545941,0.0005336491,0.000070774855,0.33667654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997818,0.000044069857,0.000018767467,0.000038868893,0.000058116646,0.0000584681],"domain_scores_gemma":[0.9998171,0.00006466708,0.000016818123,0.000017542437,0.00003851808,0.000045478195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015585643,0.00029830294,0.00041675463,0.00020884744,0.0006009664,0.0004576024,0.00032854386,0.002215658,0.013527096],"category_scores_gemma":[0.0011075299,0.00009330808,0.0002889955,0.00011056995,0.00026672112,0.0003923796,0.00037543554,0.0026874524,0.00492974],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036474597,0.00048988615,0.003945014,0.0010515508,0.00011771449,0.10110871,0.00025036072,0.00029851988,0.06472412,0.019372746,0.44006968,0.36492425],"study_design_scores_gemma":[0.00023561524,0.0003490533,0.0017721674,0.00013749793,0.000036611902,0.0520716,0.00008888631,0.00018643466,0.016844029,0.0028448068,0.9254164,0.000016959315],"about_ca_topic_score_codex":0.00062868994,"about_ca_topic_score_gemma":0.0010624394,"teacher_disagreement_score":0.013527096,"about_ca_system_score_codex":0.0007298712,"about_ca_system_score_gemma":0.0003418087,"threshold_uncertainty_score":0.04525262},"labels":[],"label_agreement":null},{"id":"W2020502963","doi":"10.2165/00128071-200405020-00001","title":"Fixed-Dose Combination Therapy for Psoriasis","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre","funders":"LEO Pharma","keywords":"Medicine; Psoriasis; Pharmacotherapy; Combination therapy; Fixed-dose combination; Dermatology; Pharmacology; Internal medicine","score_opus":0.0788575514855078,"score_gpt":0.4060985113205483,"score_spread":0.32724095983504053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020502963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005233275,0.9960169,0.00043671808,0.00025514446,0.000505342,0.000020135089,0.000029708339,0.000027914419,0.0021847077],"genre_scores_gemma":[0.0043591345,0.9899942,0.00084885216,0.0005646621,0.0007423037,0.000028954086,0.000083890154,0.000006624291,0.003371417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980193,0.000037771202,0.000029592384,0.00003559206,0.000078684345,0.000016511469],"domain_scores_gemma":[0.9997614,0.00009322701,0.000058403042,0.000010889206,0.00004890869,0.000027186268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004749788,0.0010612236,0.0018713769,0.0019806826,0.00025327443,0.0006791749,0.0011040337,0.0009389203,0.00595349],"category_scores_gemma":[0.0004436439,0.0002728769,0.00055130903,0.0015712662,0.00031629423,0.0007622681,0.00038067682,0.0016567869,0.0029057567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017608276,0.00016741731,0.00008172701,0.0043715895,0.00008844511,0.00023186691,0.000014925384,0.00014112586,0.0016291456,0.0003832867,0.023645982,0.9690684],"study_design_scores_gemma":[0.0003488612,0.00096696103,0.0022226395,0.0019135351,0.00054443016,0.0066284826,0.000040775252,0.00032668846,0.00176036,0.0008389921,0.98437446,0.000033860917],"about_ca_topic_score_codex":0.0005395632,"about_ca_topic_score_gemma":0.001819363,"teacher_disagreement_score":0.00595349,"about_ca_system_score_codex":0.00033889024,"about_ca_system_score_gemma":0.0003662902,"threshold_uncertainty_score":0.019916415},"labels":[],"label_agreement":null},{"id":"W2032390761","doi":"10.1007/s40257-014-0105-5","title":"Quality-of-Life Impairment in Patients with Hidradenitis Suppurativa: A Canadian Study","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Disease; Population; SF-36; Severity of illness; Adverse effect; Internal medicine; Prospective cohort study; Dermatology; Physical therapy; Surgery; Health related quality of life; Environmental health","score_opus":0.029863496921496216,"score_gpt":0.37528096420020396,"score_spread":0.34541746727870776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032390761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181455,0.001987504,0.0000702571,0.0005902749,0.00002794549,0.00011695393,0.00213404,0.0000035051178,0.0032550253],"genre_scores_gemma":[0.99558336,0.0018608565,0.0001809044,0.0003577244,0.00002699168,0.000057310735,0.0013608035,0.000005190415,0.00056695245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986112,0.00017128863,0.00009333473,0.00020483525,0.00043188053,0.0004874429],"domain_scores_gemma":[0.99631435,0.00026601995,0.0006707292,0.000099622106,0.0016582622,0.0009911148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016483613,0.0008192249,0.0011658514,0.0015005828,0.005451454,0.0018760052,0.0015234192,0.0010225776,0.0025213284],"category_scores_gemma":[0.0032914162,0.0006018787,0.0017887121,0.0067246673,0.0012869708,0.0010999962,0.0012521442,0.0019540929,0.0002609056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038788677,0.00032816056,0.99330527,0.000104725594,0.00021008324,0.00022447923,0.0010689241,0.000055295877,0.00014443134,0.00012275651,0.00080520735,0.0032427968],"study_design_scores_gemma":[0.00008656378,0.0001027446,0.99759823,0.000051747993,0.00009371745,0.00012276096,0.0012585452,0.00006975018,0.000017512859,0.00002252593,0.00055546704,0.000020370231],"about_ca_topic_score_codex":0.96447885,"about_ca_topic_score_gemma":0.9726644,"teacher_disagreement_score":0.03552115,"about_ca_system_score_codex":0.01804351,"about_ca_system_score_gemma":0.018364772,"threshold_uncertainty_score":0.13091546},"labels":[],"label_agreement":null},{"id":"W2032434473","doi":"10.2165/00128071-200708020-00005","title":"Placebo Response in Two Long-Term Randomized Psoriasis Studies that were Negative for Rosiglitazone","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rosiglitazone; Psoriasis; Placebo; Placebo response; Pharmacotherapy; Randomized controlled trial; Term (time); Internal medicine; Dermatology; Alternative medicine; Pathology; Receptor","score_opus":0.061996705573639385,"score_gpt":0.41234882713377624,"score_spread":0.35035212156013684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032434473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692713,0.019739194,0.0014244055,0.0018897384,0.0016812594,0.0022091488,0.001169002,0.00014660353,0.0024692253],"genre_scores_gemma":[0.9919968,0.002202509,0.001003343,0.001112173,0.00054913684,0.00082241645,0.0006890413,0.000029180088,0.0015953378],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9938433,0.003750621,0.0008398217,0.00069545687,0.000325735,0.00054501515],"domain_scores_gemma":[0.9904998,0.004632684,0.0018521767,0.0010625512,0.00083369546,0.0011190939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008903079,0.0020741394,0.006317492,0.0007200735,0.00091451436,0.0018060241,0.0010779682,0.0040524993,0.005980554],"category_scores_gemma":[0.011988538,0.0012362995,0.0068984623,0.0005839799,0.0019380843,0.0014432721,0.0007797936,0.0048922277,0.0008317319],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98217714,0.0016933427,0.0008620149,0.00059189653,0.0034380252,0.00005328979,0.00005387406,0.0000812759,0.0037794863,0.000050330582,0.00030580326,0.00691355],"study_design_scores_gemma":[0.8858479,0.09039765,0.0099236695,0.00010659582,0.009589765,0.0001007993,0.00008056541,0.0001882263,0.0019287989,0.00020658938,0.001575394,0.000054032862],"about_ca_topic_score_codex":0.0010041613,"about_ca_topic_score_gemma":0.0021193982,"teacher_disagreement_score":0.008903079,"about_ca_system_score_codex":0.0014049313,"about_ca_system_score_gemma":0.0010461679,"threshold_uncertainty_score":0.04708451},"labels":[],"label_agreement":null},{"id":"W2036513731","doi":"10.1007/s40257-014-0092-6","title":"Neutrophilic Dermatoses: An Update","year":2014,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Neutrophilic dermatosis; Dermatology; Sweet Syndrome; Vasculitis; Rheumatoid arthritis; Histopathology; Pathology; Immunology; Disease","score_opus":0.06273859119424635,"score_gpt":0.4598545913332222,"score_spread":0.39711600013897586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036513731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017518345,0.99819106,0.00010262433,0.0002990895,0.0006983268,0.000005625572,0.000032235654,0.000010028859,0.00048584465],"genre_scores_gemma":[0.001014337,0.9963278,0.00023670713,0.00063198933,0.0012894563,0.0000065146096,0.00006024992,0.0000022303561,0.00043068576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995925,0.000054745666,0.00011396774,0.00006471319,0.0001254077,0.000048841],"domain_scores_gemma":[0.99865425,0.00053651363,0.000339813,0.00003238725,0.00029111828,0.00014594241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077002053,0.001358698,0.002539254,0.0061575742,0.00036594988,0.001997624,0.0012848134,0.001713974,0.0047711516],"category_scores_gemma":[0.0013780332,0.000550354,0.00088871183,0.004027117,0.00062817155,0.0034731124,0.001341942,0.0022022778,0.0018500201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002166805,0.00016213152,0.0009247932,0.031276714,0.0002737093,0.0021291543,0.00010045167,0.00042298916,0.0015063764,0.0011743268,0.10011007,0.8617026],"study_design_scores_gemma":[0.00012613935,0.00020787842,0.0031525637,0.014227815,0.00094999163,0.01831099,0.0002081877,0.00021501558,0.00036098246,0.0010134504,0.96114916,0.00007776484],"about_ca_topic_score_codex":0.0010069271,"about_ca_topic_score_gemma":0.0033296929,"teacher_disagreement_score":0.0061575742,"about_ca_system_score_codex":0.0006338747,"about_ca_system_score_gemma":0.0015262383,"threshold_uncertainty_score":0.015961051},"labels":[],"label_agreement":null},{"id":"W2036643986","doi":"10.2165/00128071-200405040-00003","title":"Optimal Management of Fungal Infections of the Skin, Hair, and Nails","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Tinea capitis; Dermatology; Terbinafine; Seborrheic dermatitis; Pityriasis; Medicine; Itraconazole; Malassezia; Fluconazole; Scalp; Nail (fastener); Mycosis; Dermatophyte; Antifungal; Tinea versicolor; Skin infection; Trichophyton; Biology; Immunology","score_opus":0.046393686904856825,"score_gpt":0.44196638411290157,"score_spread":0.3955726972080447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036643986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001787686,0.9989354,0.00015235836,0.00015998493,0.0000892198,0.0000033385024,0.000006663446,0.000005220576,0.00046913794],"genre_scores_gemma":[0.0012562627,0.9976567,0.0004823926,0.00016945043,0.00018063796,0.000004752953,0.000020882184,9.602304e-7,0.00022789308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996877,0.000055478533,0.000049977247,0.00004169969,0.00014010225,0.000025056645],"domain_scores_gemma":[0.9996952,0.0001389462,0.000064779364,0.000008125676,0.00006923879,0.00002374477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000490954,0.0010509288,0.0019929924,0.0019404627,0.0002930262,0.0008552024,0.0011691209,0.0009987592,0.0018306761],"category_scores_gemma":[0.00081324915,0.00024939154,0.000563174,0.0012774185,0.00036247398,0.0009494939,0.00050420733,0.0015718042,0.0008503866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085748026,0.00012456565,0.0003594667,0.008995886,0.00009476554,0.00048416486,0.000031164083,0.00029985828,0.0013979165,0.00072975823,0.0130855795,0.9743111],"study_design_scores_gemma":[0.00015211233,0.0004789621,0.008683994,0.016403178,0.00066375785,0.015516782,0.00026899594,0.0005611583,0.0020850515,0.0041237506,0.95099026,0.00007189727],"about_ca_topic_score_codex":0.0010010364,"about_ca_topic_score_gemma":0.0023377358,"teacher_disagreement_score":0.0019929924,"about_ca_system_score_codex":0.0003733572,"about_ca_system_score_gemma":0.00065927336,"threshold_uncertainty_score":0.0061241984},"labels":[],"label_agreement":null},{"id":"W206428459","doi":"10.2165/00128071-200910020-00002","title":"Botulinum Toxin for Hyperhidrosis","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Allergan","keywords":"Medicine; Hyperhidrosis; Botulinum toxin; Anticholinergic; Adverse effect; Dermatology; Incidence (geometry); Population; Intensive care medicine; Surgery; Anesthesia; Internal medicine","score_opus":0.13655625956931386,"score_gpt":0.4944703802542588,"score_spread":0.357914120684945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W206428459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000203606,0.9984316,0.00007901611,0.00011156018,0.0001555128,0.000004679252,0.000012641298,0.000005869114,0.0009954954],"genre_scores_gemma":[0.0020378144,0.9961481,0.00019005552,0.00023906877,0.00026690785,0.000007040728,0.000029249653,0.0000015262974,0.0010802487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998332,0.000022502669,0.000033239157,0.000026126241,0.00006933016,0.000015519654],"domain_scores_gemma":[0.9996873,0.00013273062,0.00009348862,0.000008346452,0.000052746316,0.000025441563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003797044,0.00077722967,0.0014162685,0.0028925666,0.0002664032,0.0006192541,0.00075622345,0.0007975404,0.0038647803],"category_scores_gemma":[0.0006355621,0.00023280333,0.00044590584,0.0022694545,0.0003751488,0.0008570142,0.0004608804,0.0010078959,0.0015431871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009728587,0.000095238465,0.00025076588,0.01687611,0.0001542724,0.0008026245,0.00003432062,0.00015282708,0.0020953133,0.00064522313,0.02730091,0.9514952],"study_design_scores_gemma":[0.000117408694,0.00025717058,0.003467617,0.008015884,0.00074664963,0.0118439235,0.00009081228,0.00016248094,0.0012565873,0.0008528141,0.9731539,0.000034776353],"about_ca_topic_score_codex":0.0011149718,"about_ca_topic_score_gemma":0.0034744923,"teacher_disagreement_score":0.0038647803,"about_ca_system_score_codex":0.0004152982,"about_ca_system_score_gemma":0.0007147786,"threshold_uncertainty_score":0.012929022},"labels":[],"label_agreement":null},{"id":"W2065178330","doi":"10.1007/s40257-013-0033-9","title":"Barrier Repair Therapy in Atopic Dermatitis: An Overview","year":2013,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Filaggrin; Atopic dermatitis; Medicine; Moisturizer; Dermatology; Transepidermal water loss; Calcineurin; Stratum corneum; Atopy; Immunology; Allergy; Internal medicine; Transplantation; Pathology; Biology","score_opus":0.13413799665809717,"score_gpt":0.474881235003281,"score_spread":0.34074323834518383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065178330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006116201,0.9996026,0.000045010387,0.00004679478,0.000051594277,0.000003298164,0.000007834809,0.0000025879688,0.00017907917],"genre_scores_gemma":[0.00039555156,0.999196,0.000116496754,0.0000865278,0.00008148753,0.0000035169207,0.0000127184285,5.918046e-7,0.0001071208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997327,0.00003859892,0.000065418215,0.000055061035,0.00008528752,0.000022945895],"domain_scores_gemma":[0.9994435,0.0002939528,0.00011566765,0.00001025725,0.00009658238,0.000039992927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071290485,0.0011457163,0.0023808642,0.0038762803,0.0002712239,0.0011594334,0.0010917194,0.0012299628,0.0030309428],"category_scores_gemma":[0.0008406202,0.00043835133,0.0011265621,0.0028490438,0.00038871256,0.0016768276,0.00080269226,0.0019071348,0.0009821511],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018945015,0.0002079709,0.00037650796,0.057134025,0.00035083425,0.00037453274,0.000056871046,0.0003431292,0.0014940746,0.0009293014,0.017720237,0.92082316],"study_design_scores_gemma":[0.0002725938,0.0006825682,0.004253957,0.031814348,0.0025332747,0.006887826,0.00021674582,0.0004887965,0.0010466834,0.001746937,0.9499551,0.00010113085],"about_ca_topic_score_codex":0.0011999352,"about_ca_topic_score_gemma":0.0030336254,"teacher_disagreement_score":0.0038762803,"about_ca_system_score_codex":0.00047652953,"about_ca_system_score_gemma":0.00090965035,"threshold_uncertainty_score":0.010139585},"labels":[],"label_agreement":null},{"id":"W2065469937","doi":"10.2165/00128071-200607060-00004","title":"Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alethia Biotherapeutics (Canada); Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Retrospective cohort study; Antibody; Intravenous Immunoglobulins; Intravenous Immunoglobulin Therapy; Pediatrics; Internal medicine; Immunology","score_opus":0.0416261387925516,"score_gpt":0.364829249563414,"score_spread":0.3232031107708624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065469937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019036894,0.99615735,0.00024170507,0.00013839707,0.0001381597,0.0000070533206,0.000017608121,0.000013353779,0.0013827556],"genre_scores_gemma":[0.018851096,0.9791262,0.00045018626,0.0004320263,0.00031686036,0.000012197586,0.00006120451,0.000002578544,0.0007476622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982566,0.000036819845,0.00004191906,0.00002434321,0.000058683505,0.000012670011],"domain_scores_gemma":[0.9996055,0.00019702203,0.00011533477,0.000008698061,0.00004922034,0.000024291843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028991335,0.0004979178,0.0013580984,0.0010383452,0.00013363072,0.00043476664,0.00048737094,0.0006546483,0.0011471246],"category_scores_gemma":[0.0007782221,0.00012722633,0.00047613043,0.0008695799,0.00014942278,0.00042993083,0.0002308001,0.00068126136,0.00042640677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023364623,0.0001389469,0.00311377,0.009978232,0.00035642512,0.0022595646,0.000044357355,0.00019544656,0.002049942,0.00024064444,0.009399493,0.97198945],"study_design_scores_gemma":[0.0005383354,0.0014316224,0.052947253,0.015960604,0.00434377,0.08436481,0.00033883282,0.0009097381,0.004455122,0.0012619927,0.83334124,0.00010669589],"about_ca_topic_score_codex":0.00049849786,"about_ca_topic_score_gemma":0.0013025412,"teacher_disagreement_score":0.0013580984,"about_ca_system_score_codex":0.00016666803,"about_ca_system_score_gemma":0.00038347198,"threshold_uncertainty_score":0.0038375258},"labels":[],"label_agreement":null},{"id":"W2071154269","doi":"10.2165/00128071-200304120-00003","title":"Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Western University","funders":"","keywords":"Medicine; Psychosocial; Psychiatry; Biopsychosocial model; Comorbidity; Psychological intervention; Quality of life (healthcare); Depression (economics)","score_opus":0.06162790824897608,"score_gpt":0.4460504208589782,"score_spread":0.38442251261000215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071154269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020096009,0.9964755,0.000081502316,0.00020469133,0.00014618211,0.000005696889,0.00003432886,0.000005135712,0.0010373332],"genre_scores_gemma":[0.013283192,0.98565197,0.00023901036,0.00022791418,0.00021756996,0.000008446254,0.00005860011,8.653938e-7,0.00031244528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998462,0.000028615377,0.000033997163,0.000025283634,0.00005260574,0.000013273721],"domain_scores_gemma":[0.9995877,0.00019434863,0.00011854942,0.000007927469,0.000055442786,0.000036026046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025558914,0.0004608266,0.0011702535,0.0015642995,0.00022435455,0.000527311,0.00044622284,0.00048040642,0.001564047],"category_scores_gemma":[0.0008386844,0.0001520439,0.00045146508,0.001955088,0.00019306621,0.00046298583,0.00035765208,0.0006452153,0.00029259323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016196701,0.0001535545,0.019286284,0.012687792,0.00047388865,0.0012727148,0.00007493611,0.000153712,0.0005359834,0.00023328698,0.009307532,0.95565844],"study_design_scores_gemma":[0.00031219082,0.0008920637,0.4055521,0.03213551,0.00672976,0.0623243,0.0016033353,0.00077739503,0.0012014062,0.0015992792,0.48671162,0.00016110072],"about_ca_topic_score_codex":0.0019101767,"about_ca_topic_score_gemma":0.006427439,"teacher_disagreement_score":0.0019101767,"about_ca_system_score_codex":0.00022263786,"about_ca_system_score_gemma":0.00068248203,"threshold_uncertainty_score":0.0052322745},"labels":[],"label_agreement":null},{"id":"W2072507718","doi":"10.2165/00128071-200304070-00005","title":"Isotretinoin Use and Subsequent Depression and Suicide","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Isotretinoin; Medicine; Depression (economics); Acne; Psychiatry; Adverse effect; Dermatology; Internal medicine","score_opus":0.10421975516233965,"score_gpt":0.45094814125794763,"score_spread":0.34672838609560797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072507718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023273367,0.99662364,0.00004109347,0.0001365774,0.000093347364,0.000007621912,0.000030930594,0.0000032715348,0.0007362049],"genre_scores_gemma":[0.013938185,0.9851598,0.00011088982,0.00013725908,0.00011146704,0.000009408975,0.00004662787,4.2494403e-7,0.00048596968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998878,0.00002344496,0.000025333637,0.000015559373,0.000039645347,0.000008024777],"domain_scores_gemma":[0.9996598,0.00014731227,0.00011407655,0.000006948396,0.000054820302,0.000017059545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025428872,0.00033205296,0.000944215,0.00080022047,0.00018108575,0.0004066097,0.0003937272,0.0005025326,0.0018561824],"category_scores_gemma":[0.0007680349,0.00013310247,0.00044196477,0.001017537,0.00013015488,0.00025022277,0.00019237693,0.00046791663,0.00029680962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043061402,0.00017732347,0.007763344,0.016999757,0.0009622671,0.00071088324,0.00007694822,0.0001335342,0.0008118863,0.00026142856,0.01058449,0.96108747],"study_design_scores_gemma":[0.0007825076,0.0025062594,0.22034827,0.029760297,0.012041965,0.027517939,0.0009706258,0.0009518989,0.00302234,0.0019040602,0.70004505,0.00014880835],"about_ca_topic_score_codex":0.0026773086,"about_ca_topic_score_gemma":0.008722497,"teacher_disagreement_score":0.0026773086,"about_ca_system_score_codex":0.00021872453,"about_ca_system_score_gemma":0.00046689657,"threshold_uncertainty_score":0.0062095523},"labels":[],"label_agreement":null},{"id":"W2073969222","doi":"10.2165/00128071-200203080-00007","title":"Acne","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Acne; Dermatology; Pharmacotherapy; Internal medicine","score_opus":0.13474005083165275,"score_gpt":0.4998010469784984,"score_spread":0.3650609961468457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073969222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011546714,0.96400595,0.00074411544,0.00037644323,0.0015455808,0.000058398684,0.00012079677,0.00010526932,0.031888753],"genre_scores_gemma":[0.018474873,0.90956414,0.0014097278,0.0018209715,0.0015224525,0.000056729878,0.0004873801,0.000024957466,0.066638835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998258,0.00002094921,0.00002320791,0.00003104516,0.00007124596,0.000027739592],"domain_scores_gemma":[0.999871,0.000027920745,0.000028856814,0.000011572545,0.000043988002,0.000016702284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020067766,0.00075219787,0.0009291304,0.0017776408,0.00040875503,0.00084117305,0.00048224142,0.00075907423,0.028307365],"category_scores_gemma":[0.00055469136,0.0001614919,0.00037195787,0.0010663114,0.0002538239,0.0008715533,0.0007002252,0.0007828645,0.010221087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009910827,0.000070098766,0.00026074002,0.004659902,0.000022384193,0.0006138299,0.00002726195,0.000047311652,0.0022515114,0.0007143047,0.042799074,0.9484346],"study_design_scores_gemma":[0.00004229683,0.000116754214,0.0015942903,0.0019712378,0.0000954459,0.010783048,0.00006271123,0.000054000688,0.0013848376,0.0005103035,0.9833756,0.000009426032],"about_ca_topic_score_codex":0.00067211135,"about_ca_topic_score_gemma":0.0017681598,"teacher_disagreement_score":0.028307365,"about_ca_system_score_codex":0.00020926126,"about_ca_system_score_gemma":0.0004097719,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2079167414","doi":"10.1007/s40257-014-0096-2","title":"Topical Therapy for Toenail Onychomycosis: An Evidence-Based Review","year":2014,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dermatology; Pharmacotherapy; Terbinafine; MEDLINE; Itraconazole; Antifungal; Internal medicine","score_opus":0.23906717294927118,"score_gpt":0.5481755244134014,"score_spread":0.3091083514641303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079167414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012802122,0.9996506,0.000027147607,0.000035779656,0.000036069327,0.000011364696,0.000021999946,0.0000015333433,0.00008751278],"genre_scores_gemma":[0.001238612,0.99845004,0.00011936838,0.00009646973,0.000027579928,0.0000071893664,0.000019720357,4.4090086e-7,0.000040597326],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993243,0.00013563318,0.00023269176,0.00009068992,0.00018116919,0.000035521458],"domain_scores_gemma":[0.9980876,0.0012199242,0.00044472897,0.000022126089,0.00018244905,0.00004324252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001320845,0.0011424795,0.004396555,0.003367765,0.00030640254,0.001435293,0.0016195864,0.0015661482,0.0037622827],"category_scores_gemma":[0.0030769696,0.00048273584,0.003283749,0.0030861264,0.00045426507,0.0013875656,0.000660158,0.0011840352,0.0003801711],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005003267,0.00012476383,0.0004946114,0.61530185,0.0047523375,0.00032042092,0.00009315426,0.00030940733,0.0008619239,0.00050900603,0.0085173035,0.36821485],"study_design_scores_gemma":[0.001263941,0.0011737058,0.008552579,0.56622314,0.09208777,0.005021733,0.0005996038,0.0005428931,0.0011893352,0.001730961,0.32145038,0.0001639754],"about_ca_topic_score_codex":0.0027599419,"about_ca_topic_score_gemma":0.007537326,"teacher_disagreement_score":0.004396555,"about_ca_system_score_codex":0.0006312236,"about_ca_system_score_gemma":0.0017524494,"threshold_uncertainty_score":0.012586057},"labels":[],"label_agreement":null},{"id":"W2080670285","doi":"10.1007/s40257-014-0090-8","title":"Isotretinoin Use and Celiac Disease: A Population-Based Cross-Sectional Study","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Isotretinoin; Cross-sectional study; Pharmacotherapy; Dermatology; Population; Disease; Internal medicine; Acne; Environmental health; Pathology","score_opus":0.03873147865122249,"score_gpt":0.40728961119893337,"score_spread":0.36855813254771086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080670285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992473,0.00013046667,0.00007015732,0.000028190327,0.0000068688805,0.000014360677,0.00024074611,0.000002939671,0.0002590246],"genre_scores_gemma":[0.9992304,0.00010610509,0.00011212244,0.000081067425,0.000009936477,0.000015693337,0.000253203,0.0000025498257,0.00018908894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919206,0.00028021744,0.0000874006,0.00022038634,0.00010963944,0.000110330344],"domain_scores_gemma":[0.9985922,0.00025151472,0.00039520545,0.00019257526,0.0002041079,0.00036426686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000979948,0.00055246183,0.0006789102,0.000832912,0.00106445,0.0010752974,0.0004924531,0.00145095,0.001630864],"category_scores_gemma":[0.0015842506,0.0013144015,0.00092359236,0.0017287387,0.0006219729,0.0012248281,0.0005708541,0.0012256689,0.00053605175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002144626,0.00022473282,0.99844414,0.00000888516,0.00016210672,0.0001027093,0.00014673642,0.000016006852,0.00034192856,0.000008052199,0.000044345248,0.00028575456],"study_design_scores_gemma":[0.000029225595,0.00043954566,0.9983747,0.0000047372114,0.000115134986,0.00030689168,0.00049899396,0.00008684531,0.00003388764,0.000010942262,0.00009218322,0.0000067641295],"about_ca_topic_score_codex":0.011673717,"about_ca_topic_score_gemma":0.013375502,"teacher_disagreement_score":0.011673717,"about_ca_system_score_codex":0.0004985877,"about_ca_system_score_gemma":0.00042813373,"threshold_uncertainty_score":0.023211539},"labels":[],"label_agreement":null},{"id":"W2083686968","doi":"10.2165/00128071-200001030-00002","title":"Management of Androgenetic Alopecia","year":2000,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Minoxidil; Medicine; Finasteride; Hair loss; Hair transplantation; Dermatology; Psychosocial; Adverse effect; Hair growth; Male-pattern baldness; Internal medicine; Scalp; Physiology; Psychiatry","score_opus":0.06373997544627455,"score_gpt":0.451548055582704,"score_spread":0.3878080801364294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083686968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021661828,0.9984452,0.00017938002,0.00012510653,0.00017344789,0.000005467603,0.0000100632915,0.000011664286,0.0008330375],"genre_scores_gemma":[0.002622092,0.9951794,0.00049313105,0.0004422951,0.0004277452,0.000009002273,0.000040470015,0.0000032148407,0.0007826515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976045,0.000041643827,0.000042462663,0.000044617096,0.00009039311,0.000020471874],"domain_scores_gemma":[0.99967134,0.00016141776,0.000066897344,0.00000894475,0.00006304739,0.000028438017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045480512,0.0009664973,0.0017961345,0.002484762,0.00027779274,0.0007812246,0.001083914,0.000911227,0.0026020724],"category_scores_gemma":[0.00082514045,0.0002455607,0.00060056016,0.001580134,0.00031932778,0.0009289565,0.000455056,0.0015053564,0.001139216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008831567,0.00008984462,0.0002722502,0.009557018,0.000120317374,0.0007327445,0.000030275301,0.00024388204,0.0008571207,0.00034579012,0.015778363,0.971884],"study_design_scores_gemma":[0.00020973371,0.00042493446,0.006014217,0.009628044,0.0009163868,0.020952253,0.00015831094,0.00039476957,0.0010290252,0.0012200635,0.95899475,0.000057447203],"about_ca_topic_score_codex":0.0009198004,"about_ca_topic_score_gemma":0.002248076,"teacher_disagreement_score":0.0026020724,"about_ca_system_score_codex":0.00036054314,"about_ca_system_score_gemma":0.00047288847,"threshold_uncertainty_score":0.0087047815},"labels":[],"label_agreement":null},{"id":"W2088380888","doi":"10.1007/s40257-013-0019-7","title":"Psychiatric Comorbidities and Alexithymia in Patients with Seborrheic Dermatitis: A Questionnaire Study in Turkey","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Yeditepe Üniversitesi","keywords":"Alexithymia; Toronto Alexithymia Scale; Medicine; Anxiety; Seborrheic dermatitis; Depression (economics); Psychiatry; Internal medicine; Hospital Anxiety and Depression Scale; Clinical psychology; Dermatology","score_opus":0.011634153830529669,"score_gpt":0.3170101317609963,"score_spread":0.3053759779304666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088380888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954695,0.00014527488,0.000015096598,0.000024807945,0.00000594948,0.0000048907546,0.00004538191,6.114023e-7,0.00021095684],"genre_scores_gemma":[0.99956614,0.0001525235,0.000023888673,0.000037187623,0.000008490121,0.0000055243904,0.00008670658,6.987371e-7,0.00011891781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997516,0.00004266985,0.000042114934,0.000054381566,0.00004034306,0.00006881002],"domain_scores_gemma":[0.99960965,0.000059024725,0.00014598065,0.000012268202,0.000045549703,0.00012757696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017653174,0.00037464377,0.0004188484,0.0008938398,0.00072004367,0.00064793095,0.0002796673,0.00047363233,0.0015282066],"category_scores_gemma":[0.0006169766,0.0003164728,0.0005945046,0.00097131054,0.0003577058,0.00038972718,0.00041259296,0.0004772191,0.00019020954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010421412,0.0002362636,0.9962513,0.00002181888,0.00005924813,0.0010571377,0.00043512674,0.000025432872,0.0003183956,0.00001881522,0.00012475724,0.0013476359],"study_design_scores_gemma":[0.000009796278,0.00015138093,0.99674124,0.0000069698067,0.000030008789,0.0015423303,0.0012693797,0.000049975337,0.000022633058,0.000009422021,0.00016039226,0.0000065955455],"about_ca_topic_score_codex":0.0075420393,"about_ca_topic_score_gemma":0.008886121,"teacher_disagreement_score":0.0075420393,"about_ca_system_score_codex":0.00038914414,"about_ca_system_score_gemma":0.0003741106,"threshold_uncertainty_score":0.01499629},"labels":[],"label_agreement":null},{"id":"W2095814285","doi":"10.1007/s40257-015-0140-x","title":"Reply to Frane: Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Women's College Hospital; SickKids Foundation; University of Toronto","funders":"University of Toronto","keywords":"Epidermolysis bullosa; Medicine; Heuristics; MEDLINE; Statistics; Computer science; Pathology; Biology; Mathematics","score_opus":0.10501032219478432,"score_gpt":0.42271207310579456,"score_spread":0.31770175091101027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095814285","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007148502,0.28933725,0.00033572566,0.6297223,0.078125454,0.00006904322,0.0011186529,0.00005078301,0.0005259702],"genre_scores_gemma":[0.0062597212,0.2477254,0.00068102055,0.6662261,0.07600432,0.00017341867,0.0006303329,0.000038458384,0.0022612163],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99711007,0.0008265358,0.0010495159,0.0003558295,0.00046331744,0.00019476977],"domain_scores_gemma":[0.98146963,0.010231677,0.0030095957,0.00031838813,0.0040614526,0.00090923696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070693525,0.0010531287,0.0039224694,0.0030929071,0.00073297817,0.0022119125,0.0016365662,0.0072256834,0.0056466507],"category_scores_gemma":[0.0325917,0.0006206417,0.0019004073,0.002319174,0.0013796837,0.0034331603,0.0026381034,0.005922133,0.0018219904],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002224614,0.000020205265,0.0010845631,0.018366829,0.0008057468,0.0005630929,0.00023042406,0.00009167584,0.00024915277,0.00081219996,0.93775284,0.039800808],"study_design_scores_gemma":[0.00093107345,0.00017843033,0.00470487,0.038503185,0.0035447208,0.0029464625,0.0008818225,0.00022726912,0.00030539907,0.003768468,0.94383126,0.00017714192],"about_ca_topic_score_codex":0.0028919862,"about_ca_topic_score_gemma":0.0063982136,"teacher_disagreement_score":0.0072256834,"about_ca_system_score_codex":0.0014750087,"about_ca_system_score_gemma":0.005152623,"threshold_uncertainty_score":0.037386715},"labels":[],"label_agreement":null},{"id":"W2176024536","doi":"10.2165/00128071-200607030-00003","title":"Hydroxychloroquine-Induced Retinopathy","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hydroxychloroquine; Medicine; Maculopathy; Chloroquine; Retinopathy; Adverse effect; Ophthalmology; Pharmacotherapy; Drug; Retinal; Dermatology; Pharmacology; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Pathology; Endocrinology","score_opus":0.10989843420129636,"score_gpt":0.47732079610149536,"score_spread":0.367422361900199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176024536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027790235,0.99770653,0.00015295793,0.00012751223,0.00017659158,0.00000917191,0.000020499003,0.000012558461,0.0015161954],"genre_scores_gemma":[0.0018541607,0.9965743,0.0002242219,0.00018491666,0.00020906738,0.000005711592,0.00003187503,0.0000014394788,0.0009142728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979216,0.000028887882,0.000054373817,0.000032202643,0.000076093245,0.000016347356],"domain_scores_gemma":[0.9995252,0.00016840857,0.00015738672,0.000016401527,0.000099407036,0.00003320168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039266062,0.0007789402,0.0013298227,0.002689251,0.00023007634,0.0007619449,0.00064445595,0.0006854163,0.003845929],"category_scores_gemma":[0.00060697895,0.00022030326,0.0004914091,0.0019073698,0.00029483877,0.000807846,0.00046523436,0.00074501237,0.0011317299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007069035,0.00010949718,0.00034728512,0.015865231,0.000093714014,0.00051661406,0.000029482824,0.00014392364,0.0016764505,0.00045705025,0.0180745,0.9626156],"study_design_scores_gemma":[0.00007025784,0.00034697543,0.004824182,0.0066716466,0.00073731435,0.008553278,0.00010851621,0.00020440338,0.0019722413,0.0007918572,0.9756867,0.000032505195],"about_ca_topic_score_codex":0.0010749681,"about_ca_topic_score_gemma":0.0027845243,"teacher_disagreement_score":0.003845929,"about_ca_system_score_codex":0.00036030568,"about_ca_system_score_gemma":0.0006012325,"threshold_uncertainty_score":0.012865901},"labels":[],"label_agreement":null},{"id":"W2209243252","doi":"10.2165/00128071-200304090-00005","title":"Drug Interactions of Clinical Significance for the Dermatologist","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Drug; Medicine; Drug interaction; Pharmacogenetics; Intensive care medicine; Pharmacotherapy; Clinical Practice; Pharmacology; Psychiatry; Family medicine; Biology","score_opus":0.4406664389583803,"score_gpt":0.636099180920618,"score_spread":0.1954327419622377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209243252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024267336,0.9954881,0.00032460777,0.0007018511,0.00031976355,0.0000061803025,0.000023714554,0.000019796686,0.002873298],"genre_scores_gemma":[0.0021596183,0.99284875,0.000623211,0.00091405504,0.0005872117,0.000007898769,0.00005360063,0.000003420015,0.0028022104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997106,0.00006515416,0.00003553668,0.000046984354,0.00012182665,0.000019853906],"domain_scores_gemma":[0.99913317,0.00046117103,0.00015995848,0.00002361202,0.00016063295,0.00006140634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005306028,0.0009489449,0.0016853429,0.0018600294,0.00027466356,0.00087533135,0.000729341,0.0016070902,0.0058080642],"category_scores_gemma":[0.0009978637,0.00023223954,0.0006188992,0.0016574804,0.00032257856,0.0007125614,0.0004757532,0.0013837868,0.0030841378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008769692,0.00008373375,0.00049755047,0.0032974454,0.00007666911,0.0008646696,0.000019878004,0.0001936225,0.0011006978,0.00054957916,0.03283887,0.9603897],"study_design_scores_gemma":[0.00007005647,0.00020332038,0.0030593695,0.0029114275,0.0002776657,0.010652887,0.00007775043,0.0002073129,0.0010329292,0.0014208059,0.98006094,0.000025711015],"about_ca_topic_score_codex":0.0010472154,"about_ca_topic_score_gemma":0.0036273357,"teacher_disagreement_score":0.0058080642,"about_ca_system_score_codex":0.00044795102,"about_ca_system_score_gemma":0.0008445864,"threshold_uncertainty_score":0.019429862},"labels":[],"label_agreement":null},{"id":"W2220339981","doi":"10.2165/00128071-200304090-00003","title":"Botulinum Toxin A","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Botulinum toxin; Clostridium botulinum; Tolerability; Blepharospasm; Flaccid paralysis; Anesthesia; Dermatology; Surgery; Paralysis; Toxin; Adverse effect; Pharmacology; Microbiology","score_opus":0.10821853953778518,"score_gpt":0.46736001827310353,"score_spread":0.3591414787353183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220339981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031303286,0.9932528,0.00026142504,0.00022075353,0.00042440556,0.0000132328005,0.000032672568,0.000017299395,0.0054643904],"genre_scores_gemma":[0.0029505724,0.99064094,0.0004068281,0.0006862901,0.0003684236,0.000017914346,0.00008292062,0.0000033691208,0.004842648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997712,0.000030358662,0.000039708644,0.000042771073,0.00008751465,0.00002849116],"domain_scores_gemma":[0.9997615,0.00008009219,0.00006957097,0.000011950106,0.00005190177,0.000025037381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035919348,0.0012906535,0.0012847822,0.0036659825,0.00036243006,0.0008183484,0.00079484517,0.0010570155,0.006252721],"category_scores_gemma":[0.00074013456,0.00023804481,0.00045300042,0.0025962032,0.00040622128,0.0010342667,0.00080081506,0.0009338657,0.0044631585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007292477,0.00007511741,0.0002493745,0.0067946045,0.0000638245,0.0010579396,0.00002845146,0.00009390706,0.0025800124,0.0007830061,0.034180723,0.9540201],"study_design_scores_gemma":[0.000038005746,0.00010022362,0.001732962,0.0031349363,0.00020333631,0.010959981,0.000039508042,0.000059515,0.001136522,0.0005146489,0.98206526,0.000015116199],"about_ca_topic_score_codex":0.0015875152,"about_ca_topic_score_gemma":0.0030566438,"teacher_disagreement_score":0.006252721,"about_ca_system_score_codex":0.00062850723,"about_ca_system_score_gemma":0.0011416494,"threshold_uncertainty_score":0.020917475},"labels":[],"label_agreement":null},{"id":"W2224097706","doi":"10.1007/s40257-015-0161-5","title":"Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Adalimumab; Psoriasis; Placebo; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Post-hoc analysis; Clinical trial; Discontinuation; Population; Dermatology; Rheumatoid arthritis","score_opus":0.11885768880016609,"score_gpt":0.3976571667334317,"score_spread":0.27879947793326565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224097706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7697896,0.20049909,0.012161929,0.00040149712,0.0013571578,0.008218883,0.004565458,0.0003795481,0.002626909],"genre_scores_gemma":[0.97856766,0.0093693165,0.004632565,0.0004066538,0.00048787563,0.00415443,0.0019145795,0.000075727665,0.00039130435],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95698434,0.02599631,0.008063119,0.004407561,0.0036507568,0.00089791266],"domain_scores_gemma":[0.96987826,0.018771602,0.0060390416,0.0029135954,0.0018939889,0.0005035576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04743768,0.002569973,0.01438089,0.0027105424,0.0005787442,0.0024044218,0.0010304438,0.0016927288,0.00239708],"category_scores_gemma":[0.030915927,0.0009994427,0.021493793,0.0020848736,0.0010552809,0.0012651074,0.0011042726,0.0011911121,0.00025665725],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50951546,0.0006546879,0.022249486,0.014035667,0.41649076,0.00014025452,0.00016189986,0.0011465611,0.004910419,0.0000804983,0.0005577314,0.030056564],"study_design_scores_gemma":[0.19033521,0.06323741,0.14606094,0.0012982073,0.5882135,0.00037601075,0.00017199732,0.0024096367,0.0037510083,0.00059841253,0.0033285236,0.00021919234],"about_ca_topic_score_codex":0.00046173896,"about_ca_topic_score_gemma":0.00086728204,"teacher_disagreement_score":0.04743768,"about_ca_system_score_codex":0.0009296285,"about_ca_system_score_gemma":0.0012231877,"threshold_uncertainty_score":0.25087744},"labels":[],"label_agreement":null},{"id":"W2224929295","doi":"10.2165/11539770-000000000-00000","title":"Pseudomonas Skin Infection","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pseudomonas aeruginosa; Medicine; Intensive care medicine; Antimicrobial; Disease; Skin infection; Pharmacotherapy; Antibiotics; Dermatology; Microbiology; Internal medicine; Bacteria; Staphylococcus aureus; Biology","score_opus":0.14117046303926725,"score_gpt":0.48883982594412767,"score_spread":0.3476693629048604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224929295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026964847,0.99602544,0.00014451864,0.00019040145,0.00038941967,0.0000092893115,0.000018997875,0.00001115848,0.0029411104],"genre_scores_gemma":[0.0037129854,0.9935675,0.00024162378,0.0004588291,0.00054655486,0.000008722883,0.000051770734,0.0000020670961,0.0014098765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997019,0.00004942147,0.000057341284,0.000043609638,0.00011252916,0.000035250952],"domain_scores_gemma":[0.9996012,0.00013876458,0.00012251994,0.000015630845,0.000081328544,0.000040589865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002511116,0.0010304383,0.0012384446,0.0029909073,0.0003814597,0.00092225353,0.0004947556,0.00078096555,0.0054698014],"category_scores_gemma":[0.00082523824,0.0002149609,0.00047453665,0.0019633577,0.0003637674,0.001085145,0.00069104804,0.0011064954,0.0019398318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064611726,0.00007662668,0.00045468396,0.012767528,0.00007187964,0.0011458766,0.000030693747,0.000070666705,0.0013355273,0.0005097736,0.031748902,0.9517231],"study_design_scores_gemma":[0.00007117551,0.0002889222,0.0052868593,0.013590544,0.0006896656,0.038716607,0.00018872127,0.00015744827,0.001626925,0.0011319353,0.9382079,0.00004338437],"about_ca_topic_score_codex":0.0007803455,"about_ca_topic_score_gemma":0.0021151467,"teacher_disagreement_score":0.0054698014,"about_ca_system_score_codex":0.00028289933,"about_ca_system_score_gemma":0.0008324974,"threshold_uncertainty_score":0.018298328},"labels":[],"label_agreement":null},{"id":"W2229458843","doi":"10.1007/s40257-013-0010-3","title":"Health Status, Coping Strategies, and Alexithymia in Subjects with Androgenetic Alopecia","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Forskningsrådet om Hälsa, Arbetsliv och Välfärd; Ministero della Salute","keywords":"Alexithymia; Medicine; Coping (psychology); Anxiety; General Health Questionnaire; Toronto Alexithymia Scale; Clinical psychology; Logistic regression; Psychiatry; Internal medicine","score_opus":0.022180066614334307,"score_gpt":0.35015424731431666,"score_spread":0.32797418069998235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2229458843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990533,0.00024211453,0.0000101807145,0.00004096416,0.000005413706,0.0000069932667,0.000038882525,0.0000012448508,0.0006009071],"genre_scores_gemma":[0.9996655,0.00009384164,0.000015751564,0.00002346303,0.000007952506,0.0000039783185,0.00004363534,2.9905846e-7,0.00014560643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984837,0.000041091407,0.000018085402,0.000019203584,0.000036368117,0.00003687818],"domain_scores_gemma":[0.99957365,0.00010101492,0.00015411223,0.000013016292,0.00003248236,0.00012574927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024913962,0.000248192,0.000325162,0.000745927,0.0005460279,0.0005102669,0.00018760806,0.00047372087,0.0015780132],"category_scores_gemma":[0.0012292571,0.00016835536,0.00033369684,0.0007129904,0.00026154018,0.0003084998,0.00029080696,0.0005164261,0.0001317806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021552334,0.0003807425,0.99587786,0.000017090804,0.000068682246,0.00033731884,0.00024075946,0.00004668208,0.00035593653,0.000018065435,0.00005843123,0.0023829644],"study_design_scores_gemma":[0.000009462411,0.00015106195,0.9992723,0.0000028918728,0.000015968482,0.00018459387,0.00023902897,0.000064141044,0.000012280072,0.000013608054,0.00003238245,0.000002222899],"about_ca_topic_score_codex":0.0063407538,"about_ca_topic_score_gemma":0.008094687,"teacher_disagreement_score":0.0063407538,"about_ca_system_score_codex":0.0002627421,"about_ca_system_score_gemma":0.0002250429,"threshold_uncertainty_score":0.012607694},"labels":[],"label_agreement":null},{"id":"W2247667909","doi":"10.2165/11589040-000000000-00000","title":"Pediatric Psychocutaneous Disorders","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Psychopathology; Psychiatry; Psychogenic disease; Psychosis; Eating disorders; Comorbidity; Body dysmorphic disorder; Anxiety; Dermatology","score_opus":0.053594653762756364,"score_gpt":0.44185717270717356,"score_spread":0.3882625189444172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247667909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006658234,0.99537164,0.00023929878,0.0002123222,0.0002786184,0.000007161488,0.000021714088,0.000016858809,0.0031866683],"genre_scores_gemma":[0.0052448427,0.991732,0.0004606849,0.0003566714,0.0004412157,0.000008087716,0.00006473157,0.0000029998757,0.0016888253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998357,0.000019509489,0.000030268253,0.000033601948,0.00005461546,0.000026275105],"domain_scores_gemma":[0.9996909,0.00012020154,0.00008732855,0.000011303262,0.000052971132,0.00003738914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022607583,0.00079533196,0.0007881637,0.0028370665,0.00027596366,0.00066062185,0.0005151832,0.0005387828,0.004223879],"category_scores_gemma":[0.00067563646,0.00021496377,0.00033052213,0.0019562887,0.00031560447,0.0008350075,0.00072922633,0.0009744081,0.0011572861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003334753,0.00006073682,0.0009291147,0.004053058,0.00005226886,0.0012994815,0.000034184475,0.00013611664,0.0008727959,0.00053282495,0.02073254,0.9712635],"study_design_scores_gemma":[0.000042182368,0.0001013552,0.008689297,0.007323912,0.00051838986,0.04730644,0.00020623641,0.00017119087,0.0012035889,0.0010636136,0.9333417,0.000032073644],"about_ca_topic_score_codex":0.0009239999,"about_ca_topic_score_gemma":0.002528766,"teacher_disagreement_score":0.004223879,"about_ca_system_score_codex":0.00032883717,"about_ca_system_score_gemma":0.000805304,"threshold_uncertainty_score":0.014130294},"labels":[],"label_agreement":null},{"id":"W2308193643","doi":"10.1007/s40257-016-0187-3","title":"Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bozok Üniversitesi","keywords":"Psoriasis; Medicine; Montreal Cognitive Assessment; Odds ratio; Internal medicine; Cognition; Cross-sectional study; Beck Depression Inventory; Physical therapy; Psychiatry; Dementia; Disease; Dermatology; Pathology; Anxiety","score_opus":0.03376329744548311,"score_gpt":0.3681341402364533,"score_spread":0.3343708427909702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308193643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888057,0.0002980821,0.000055018823,0.000053021908,0.000010686085,0.000018903886,0.00026141194,0.000005443805,0.00041684686],"genre_scores_gemma":[0.999148,0.00015860998,0.000076846736,0.00006901043,0.000013660631,0.0000129865875,0.0003015997,0.000002206845,0.00021698173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994043,0.00012298321,0.00007493619,0.00012474254,0.00015950021,0.00011354622],"domain_scores_gemma":[0.99866295,0.0001355023,0.00057996303,0.00008636049,0.00023268838,0.00030248772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008485088,0.00081244676,0.0009687509,0.0012870039,0.0010390427,0.0012999505,0.00061588176,0.0012065,0.00091984635],"category_scores_gemma":[0.002375365,0.0005739333,0.0012224261,0.0018947555,0.00042505292,0.00091529486,0.0006369426,0.001663705,0.00031725795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021246527,0.00028460752,0.99799913,0.000009741689,0.00020170574,0.00009394477,0.00011978363,0.000031945085,0.00012767778,0.000007897461,0.00006981842,0.00084123854],"study_design_scores_gemma":[0.000011217656,0.00017259347,0.99936527,0.0000024578785,0.000055471377,0.00013583951,0.0001222435,0.00006045366,0.000015962034,0.000009539286,0.000043640543,0.000005344119],"about_ca_topic_score_codex":0.035943985,"about_ca_topic_score_gemma":0.035276216,"teacher_disagreement_score":0.035943985,"about_ca_system_score_codex":0.00081738975,"about_ca_system_score_gemma":0.00057729665,"threshold_uncertainty_score":0.071469545},"labels":[],"label_agreement":null},{"id":"W2327510397","doi":"10.2165/11310950-000000000-00000","title":"The Authorsʼ Reply","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Ipsen; Allergan; University of Toronto","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Medical physics; Internal medicine","score_opus":0.0320205664539577,"score_gpt":0.3980484929112934,"score_spread":0.36602792645733573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327510397","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006747087,0.0015323784,0.00010438604,0.9313055,0.06475998,0.0000148849895,0.000041951447,0.000032941385,0.001533143],"genre_scores_gemma":[0.0049636546,0.00065747544,0.00014729434,0.955401,0.034333907,0.000029404584,0.000015802247,0.00002221101,0.0044292854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996027,0.000947322,0.00051000435,0.00083573855,0.0010687524,0.00061127497],"domain_scores_gemma":[0.9801415,0.0094488505,0.002004243,0.0009069491,0.0053814263,0.002117076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039963243,0.00067882193,0.0018756925,0.0009744053,0.0039986274,0.0040821526,0.0030481117,0.05249411,0.009127759],"category_scores_gemma":[0.046145894,0.0010698737,0.0016145448,0.00068232504,0.0033807375,0.0033404373,0.0031276974,0.056579445,0.0065218783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050410796,0.00001925599,0.0008068459,0.00006657678,0.00004373935,0.002267132,0.00039152196,0.00003759716,0.00025992538,0.002446716,0.9901427,0.003467434],"study_design_scores_gemma":[0.0000862224,0.000056303557,0.0020968225,0.00027342633,0.0000823517,0.003663449,0.0012031563,0.00023571093,0.0005283898,0.0045614974,0.987079,0.00013366835],"about_ca_topic_score_codex":0.003894349,"about_ca_topic_score_gemma":0.004837339,"teacher_disagreement_score":0.05249411,"about_ca_system_score_codex":0.0031694302,"about_ca_system_score_gemma":0.0043437574,"threshold_uncertainty_score":0.0305354},"labels":[],"label_agreement":null},{"id":"W2328064285","doi":"10.1007/s40257-016-0186-4","title":"Radiodermatitis: A Review of Our Current Understanding","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":388,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radiodermatitis; Medicine; Erythema; Desquamation; Radiation therapy; Dermatology; Ionizing radiation; Surgery; Irradiation","score_opus":0.1577204286299851,"score_gpt":0.517902556431205,"score_spread":0.3601821278012199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328064285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007638472,0.9995042,0.000032604832,0.00012739866,0.00008698363,0.000002463858,0.000013950973,0.0000021989601,0.00015371316],"genre_scores_gemma":[0.0005384709,0.99892753,0.000102839025,0.00015516224,0.00017826684,0.0000026060752,0.000014273829,5.5541705e-7,0.00008018802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995635,0.00007120554,0.00012590725,0.00008594624,0.00012381274,0.000029520925],"domain_scores_gemma":[0.99876523,0.00068736874,0.00029254504,0.0000193772,0.00017586959,0.000059602706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008972398,0.0009869364,0.0021019052,0.004018692,0.00034524134,0.0014519603,0.0009900744,0.0011036005,0.0033216355],"category_scores_gemma":[0.001668729,0.00040403637,0.00092243985,0.0035954488,0.00054252514,0.00212264,0.0010065857,0.0013093224,0.00060246635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017056744,0.000108243636,0.001154569,0.09576209,0.00035707274,0.0007824948,0.00023620565,0.00037798402,0.0014078943,0.0019234725,0.036738083,0.8609813],"study_design_scores_gemma":[0.00005768052,0.00023175831,0.004755776,0.04151431,0.0013431377,0.009233206,0.0005826912,0.00022801557,0.00052104366,0.0022572833,0.9391842,0.000090875656],"about_ca_topic_score_codex":0.0013877188,"about_ca_topic_score_gemma":0.0033212358,"teacher_disagreement_score":0.004018692,"about_ca_system_score_codex":0.00059456495,"about_ca_system_score_gemma":0.0015378447,"threshold_uncertainty_score":0.011112034},"labels":[],"label_agreement":null},{"id":"W2329343309","doi":"10.2165/11539080-000000000-00000","title":"A Systematic Approach to Systemic Contact Dermatitis and Symmetric Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Intertriginous; Medicine; Dermatology; Contact dermatitis; Erythema; Erythroderma; Buttocks; Allergic contact dermatitis; Allergy; Immunology; Surgery; Pathology","score_opus":0.04973093199240814,"score_gpt":0.365835247372309,"score_spread":0.31610431537990086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329343309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004035644,0.99874264,0.0001398284,0.0001795336,0.00011537255,0.00013756184,0.000079033256,0.0000044104586,0.0001980815],"genre_scores_gemma":[0.004771483,0.9933296,0.0009913737,0.00043156286,0.00009035237,0.00013965397,0.00008077529,0.0000017345908,0.00016351904],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975216,0.00064220483,0.0010673268,0.00022009702,0.00046509784,0.00008365628],"domain_scores_gemma":[0.9940731,0.003253463,0.0017777557,0.00011440421,0.00063375564,0.00014751549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026424783,0.0014058079,0.005058275,0.01432521,0.00047255386,0.0015175577,0.0010179174,0.0013417732,0.0035530934],"category_scores_gemma":[0.009012908,0.0007007065,0.00433048,0.007885263,0.0005749232,0.0019525943,0.0015607412,0.0009792546,0.0002529513],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002777585,0.00007684588,0.0008601256,0.72161126,0.0059827403,0.0003263812,0.0002150158,0.00018331109,0.0007334164,0.0006165625,0.005491702,0.26362482],"study_design_scores_gemma":[0.0008455296,0.00075651746,0.0082275225,0.7609209,0.06300772,0.003404449,0.00051794515,0.00028956254,0.000673676,0.0011241261,0.16013137,0.000100815334],"about_ca_topic_score_codex":0.0047358293,"about_ca_topic_score_gemma":0.018751202,"teacher_disagreement_score":0.01432521,"about_ca_system_score_codex":0.0018013436,"about_ca_system_score_gemma":0.0053022015,"threshold_uncertainty_score":0.013974965},"labels":[],"label_agreement":null},{"id":"W2416195067","doi":"10.1007/s40257-016-0200-x","title":"Management of Pain Associated with Selected Conditions in Dermatology","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of Alberta; University of Ottawa; Ottawa Hospital; Children's Hospital of Eastern Ontario; McGill University","funders":"","keywords":"Medicine; Dermatology; Pharmacotherapy; MEDLINE; Pain management; Physical therapy; Internal medicine","score_opus":0.050425995450952076,"score_gpt":0.4191167259120384,"score_spread":0.36869073046108636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416195067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018801434,0.9989807,0.00007900084,0.00010736022,0.00008670407,0.0000046166842,0.000010107267,0.0000034290065,0.00054004707],"genre_scores_gemma":[0.0026168486,0.9960968,0.0003181523,0.00029531328,0.00033397067,0.000006181693,0.000024876612,0.0000011390999,0.00030665434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997297,0.000047887923,0.00006663204,0.00004160519,0.00009215562,0.000022072256],"domain_scores_gemma":[0.9995018,0.00028809058,0.00011897935,0.0000071403265,0.00006254436,0.00002129893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040557166,0.00062113523,0.0011661568,0.002601585,0.0002813243,0.0009798043,0.00071683124,0.00086437556,0.002864398],"category_scores_gemma":[0.00098616,0.00023205695,0.00064076355,0.0018820524,0.00040663357,0.0008984242,0.00053858204,0.0012773217,0.0005673725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009075577,0.0001202149,0.00084121485,0.04092304,0.00025728912,0.0011118193,0.000097201766,0.00025752283,0.0013614924,0.0009912709,0.015426641,0.93852144],"study_design_scores_gemma":[0.0001853091,0.00039408385,0.0114990985,0.040487252,0.0014687976,0.030984623,0.0004977055,0.00046155485,0.0010413309,0.002438214,0.91044223,0.00009975219],"about_ca_topic_score_codex":0.0010441323,"about_ca_topic_score_gemma":0.0029771323,"teacher_disagreement_score":0.002864398,"about_ca_system_score_codex":0.00033460604,"about_ca_system_score_gemma":0.0006286627,"threshold_uncertainty_score":0.009582341},"labels":[],"label_agreement":null},{"id":"W2494434948","doi":"10.1007/s40257-016-0214-4","title":"Critical Evaluation of Delayed Healing of Venous Leg Ulcers: A Retrospective Analysis in Canadian Patients","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Retrospective cohort study; Varicose Ulcer; Venous leg ulcer; Surgery; Intensive care medicine; Internal medicine","score_opus":0.03837903412437305,"score_gpt":0.42373610280507074,"score_spread":0.3853570686806977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494434948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965307,0.0012128707,0.000055854147,0.00017353747,0.0000151707245,0.00004127958,0.0006379833,0.0000043243613,0.0013282817],"genre_scores_gemma":[0.99896014,0.00042361865,0.00009021891,0.00008470563,0.000014322813,0.000009606367,0.00032948345,0.0000029358796,0.00008498981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782336,0.00020063663,0.00023186192,0.00028112717,0.0007368662,0.0007261994],"domain_scores_gemma":[0.99329424,0.0007987346,0.0025923068,0.00023749685,0.002048004,0.0010292247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010798645,0.0005253249,0.0006173636,0.0022290184,0.0024886983,0.0014279642,0.0014388518,0.00092178705,0.0019399963],"category_scores_gemma":[0.0069439006,0.00058763317,0.0006381992,0.003791092,0.0010514872,0.00055378745,0.00069913827,0.0010290468,0.0001213294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014575162,0.000030476293,0.99750656,0.000033781733,0.000030730647,0.0005015315,0.00026271594,0.000022548493,0.000075667675,0.0000425668,0.0002533101,0.001094476],"study_design_scores_gemma":[0.000012104165,0.00007091233,0.99674326,0.000041813502,0.000045625693,0.0009833641,0.0015300368,0.000102916994,0.000049033137,0.000020441865,0.00038591298,0.000014461803],"about_ca_topic_score_codex":0.779204,"about_ca_topic_score_gemma":0.7901022,"teacher_disagreement_score":0.22079599,"about_ca_system_score_codex":0.013699069,"about_ca_system_score_gemma":0.01821587,"threshold_uncertainty_score":0.4441926},"labels":[],"label_agreement":null},{"id":"W2525858747","doi":"10.1007/s40257-016-0226-0","title":"Relapsing Polychondritis: A Review and Guide for the Dermatologist","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Toronto; University of Alberta","keywords":"Medicine; Relapsing polychondritis; Dermatology; Disease; Treatment modality; Therapeutic modalities; Pathology; Surgery; Internal medicine","score_opus":0.06749774066486361,"score_gpt":0.46959064946279083,"score_spread":0.40209290879792725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525858747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004894731,0.9975802,0.00011343565,0.0010448429,0.00072993455,0.000016940035,0.000052269927,0.000015265156,0.00039822148],"genre_scores_gemma":[0.00028191536,0.9953909,0.00065971154,0.0016492609,0.0010015429,0.000026577123,0.00008428747,0.0000026493801,0.00090326153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994948,0.000087431246,0.00014810477,0.000059017835,0.00017859717,0.00003207927],"domain_scores_gemma":[0.9985965,0.00052139396,0.00032751018,0.00003078923,0.0003728186,0.00015097996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001047993,0.0014504609,0.002653433,0.006025466,0.0004926029,0.0016632655,0.0015184018,0.0021201991,0.0059361625],"category_scores_gemma":[0.0019401523,0.00054257375,0.00115327,0.0035205567,0.00049134326,0.0035160612,0.0012572226,0.0025481295,0.002916392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009285292,0.00012079495,0.00047297418,0.036552668,0.00015090918,0.0007003975,0.000113339425,0.00024594297,0.0007459505,0.0010192288,0.25193557,0.70784926],"study_design_scores_gemma":[0.0000840894,0.00019372156,0.0019967596,0.035903364,0.00032276765,0.0040909075,0.00026179646,0.00016290044,0.00012873871,0.001893825,0.9548956,0.000065508684],"about_ca_topic_score_codex":0.0029877466,"about_ca_topic_score_gemma":0.009868527,"teacher_disagreement_score":0.006025466,"about_ca_system_score_codex":0.0009201316,"about_ca_system_score_gemma":0.0024897205,"threshold_uncertainty_score":0.01985848},"labels":[],"label_agreement":null},{"id":"W2536945044","doi":"10.1007/s40257-016-0230-4","title":"Treating Alopecia Areata: Current Practices Versus New Directions","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Alopecia areata; Medicine; Hair loss; Minoxidil; Dermatology; Scalp","score_opus":0.2002524330469345,"score_gpt":0.5407466972916677,"score_spread":0.34049426424473317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536945044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005475225,0.99947435,0.000029023067,0.00016072979,0.00008792186,0.0000017365779,0.0000047347867,0.0000022767447,0.00018448036],"genre_scores_gemma":[0.00087884977,0.99833554,0.0001492873,0.00028931626,0.00022149924,0.0000028668915,0.000010137826,9.0990613e-7,0.000111623616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994867,0.000098269295,0.00010825242,0.000101410944,0.00017158601,0.000033787706],"domain_scores_gemma":[0.998852,0.00071318616,0.00017871258,0.000020151314,0.00017726487,0.00005861708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012388197,0.00075162115,0.00208385,0.0021112745,0.000354347,0.0013968413,0.0011158984,0.0013911354,0.004117163],"category_scores_gemma":[0.0017711341,0.00030693025,0.00077745045,0.0018350756,0.0007210775,0.001841934,0.0007563085,0.0022365833,0.0008621143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001328365,0.0000888896,0.00034999277,0.030805409,0.00023408058,0.00016429216,0.00007231307,0.00019136175,0.00053863885,0.001238616,0.017422056,0.9487615],"study_design_scores_gemma":[0.00021784767,0.00035964808,0.0035981208,0.038655985,0.0013803659,0.004399534,0.0004688255,0.00029664856,0.00046303755,0.0028347035,0.9472566,0.000068610425],"about_ca_topic_score_codex":0.0011177486,"about_ca_topic_score_gemma":0.003179493,"teacher_disagreement_score":0.004117163,"about_ca_system_score_codex":0.0005343943,"about_ca_system_score_gemma":0.0009978295,"threshold_uncertainty_score":0.0137732625},"labels":[],"label_agreement":null},{"id":"W2548177504","doi":"10.1007/s40257-016-0232-2","title":"Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Pimecrolimus; Medicine; Dermatology; Seborrheic dermatitis; Cochrane Library; Randomized controlled trial; Mometasone furoate; MEDLINE; Tacrolimus; Corticosteroid; Internal medicine","score_opus":0.07574893999910119,"score_gpt":0.47351716075296685,"score_spread":0.39776822075386564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548177504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008535119,0.9986945,0.00004741529,0.00005480697,0.00004880438,0.00005844898,0.00010034506,0.0000033499234,0.00013895294],"genre_scores_gemma":[0.010545177,0.9886389,0.00027647393,0.0002935809,0.000042551972,0.000049997667,0.00006836466,0.0000019381505,0.00008306028],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986224,0.0003826269,0.000519642,0.00016092855,0.00024050471,0.00007398567],"domain_scores_gemma":[0.9963322,0.0023940832,0.00086205325,0.0000560058,0.00027846097,0.000077304954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018858812,0.0011011935,0.0059152925,0.0030338606,0.0003940723,0.0014156543,0.001535154,0.0015436558,0.0053338064],"category_scores_gemma":[0.0068190997,0.00069652667,0.0065385215,0.0034409347,0.00055987126,0.001356219,0.0008957974,0.0011523202,0.00029877684],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007122603,0.00006247564,0.0007562687,0.92662776,0.018348046,0.00014973356,0.00012282858,0.00010758647,0.00029025198,0.00011204615,0.0016910585,0.05101967],"study_design_scores_gemma":[0.0020427285,0.0010377305,0.011169799,0.59091663,0.35023403,0.0010905181,0.0005905131,0.0001829334,0.00041635468,0.00040096763,0.04181676,0.000100879566],"about_ca_topic_score_codex":0.005324555,"about_ca_topic_score_gemma":0.022651337,"teacher_disagreement_score":0.0059152925,"about_ca_system_score_codex":0.00096970383,"about_ca_system_score_gemma":0.0024307913,"threshold_uncertainty_score":0.017843366},"labels":[],"label_agreement":null},{"id":"W2570401170","doi":"10.1007/s40257-016-0246-9","title":"Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)","year":2017,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Etanercept; Plaque psoriasis; Randomized controlled trial; Psoriasis; Pharmacotherapy; Clinical trial; Internal medicine; Dermatology; Psoriatic arthritis; Secukinumab; Tumor necrosis factor alpha","score_opus":0.06534057836563588,"score_gpt":0.4286594761625303,"score_spread":0.3633188977968944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570401170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959315,0.0051184776,0.00097648415,0.00017684778,0.00014357452,0.0023973535,0.0008070666,0.000049596456,0.0007374056],"genre_scores_gemma":[0.99391913,0.0011243115,0.0008417525,0.00035374556,0.00014667668,0.002013479,0.0010206233,0.000024552466,0.00055565493],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99088895,0.0062867464,0.0010366284,0.0007486704,0.0006135064,0.00042553653],"domain_scores_gemma":[0.9916455,0.004147082,0.0018768414,0.0010895377,0.00053767074,0.0007033385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0148096755,0.001471645,0.0042068837,0.0005186645,0.00044249403,0.001334926,0.0007397488,0.0013245462,0.0019950182],"category_scores_gemma":[0.008212645,0.0006185377,0.0073540956,0.0006046483,0.0010233837,0.0009797012,0.00059880514,0.0023107096,0.00033271144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9664642,0.0021391911,0.0073778625,0.0005692855,0.00986996,0.000037793314,0.00007005206,0.00033598975,0.0033642007,0.000036122008,0.00025063774,0.009484735],"study_design_scores_gemma":[0.6872787,0.21152732,0.07156677,0.00011331199,0.022621352,0.00022821994,0.00011899913,0.0010748273,0.0034257537,0.00030350883,0.0016782697,0.00006299717],"about_ca_topic_score_codex":0.00030279148,"about_ca_topic_score_gemma":0.0007118681,"teacher_disagreement_score":0.0148096755,"about_ca_system_score_codex":0.00064578647,"about_ca_system_score_gemma":0.00097414915,"threshold_uncertainty_score":0.07832205},"labels":[],"label_agreement":null},{"id":"W2590362558","doi":"10.1007/s40257-017-0251-7","title":"Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment","year":2017,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":316,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Women's College Hospital","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Disease; Intensive care medicine; Neutrophilic dermatosis; Inflammation; Pathophysiology; Dermatology; Pharmacotherapy; Bioinformatics; Immunology; Pathology; Internal medicine","score_opus":0.16858302196326444,"score_gpt":0.4904569408922327,"score_spread":0.3218739189289682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590362558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009745056,0.99891603,0.0000881319,0.00024050796,0.00032290755,0.0000036683823,0.000019900845,0.0000057726234,0.0003056303],"genre_scores_gemma":[0.00059310807,0.9975382,0.00025101696,0.00049864704,0.0008429954,0.000004805281,0.000039255618,0.0000015145557,0.00023050608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996057,0.00006593551,0.000103868006,0.00005764928,0.00013133528,0.00003547458],"domain_scores_gemma":[0.9989574,0.0005348254,0.00020422656,0.000025131976,0.00021191734,0.00006639631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087172445,0.0009833969,0.0020965072,0.0035565088,0.00031906454,0.0014475245,0.0011476349,0.0012157399,0.0035463534],"category_scores_gemma":[0.0014896976,0.00041930383,0.0008810237,0.002579926,0.0005034042,0.0022300717,0.0009344754,0.0019718083,0.001139617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014067706,0.00011488693,0.0006193419,0.02642015,0.00020688267,0.0006128147,0.000073279116,0.00040873175,0.0011887951,0.0011282862,0.05780126,0.911285],"study_design_scores_gemma":[0.00008770497,0.00020864155,0.0022458436,0.012896302,0.00078816526,0.0071965447,0.00014747176,0.00026998908,0.0003617911,0.001667477,0.97406083,0.000069226415],"about_ca_topic_score_codex":0.0010711428,"about_ca_topic_score_gemma":0.0032444363,"teacher_disagreement_score":0.0035565088,"about_ca_system_score_codex":0.00048762027,"about_ca_system_score_gemma":0.0014127755,"threshold_uncertainty_score":0.011863768},"labels":[],"label_agreement":null},{"id":"W2626152381","doi":"10.1007/s40257-017-0308-7","title":"Drug-Induced Pyoderma Gangrenosum: A Review","year":2017,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Assembly of First Nations; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Isotretinoin; Pyoderma gangrenosum; Drug; Propylthiouracil; Dermatology; Adverse effect; Adverse drug reaction; Sunitinib; Pharmacotherapy; MEDLINE; Internal medicine; Pharmacology; Cancer; Acne","score_opus":0.188495914818479,"score_gpt":0.5189946154213417,"score_spread":0.33049870060286274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626152381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090774796,0.99943477,0.000032961183,0.00008179964,0.00014531593,0.00000394603,0.000019059778,0.0000035120859,0.00018781998],"genre_scores_gemma":[0.00058425695,0.99869233,0.000114003866,0.00019797107,0.00024186139,0.0000038960125,0.000025095855,8.23571e-7,0.000139679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996531,0.00004414549,0.00010983678,0.00006454761,0.00009886353,0.00002945057],"domain_scores_gemma":[0.9991283,0.00036256266,0.00029104375,0.000016885098,0.00012394499,0.00007718808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005869413,0.0011904099,0.0022935125,0.0058509703,0.00037723745,0.001581823,0.0010757385,0.0012497951,0.004676626],"category_scores_gemma":[0.0012460864,0.0004407161,0.0010042532,0.0047378256,0.00048041882,0.002405179,0.0013027119,0.0013548563,0.0010195271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023760305,0.00018538423,0.0010279194,0.10747545,0.00063780334,0.0014634718,0.00017317157,0.0004187772,0.0015788322,0.0012503951,0.051352967,0.8341981],"study_design_scores_gemma":[0.00012894953,0.0003005355,0.0037649735,0.036356613,0.0022944603,0.01299852,0.00038430715,0.00019253338,0.00045838603,0.001394795,0.94162196,0.00010393303],"about_ca_topic_score_codex":0.00097306987,"about_ca_topic_score_gemma":0.002571926,"teacher_disagreement_score":0.0058509703,"about_ca_system_score_codex":0.00044199955,"about_ca_system_score_gemma":0.0014375295,"threshold_uncertainty_score":0.015644908},"labels":[],"label_agreement":null},{"id":"W2785647181","doi":"10.1007/s40257-017-0341-6","title":"Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"AbbVie","keywords":"Hidradenitis suppurativa; Medicine; Adalimumab; Psoriasis; Dermatology; Pharmacotherapy; Internal medicine; Disease","score_opus":0.030188051055915807,"score_gpt":0.3360196623802492,"score_spread":0.3058316113243334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785647181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8510457,0.1379293,0.0010101594,0.0009764416,0.00016659136,0.0007022646,0.00041874874,0.000030903062,0.0077199326],"genre_scores_gemma":[0.98475605,0.012725228,0.0005962963,0.00094335945,0.00029763236,0.00018031463,0.00017555857,0.0000065295203,0.00031909952],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99768794,0.0014529824,0.00023461308,0.0002218979,0.00031072323,0.00009178691],"domain_scores_gemma":[0.99573684,0.002107242,0.001282053,0.00022785096,0.0004325621,0.00021340107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004791787,0.0003949194,0.0012712077,0.00027742353,0.00031489064,0.0008926708,0.00027952658,0.00057504047,0.0021762229],"category_scores_gemma":[0.0033179119,0.00019287413,0.0018352317,0.00035617265,0.0003580381,0.00050142204,0.0002940791,0.0011607357,0.00025813142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15677068,0.0039629196,0.11878439,0.01728365,0.0071638655,0.0010826738,0.0007645939,0.00091377704,0.027436642,0.0004658725,0.0030634666,0.6623074],"study_design_scores_gemma":[0.083164275,0.42891258,0.40501416,0.0045999447,0.013130419,0.0076251477,0.0007247292,0.001830462,0.018675458,0.0008498325,0.03537206,0.00010092233],"about_ca_topic_score_codex":0.0002459147,"about_ca_topic_score_gemma":0.00051585294,"teacher_disagreement_score":0.004791787,"about_ca_system_score_codex":0.00039786284,"about_ca_system_score_gemma":0.0005086673,"threshold_uncertainty_score":0.02534169},"labels":[],"label_agreement":null},{"id":"W2794146536","doi":"10.1007/s40257-018-0352-y","title":"Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Windsor Clinical Research; Occupational Cancer Research Centre; Western University; Innovaderm (Canada)","funders":"Galderma","keywords":"Medicine; Acne; Tolerability; Benzoyl peroxide; Dermatology; Adapalene; Acne scars; Randomized controlled trial; Clinical trial; Scars; Surgery; Internal medicine; Adverse effect","score_opus":0.06676159548000438,"score_gpt":0.40594074792914714,"score_spread":0.33917915244914276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794146536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946563,0.0037332634,0.00029062555,0.000081859864,0.0000790114,0.0006943359,0.00010804574,0.000032246855,0.00032442342],"genre_scores_gemma":[0.995207,0.0021610528,0.00095968,0.00016566538,0.00017540406,0.00069204945,0.00014115282,0.000009279387,0.00048874266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993284,0.00035232957,0.000060497394,0.00009475553,0.000084617175,0.00007944501],"domain_scores_gemma":[0.99925154,0.00023537282,0.00018473268,0.00006220436,0.00007222489,0.00019396059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019772435,0.0007137219,0.0020051082,0.00047501383,0.00030705438,0.00052948605,0.00065840717,0.00093429966,0.0023229439],"category_scores_gemma":[0.0009703374,0.00039000035,0.0012542718,0.00031174318,0.00062441104,0.00042543217,0.00024466676,0.001245103,0.00029270427],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85448855,0.03898673,0.002451889,0.0017362635,0.0015069374,0.000074063086,0.00016904339,0.000355334,0.037164066,0.000070119444,0.00037878298,0.062618084],"study_design_scores_gemma":[0.46610367,0.5122322,0.015428157,0.00006705468,0.0010882778,0.00007561496,0.00006240666,0.00048731637,0.0038655999,0.00006260313,0.00050896325,0.000018279183],"about_ca_topic_score_codex":0.00047196352,"about_ca_topic_score_gemma":0.0008810196,"teacher_disagreement_score":0.0023229439,"about_ca_system_score_codex":0.00022320516,"about_ca_system_score_gemma":0.00047748868,"threshold_uncertainty_score":0.0104568},"labels":[],"label_agreement":null},{"id":"W2893494515","doi":"10.1007/s40257-018-0388-z","title":"Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Janssen Scientific Affairs; University of Pennsylvania","keywords":"Medicine; Psoriasis; Etanercept; Infliximab; Adalimumab; Internal medicine; Odds ratio; Confidence interval; Psoriasis Area and Severity Index; Methotrexate; Ustekinumab; Surgery; Dermatology; Rheumatoid arthritis; Disease","score_opus":0.04066805683277146,"score_gpt":0.39020595001039104,"score_spread":0.3495378931776196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893494515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995884,0.002125317,0.00033463218,0.00021831781,0.00004863818,0.000020586649,0.000502125,0.000011962628,0.0008544741],"genre_scores_gemma":[0.9991642,0.00017318159,0.000111697955,0.000055932152,0.00004760019,0.000012748504,0.00029575103,0.0000046827527,0.00013416825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9899997,0.0066812485,0.00049132894,0.0015208523,0.0007941741,0.00051277713],"domain_scores_gemma":[0.97115505,0.013846733,0.011014696,0.0013898971,0.00090593396,0.0016877799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011950119,0.00046900936,0.00070405734,0.00062896294,0.00029855332,0.000800664,0.00051079807,0.00065884594,0.0013976177],"category_scores_gemma":[0.01828566,0.00024220004,0.0019035138,0.0007437191,0.00029473673,0.0009196478,0.00074251427,0.0012683602,0.00018655525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028697276,0.0000638277,0.9933176,0.000031735737,0.00085976836,0.000030117712,0.000032320433,0.000107598215,0.000082302424,0.000017218505,0.00013834093,0.0024493723],"study_design_scores_gemma":[0.00009477562,0.0011142882,0.99702114,0.00002201674,0.0006272042,0.00014255593,0.000060235012,0.0005842288,0.00006881384,0.000032235635,0.00022463243,0.000007904309],"about_ca_topic_score_codex":0.0018810638,"about_ca_topic_score_gemma":0.0019947875,"teacher_disagreement_score":0.011950119,"about_ca_system_score_codex":0.0002583949,"about_ca_system_score_gemma":0.00038151356,"threshold_uncertainty_score":0.06319904},"labels":[],"label_agreement":null},{"id":"W2900867377","doi":"10.1007/s40257-018-0403-4","title":"A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Dermatophyte; Cure rate; Antifungal; Organism; Disease; Dermatology; Surgery; Internal medicine","score_opus":0.12369268240485418,"score_gpt":0.4623947374434581,"score_spread":0.33870205503860396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900867377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006881869,0.9896493,0.001240837,0.0042403475,0.001408907,0.000033462336,0.00009380574,0.000079798505,0.0031846948],"genre_scores_gemma":[0.0005551848,0.985794,0.0037828896,0.0051169484,0.0009738552,0.000053549626,0.000163134,0.000011739242,0.0035485954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999443,0.000120880584,0.0001067776,0.000059786777,0.00024115935,0.00002840263],"domain_scores_gemma":[0.9991904,0.00040402653,0.0001072803,0.000022665012,0.0001945465,0.00008113185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080650195,0.0011679145,0.0016203637,0.0025284835,0.00045822162,0.001270444,0.0015553803,0.0024915377,0.009927276],"category_scores_gemma":[0.001724024,0.00040082348,0.0007462082,0.0015426582,0.00070386444,0.0023763934,0.0009897306,0.0040930035,0.007029497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034014116,0.00013532984,0.00013673873,0.013549226,0.00005023117,0.00030321005,0.00009610784,0.00017655945,0.0008591386,0.003101701,0.26602948,0.71552813],"study_design_scores_gemma":[0.000021369178,0.00005209672,0.00058747875,0.008443392,0.000046888727,0.0017270567,0.00007278929,0.00006546855,0.000111913956,0.0024473437,0.9863987,0.000025500714],"about_ca_topic_score_codex":0.0018851875,"about_ca_topic_score_gemma":0.0063462695,"teacher_disagreement_score":0.009927276,"about_ca_system_score_codex":0.0005447644,"about_ca_system_score_gemma":0.0016360647,"threshold_uncertainty_score":0.03321004},"labels":[],"label_agreement":null},{"id":"W2901523494","doi":"10.1007/s40257-018-0396-z","title":"Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Dermatology Life Quality Index; Medicine; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Placebo; Quality of life (healthcare); Internal medicine; Minimal clinically important difference; Dermatology; Randomized controlled trial; Disease; Pathology","score_opus":0.03698518268949746,"score_gpt":0.34539625998573364,"score_spread":0.3084110772962362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901523494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694391,0.028195633,0.0005693597,0.00016488855,0.00006145145,0.00028531245,0.00045656957,0.000033475222,0.0007942203],"genre_scores_gemma":[0.9945589,0.00377882,0.00053211156,0.00019718175,0.00006834947,0.00020548918,0.00046306488,0.000008903335,0.00018716141],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979001,0.00136345,0.0001736007,0.00018839758,0.0002673072,0.00010714871],"domain_scores_gemma":[0.9970829,0.0011264649,0.0011503763,0.00019810114,0.00017899951,0.00026322567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007192449,0.00064038596,0.0022053218,0.0003835683,0.0002107066,0.0007619028,0.0004890882,0.00057839375,0.00088609196],"category_scores_gemma":[0.0030301993,0.00030051492,0.0028744626,0.0005130346,0.0004314643,0.00048686203,0.00038620326,0.0011626291,0.00013651531],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65775156,0.0073477686,0.0889206,0.004234123,0.025915982,0.00006892381,0.0002966559,0.0016138867,0.019671937,0.000099178644,0.0018039499,0.19227555],"study_design_scores_gemma":[0.2014344,0.2966909,0.4700035,0.00060934166,0.017986549,0.0004920197,0.00017379773,0.001474358,0.0071428353,0.00026356254,0.0036459947,0.000082728206],"about_ca_topic_score_codex":0.0003057661,"about_ca_topic_score_gemma":0.00086802436,"teacher_disagreement_score":0.007192449,"about_ca_system_score_codex":0.00037029656,"about_ca_system_score_gemma":0.00045401396,"threshold_uncertainty_score":0.038037777},"labels":[],"label_agreement":null},{"id":"W2911080709","doi":"10.1007/s40257-018-00416-4","title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Drug; Dermatology; Eosinophilia; Pharmacotherapy; Adverse drug reaction; Intensive care medicine; Immunology; Antibody; Internal medicine; Pharmacology","score_opus":0.06548412371774488,"score_gpt":0.40122810467147463,"score_spread":0.33574398095372976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911080709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047044054,0.9990783,0.000039129383,0.00030219046,0.00027414228,0.0000015163386,0.000006406548,0.0000038426583,0.00024736996],"genre_scores_gemma":[0.00063321495,0.99788636,0.00010496585,0.00053493644,0.00054710766,0.0000026052264,0.000012801136,9.89172e-7,0.00027703098],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996062,0.00007484875,0.00007693083,0.00006345374,0.00014388273,0.000034770943],"domain_scores_gemma":[0.9990355,0.00045114878,0.00020600016,0.000019195657,0.00020326163,0.00008486987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092864403,0.000876367,0.002484156,0.0016703996,0.0003043616,0.0016877161,0.00094238564,0.0019959898,0.0033643062],"category_scores_gemma":[0.0014225933,0.00030806128,0.00083872315,0.0015771788,0.00056440703,0.0018501009,0.00065649516,0.002479349,0.0014097308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012552291,0.00007778361,0.00048237815,0.018453771,0.00018784998,0.0004115783,0.000043809065,0.00016926575,0.00046216484,0.001191069,0.043292265,0.9351026],"study_design_scores_gemma":[0.0001440017,0.00025221484,0.0033420085,0.017833693,0.0008150813,0.006688152,0.0002442877,0.00025339186,0.0002947996,0.0022915804,0.96777534,0.000065512606],"about_ca_topic_score_codex":0.001140446,"about_ca_topic_score_gemma":0.0030374264,"teacher_disagreement_score":0.0033643062,"about_ca_system_score_codex":0.0004626179,"about_ca_system_score_gemma":0.0010338121,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2937897222","doi":"10.1007/s40257-019-00441-x","title":"Vascular Tests for Dermatologists","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Arterial insufficiency; Ankle; Duplex ultrasonography; Vascular Medicine; Vascular disease; Arterial disease; Critical limb ischemia; Intensive care medicine; Radiology; Surgery","score_opus":0.17649225607597663,"score_gpt":0.5082409295017222,"score_spread":0.33174867342574554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937897222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059951468,0.99689794,0.00009956397,0.0009632124,0.0008144205,0.0000051384036,0.000017987308,0.0000120883915,0.0011296724],"genre_scores_gemma":[0.0013207521,0.99258935,0.00042193587,0.0024153779,0.0020258168,0.000012317462,0.00005921681,0.000004606876,0.0011506415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999345,0.00017473802,0.000116115225,0.00010362724,0.00020790785,0.000052609514],"domain_scores_gemma":[0.9973807,0.0014128061,0.0004247144,0.00006555231,0.0005127689,0.00020349471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000952429,0.0011791184,0.0013957389,0.004513112,0.00049729005,0.001505542,0.0010208543,0.0023539818,0.00957402],"category_scores_gemma":[0.004647712,0.0003861521,0.0008462,0.0021726794,0.00067068764,0.0018206943,0.0012215088,0.0031871474,0.0034530282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006341146,0.000061036255,0.00055456604,0.011228657,0.000086580985,0.00031461395,0.000033035165,0.00007503329,0.00029948723,0.00060117745,0.109387375,0.8772951],"study_design_scores_gemma":[0.00012069415,0.00013338315,0.00394893,0.040170543,0.00074242975,0.0066656894,0.00014184946,0.00012009435,0.00029579308,0.0019632527,0.94565153,0.000045858244],"about_ca_topic_score_codex":0.0015266227,"about_ca_topic_score_gemma":0.0042922148,"teacher_disagreement_score":0.00957402,"about_ca_system_score_codex":0.0007677027,"about_ca_system_score_gemma":0.0015651502,"threshold_uncertainty_score":0.032028317},"labels":[],"label_agreement":null},{"id":"W2949528356","doi":"10.1007/s40257-019-00458-2","title":"Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Probity Medical Research","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research; Amgen","keywords":"Psoriasis; Medicine; Pharmacotherapy; Intensive care medicine; Dermatology; Psychiatry","score_opus":0.062405782343731356,"score_gpt":0.3399270085649656,"score_spread":0.27752122622123426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949528356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671507,0.0005071496,0.00022426406,0.000361638,0.000025089821,0.00024976957,0.00018792709,0.0000061371597,0.0017229534],"genre_scores_gemma":[0.99884135,0.00016019307,0.00036390076,0.00018119738,0.00002192159,0.00017515768,0.0001841697,0.0000047252856,0.00006738064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98218244,0.010424909,0.0015465511,0.0010169764,0.0040850174,0.00074413675],"domain_scores_gemma":[0.9306847,0.038234197,0.017497504,0.0021508385,0.0071802316,0.0042525036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020848151,0.00032822328,0.000612531,0.0013017848,0.00106257,0.0019060321,0.0008468759,0.00089124823,0.0012962803],"category_scores_gemma":[0.08262559,0.0006328938,0.0008331171,0.001668312,0.0011093075,0.0013763569,0.0016869956,0.0017172856,0.00034660057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040107733,0.00038762964,0.9903396,0.0000632455,0.00009214706,0.000054871503,0.0015568922,0.000050517374,0.00007314083,0.000041040184,0.00039322808,0.0065465868],"study_design_scores_gemma":[0.00014338708,0.00078756816,0.9965894,0.000050405608,0.00003595791,0.00015211671,0.0013327961,0.00031154658,0.00003286719,0.000035431276,0.0005146056,0.000013783689],"about_ca_topic_score_codex":0.0049655186,"about_ca_topic_score_gemma":0.0054327087,"teacher_disagreement_score":0.020848151,"about_ca_system_score_codex":0.0016749845,"about_ca_system_score_gemma":0.0017971898,"threshold_uncertainty_score":0.11025691},"labels":[],"label_agreement":null},{"id":"W2950914207","doi":"10.1007/s40257-019-00454-6","title":"Long-Term Effectiveness and Safety of Up to 48 Weeks’ Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Windsor Clinical Research; Occupational Cancer Research Centre; Western University; Innovaderm (Canada)","funders":"Galderma","keywords":"Medicine; Acne; Adapalene; Tolerability; Benzoyl peroxide; Dermatology; Scars; Acne scars; Surgery; Adverse effect; Internal medicine","score_opus":0.01885888520017651,"score_gpt":0.3446266133717555,"score_spread":0.32576772817157895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950914207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961106,0.0028461944,0.00014202562,0.000063146996,0.00006241441,0.000032984535,0.00012376299,0.000012547751,0.0006063283],"genre_scores_gemma":[0.9977192,0.0006065075,0.00010277626,0.00003992823,0.000051671024,0.000037829872,0.0001613455,0.0000040459518,0.0012766274],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99970466,0.00009190432,0.000026642098,0.000051318544,0.000040363444,0.00008496381],"domain_scores_gemma":[0.99965227,0.00008117741,0.000058663314,0.00007620096,0.000052133106,0.000079704296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050292385,0.00030934712,0.00074211985,0.0002145618,0.00029945528,0.00030703945,0.00032297522,0.00061641086,0.0029924735],"category_scores_gemma":[0.00057924143,0.00016187702,0.0009416116,0.00016723412,0.00035351323,0.0006396573,0.0001908452,0.0010858605,0.0005458278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33055282,0.046764366,0.017616691,0.0007761911,0.0011224954,0.00057077286,0.00048438093,0.0012216307,0.2773938,0.00019394897,0.0012065943,0.32209635],"study_design_scores_gemma":[0.014182596,0.6153664,0.24045165,0.00013537651,0.0024338383,0.0009927256,0.0004253708,0.001960587,0.11604524,0.000309756,0.0075961947,0.00010027933],"about_ca_topic_score_codex":0.0006072312,"about_ca_topic_score_gemma":0.00091142714,"teacher_disagreement_score":0.0029924735,"about_ca_system_score_codex":0.00016301766,"about_ca_system_score_gemma":0.00015623884,"threshold_uncertainty_score":0.0100108385},"labels":[],"label_agreement":null},{"id":"W2955778729","doi":"10.1007/s40257-019-00460-8","title":"Authors’ Reply to Laneelle et al.: “Vascular Tests for Dermatologists”","year":2019,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacotherapy; Dermatology; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.061218713995391943,"score_gpt":0.42163564696742384,"score_spread":0.3604169329720319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955778729","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003519293,0.0007255273,0.000042464362,0.9808992,0.0162668,0.0000069687517,0.000041445244,0.00002644938,0.0016392336],"genre_scores_gemma":[0.003846584,0.0005938873,0.000110522975,0.9646958,0.027743723,0.000022075059,0.00002913819,0.00001932588,0.002938957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699795,0.0010060153,0.00043291296,0.00037553872,0.00067540875,0.000512202],"domain_scores_gemma":[0.9902452,0.0048476662,0.0007194427,0.0002365577,0.002538558,0.0014124892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002370511,0.0007665977,0.0011226209,0.00096188165,0.003877873,0.0032483928,0.0017999045,0.053993337,0.010435943],"category_scores_gemma":[0.029185511,0.00076560484,0.00096843025,0.0008368583,0.0025432608,0.00356875,0.0013034132,0.02914334,0.008698871],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040453866,0.000018556524,0.00074889674,0.00003109969,0.0000071261907,0.002773562,0.0001304933,0.0000296673,0.00007347259,0.0007135426,0.9928489,0.0025842173],"study_design_scores_gemma":[0.00021759886,0.0000955888,0.0027020006,0.00081568415,0.0000523357,0.016373536,0.0014321246,0.0005814646,0.00051865494,0.0082307635,0.9688158,0.0001643906],"about_ca_topic_score_codex":0.0052857497,"about_ca_topic_score_gemma":0.0063788234,"teacher_disagreement_score":0.053993337,"about_ca_system_score_codex":0.002792363,"about_ca_system_score_gemma":0.0034753974,"threshold_uncertainty_score":0.034911692},"labels":[],"label_agreement":null},{"id":"W2972256509","doi":"10.1007/s40257-019-00466-2","title":"Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Bausch Health; Ortho Dermatologics; AstraZeneca; Amgen","keywords":"Medicine; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Tolerability; Psoriasis; Adverse effect; Internal medicine; Quality of life (healthcare); Dermatology","score_opus":0.025764928863366485,"score_gpt":0.3379926812463918,"score_spread":0.3122277523830253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972256509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982174,0.0009898504,0.000108861735,0.00004962502,0.000017865656,0.0002231028,0.00011101413,0.0000108242,0.00027138833],"genre_scores_gemma":[0.9981997,0.0003775416,0.00030073186,0.00017648353,0.00006620664,0.00028968163,0.00031600997,0.000002743328,0.0002709292],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99924767,0.00037929325,0.0000618094,0.00010222593,0.000118587544,0.00009038345],"domain_scores_gemma":[0.99853325,0.00028765638,0.0005264427,0.00010486295,0.00010344968,0.00044432923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029070112,0.0008567766,0.0015192927,0.00028845956,0.00043058745,0.00080444146,0.0005107754,0.00087768526,0.0012483537],"category_scores_gemma":[0.0012780458,0.00039444305,0.0016377565,0.00026020652,0.00046839865,0.00053549465,0.00026006738,0.0018324797,0.00029965007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6936445,0.06981485,0.11183668,0.0011491819,0.004523151,0.00044122414,0.000453472,0.0016894231,0.033517208,0.000074270276,0.0012144495,0.081641525],"study_design_scores_gemma":[0.2087921,0.50292265,0.28057513,0.0000669975,0.0015710361,0.00056881545,0.00010982503,0.0017204765,0.0024385042,0.00006736795,0.0011097024,0.00005735936],"about_ca_topic_score_codex":0.00029129005,"about_ca_topic_score_gemma":0.00052336947,"teacher_disagreement_score":0.0029070112,"about_ca_system_score_codex":0.00039905976,"about_ca_system_score_gemma":0.0005333793,"threshold_uncertainty_score":0.015373886},"labels":[],"label_agreement":null},{"id":"W2985449845","doi":"10.1007/s40257-019-00480-4","title":"Twenty Clinically Pertinent Factors/Observations for Percutaneous Absorption in Humans","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Neonatal skin health care","field":"Health Professions","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Stratum corneum; Human skin; Medicine; Drug; Toxicokinetics; Pharmacokinetics; Absorption (acoustics); Pharmacology; Population; Toxicity; Dermatology; Physiology; Toxicology; Pathology; Internal medicine; Biology; Environmental health; Materials science","score_opus":0.35643886279236486,"score_gpt":0.5815073270385457,"score_spread":0.22506846424618082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985449845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012733022,0.9965808,0.00028415563,0.00024163951,0.0001172142,0.000020005804,0.000049130358,0.000009014082,0.0014248339],"genre_scores_gemma":[0.008531955,0.9893756,0.0006521222,0.00034804182,0.00014788468,0.000018298882,0.000068145295,0.0000031696231,0.00085482077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995987,0.00007274974,0.00007557363,0.00007822434,0.00014383707,0.000030939816],"domain_scores_gemma":[0.9990471,0.00052596716,0.00022081191,0.000029962805,0.00015294245,0.000023203018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074482174,0.000674898,0.00080560485,0.0019715175,0.00033714736,0.0009673214,0.00052141136,0.00072589,0.0038682004],"category_scores_gemma":[0.0016432459,0.00023350315,0.0009981884,0.0013460777,0.0006533851,0.0008468021,0.0005337246,0.0008283155,0.0009393244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021128422,0.00017583962,0.0027237704,0.035684027,0.00022592774,0.0005711446,0.00014794916,0.00012692531,0.004179598,0.0012525604,0.009649337,0.9450515],"study_design_scores_gemma":[0.00012177947,0.0010902804,0.02690928,0.028490623,0.0029323476,0.011964412,0.00097198016,0.00024289425,0.01724806,0.0027962464,0.9071157,0.000116463496],"about_ca_topic_score_codex":0.0015047939,"about_ca_topic_score_gemma":0.0030327803,"teacher_disagreement_score":0.0038682004,"about_ca_system_score_codex":0.0005229391,"about_ca_system_score_gemma":0.0016599827,"threshold_uncertainty_score":0.012940407},"labels":[],"label_agreement":null},{"id":"W2986842764","doi":"10.1007/s40257-019-00485-z","title":"Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Medicine; Drug; Pharmacotherapy; Intensive care medicine; Systematic review; Pharmacology; MEDLINE; Internal medicine","score_opus":0.10905418606962518,"score_gpt":0.4622674421520058,"score_spread":0.35321325608238063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986842764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052173727,0.9989261,0.000055121855,0.00009604991,0.00006673232,0.000070895956,0.00017105872,0.0000029089579,0.000089460686],"genre_scores_gemma":[0.010208141,0.9886143,0.00039145668,0.00042334088,0.00008751848,0.00009498166,0.00012418603,0.0000027789235,0.000053185347],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99478865,0.0011957304,0.0025628053,0.00046346968,0.00083438825,0.00015499724],"domain_scores_gemma":[0.97959536,0.013872875,0.0049748803,0.00024699298,0.0011112537,0.0001985858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057051526,0.0013531001,0.00859028,0.00930726,0.00049167476,0.0023135308,0.001812714,0.0019056203,0.0043622144],"category_scores_gemma":[0.02270713,0.0010414396,0.009665428,0.007777452,0.00074895134,0.002421091,0.0017261344,0.0012922555,0.00024764336],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003174801,0.000023634148,0.0021023746,0.9235927,0.033825178,0.00014894055,0.00013929137,0.000117004936,0.00012774659,0.00019783723,0.0018424348,0.03756536],"study_design_scores_gemma":[0.0007630189,0.00031450708,0.013372989,0.60017127,0.35494256,0.00085262523,0.00040875457,0.00020565047,0.00019621266,0.00056910893,0.028087735,0.00011570874],"about_ca_topic_score_codex":0.006398135,"about_ca_topic_score_gemma":0.028145622,"teacher_disagreement_score":0.00930726,"about_ca_system_score_codex":0.0019530135,"about_ca_system_score_gemma":0.0055881124,"threshold_uncertainty_score":0.03017205},"labels":[],"label_agreement":null},{"id":"W2989913215","doi":"10.1007/s40257-019-00487-x","title":"Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"Paracelsus Medizinische Privatuniversität","keywords":"Medicine; Epidemiology; Lymphadenectomy; Population; Confidence interval; Lymph node; Oncology; Internal medicine; Proportional hazards model; Univariate analysis; Surgery; Multivariate analysis","score_opus":0.014053972914830631,"score_gpt":0.31501555023831695,"score_spread":0.30096157732348633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989913215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824166,0.0002480774,0.00007789095,0.00003019364,0.000004222725,0.000012392732,0.0010890322,0.0000039764727,0.00029264105],"genre_scores_gemma":[0.99870074,0.00017257627,0.00005665899,0.000030350431,0.0000070571346,0.000015733827,0.0009081477,0.0000020261398,0.00010661551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996985,0.000070090406,0.00003331859,0.000092742834,0.000053788168,0.000051557323],"domain_scores_gemma":[0.9994493,0.00009706283,0.00024236695,0.000052168078,0.000050757157,0.000108326036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044168805,0.00025311316,0.00043166094,0.000609972,0.00043742658,0.0004928389,0.00028750655,0.0003548774,0.0011542026],"category_scores_gemma":[0.00096932385,0.00040030168,0.0003319093,0.0013551171,0.0002613667,0.00054528733,0.00039949882,0.0004192147,0.0003103299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031147752,0.000013387645,0.999099,0.0000061964706,0.000021220878,0.00007057684,0.0000619979,0.000027195474,0.000085534826,0.0000062613267,0.000105269355,0.00047208648],"study_design_scores_gemma":[0.00000681307,0.000066874796,0.9990075,0.000006211191,0.000016812219,0.00033447036,0.00017905093,0.0000925226,0.000020412512,0.000008760837,0.00025813864,0.000002413574],"about_ca_topic_score_codex":0.0076583982,"about_ca_topic_score_gemma":0.00848337,"teacher_disagreement_score":0.0076583982,"about_ca_system_score_codex":0.00036669022,"about_ca_system_score_gemma":0.00034207568,"threshold_uncertainty_score":0.015227616},"labels":[],"label_agreement":null},{"id":"W2991114477","doi":"10.1007/s40257-019-00482-2","title":"Updates on Botulinum Neurotoxins in Dermatology","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Botulinum neurotoxin; Botulinum toxin; Neurotoxin; Dermatology; Surgery; Internal medicine; Biology; Toxin","score_opus":0.11962505094078946,"score_gpt":0.46365578601605417,"score_spread":0.3440307350752647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991114477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006188221,0.9964713,0.00007107088,0.00050486106,0.0017484577,0.000005721932,0.000032922424,0.000010230521,0.001093655],"genre_scores_gemma":[0.0004520198,0.9946221,0.00020435874,0.0011274847,0.002359839,0.0000073155416,0.00006738914,0.0000030639578,0.0011563709],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999401,0.00011131676,0.00014491357,0.000072667885,0.00021157757,0.000058612502],"domain_scores_gemma":[0.9981651,0.000792204,0.00037272897,0.000045244422,0.0004414913,0.00018333446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013295017,0.0011788843,0.0018676638,0.0067511736,0.00037815794,0.0018988014,0.0010786148,0.001771748,0.010380518],"category_scores_gemma":[0.0028416568,0.000418409,0.0008533912,0.0047211065,0.000498529,0.0025916696,0.0013703111,0.0018515852,0.003370812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113426984,0.00007452093,0.00025247832,0.034153722,0.0001744462,0.00038753127,0.00007967535,0.00024291582,0.0012436163,0.001573194,0.16410927,0.7975953],"study_design_scores_gemma":[0.000035074783,0.00006606639,0.0007740425,0.007988041,0.00026636058,0.0012222751,0.000042441337,0.0000556024,0.000120777026,0.00062205945,0.98878807,0.000019145618],"about_ca_topic_score_codex":0.0011414433,"about_ca_topic_score_gemma":0.003565259,"teacher_disagreement_score":0.010380518,"about_ca_system_score_codex":0.0008425692,"about_ca_system_score_gemma":0.0020872003,"threshold_uncertainty_score":0.034726262},"labels":[],"label_agreement":null},{"id":"W3012736954","doi":"10.1007/s40257-020-00512-4","title":"Malignancy Rates in Brodalumab Clinical Studies for Psoriasis","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics; Amgen","keywords":"Medicine; Ustekinumab; Psoriasis; Internal medicine; Ixekizumab; Psoriasis Area and Severity Index; Dermatology; Secukinumab; Psoriatic arthritis; Adalimumab","score_opus":0.11959967372461948,"score_gpt":0.4233082742569633,"score_spread":0.30370860053234383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012736954","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44633663,0.468762,0.01985725,0.0013048165,0.0007185054,0.010566985,0.031122625,0.00030010793,0.021030923],"genre_scores_gemma":[0.9606553,0.01632037,0.005857522,0.001001887,0.00040088574,0.004581591,0.010132156,0.00013005237,0.00092011824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.846639,0.09490532,0.030063368,0.01088361,0.016416742,0.0010920072],"domain_scores_gemma":[0.78878963,0.11141104,0.07385982,0.012573281,0.012069767,0.0012964874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.105504565,0.0007109298,0.0023625146,0.006798256,0.0006792846,0.00229026,0.0013134461,0.0008590541,0.003963966],"category_scores_gemma":[0.10741905,0.00072734617,0.0052301735,0.006694928,0.0007495746,0.0012169934,0.002195443,0.00122576,0.0003726537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046158902,0.00026804884,0.7571042,0.024615856,0.06626771,0.00032786312,0.0012885524,0.0010658628,0.0022640931,0.001619623,0.009113885,0.089905344],"study_design_scores_gemma":[0.004735982,0.004778292,0.9061192,0.0048225434,0.031474203,0.0017892478,0.0003662606,0.0010906958,0.001764574,0.0013340705,0.041598085,0.00012683505],"about_ca_topic_score_codex":0.00089261343,"about_ca_topic_score_gemma":0.0016463114,"teacher_disagreement_score":0.105504565,"about_ca_system_score_codex":0.0012104113,"about_ca_system_score_gemma":0.0010898962,"threshold_uncertainty_score":0.55796814},"labels":[],"label_agreement":null},{"id":"W3013797294","doi":"10.1007/s40257-020-00510-6","title":"Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Pharmacokinetics; Open label; Pharmacotherapy; Dermatology; Anesthesia; Adverse effect; Pharmacology; Internal medicine","score_opus":0.04448782415435957,"score_gpt":0.4222697355113028,"score_spread":0.3777819113569432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013797294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985929,0.00088289916,0.00009311335,0.000027494292,0.000008285199,0.0001423752,0.00009987156,0.000008337187,0.00014460886],"genre_scores_gemma":[0.9971975,0.0011867126,0.0006284355,0.00013351435,0.00004009787,0.00020825537,0.00028689785,0.00000449844,0.00031412113],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996282,0.00020047154,0.000030543444,0.00004498266,0.00006026157,0.000035493176],"domain_scores_gemma":[0.99949574,0.00013212126,0.00017805348,0.000033227687,0.000040291176,0.00012058563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011212085,0.00041756468,0.0010141598,0.0001947368,0.00016831556,0.00031851992,0.00030338587,0.00045703855,0.0007612475],"category_scores_gemma":[0.0007937427,0.00019711246,0.00063806056,0.0001401539,0.0003295276,0.00031713035,0.00015361204,0.0009596477,0.00016542217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44940123,0.061767552,0.07037237,0.0019371592,0.0015760412,0.0012783465,0.00090100744,0.001602121,0.16963017,0.00018569922,0.0015702368,0.23977801],"study_design_scores_gemma":[0.04918082,0.80316126,0.13323857,0.00005688035,0.00058442104,0.00096698484,0.000148652,0.0010083384,0.009382489,0.00005467157,0.002180452,0.00003641519],"about_ca_topic_score_codex":0.0004306207,"about_ca_topic_score_gemma":0.0012030315,"teacher_disagreement_score":0.0011212085,"about_ca_system_score_codex":0.000303041,"about_ca_system_score_gemma":0.0004467902,"threshold_uncertainty_score":0.0059295893},"labels":[],"label_agreement":null},{"id":"W3036352764","doi":"10.1007/s40257-020-00527-x","title":"Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Open label; Adverse effect; Internal medicine","score_opus":0.04485148388255634,"score_gpt":0.3839348872599036,"score_spread":0.33908340337734727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036352764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742293,0.0014310727,0.00015692334,0.000088773544,0.000018233772,0.00016631903,0.00023173749,0.000016391086,0.00046761305],"genre_scores_gemma":[0.99806005,0.0005167492,0.00039566238,0.00013920756,0.0000686651,0.00011916426,0.0003734426,0.0000046455693,0.0003224672],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994717,0.000288249,0.00004518094,0.00007030457,0.0000730904,0.00005149094],"domain_scores_gemma":[0.9990067,0.00025921522,0.00029101418,0.000073399715,0.00011241969,0.00025718627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020435834,0.00037278747,0.0006948138,0.00015094316,0.00026112085,0.00040400613,0.00019953231,0.00038962357,0.0017438037],"category_scores_gemma":[0.0012213936,0.00014893047,0.00062248943,0.00015484219,0.00022464737,0.00040366393,0.00019121349,0.000859147,0.00027404234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48640028,0.03602852,0.11663678,0.0016011732,0.0024950376,0.0006937541,0.00088448037,0.0008141667,0.067488015,0.00014179258,0.0040129586,0.28280306],"study_design_scores_gemma":[0.10669002,0.56352043,0.31026265,0.00010927721,0.0017748433,0.0016875311,0.00019869559,0.0017583581,0.0075967987,0.00010455325,0.006252008,0.000044817138],"about_ca_topic_score_codex":0.0003171766,"about_ca_topic_score_gemma":0.00091459753,"teacher_disagreement_score":0.0020435834,"about_ca_system_score_codex":0.00025118823,"about_ca_system_score_gemma":0.0004163063,"threshold_uncertainty_score":0.010807693},"labels":[],"label_agreement":null},{"id":"W3047072658","doi":"10.1007/s40257-020-00542-y","title":"Effects of Diet on Acne and Its Response to Treatment","year":2020,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Medicine; Acne; Pharmacotherapy; Dermatology; Internal medicine; Intensive care medicine","score_opus":0.06127595997462017,"score_gpt":0.4608400220138732,"score_spread":0.39956406203925304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047072658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016470537,0.99924797,0.000024744015,0.000077315286,0.000055121796,0.0000032391376,0.000016772174,0.0000025128393,0.0004076532],"genre_scores_gemma":[0.0013179055,0.9982516,0.000063316715,0.00009521603,0.000062619525,0.0000060099233,0.000023125847,7.6595103e-7,0.00017934559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997379,0.000059402886,0.000058509097,0.000040625277,0.000085375854,0.000018144383],"domain_scores_gemma":[0.99957174,0.00027033844,0.000070195296,0.000007948569,0.000064257634,0.000015585445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044499736,0.0005236419,0.0013038316,0.0016537878,0.0001760285,0.00071629824,0.00048268662,0.00079741504,0.004272251],"category_scores_gemma":[0.0012092129,0.0001619502,0.0009395651,0.0011853345,0.00024540973,0.0005732854,0.00036750227,0.00088545046,0.0008349033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021477506,0.00010782238,0.00039347034,0.059897497,0.00045914776,0.0001363043,0.000049962633,0.00016831815,0.00095794606,0.0008013168,0.010240674,0.9265728],"study_design_scores_gemma":[0.00017137537,0.00058357744,0.010448011,0.06740961,0.0028550823,0.0041539106,0.00020131827,0.00022345316,0.0015477625,0.0018752412,0.9104778,0.000052815452],"about_ca_topic_score_codex":0.0008966496,"about_ca_topic_score_gemma":0.0016532982,"teacher_disagreement_score":0.004272251,"about_ca_system_score_codex":0.00036309994,"about_ca_system_score_gemma":0.00046719486,"threshold_uncertainty_score":0.014292121},"labels":[],"label_agreement":null},{"id":"W3097770867","doi":"10.1007/s40257-020-00566-4","title":"Granulomatous Cutaneous Drug Eruptions: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Granuloma annulare; Medicine; Sarcoidosis; Granulomatous inflammation; Dermatology; Cutaneous Sarcoidosis; Granuloma; Drug eruption; Drug; Pathology; Pharmacology","score_opus":0.0500571691170715,"score_gpt":0.4440620668684573,"score_spread":0.3940048977513858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097770867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005997892,0.9988599,0.000045170895,0.00007782355,0.00006127333,0.0000817271,0.00016974364,0.0000037439504,0.00010085235],"genre_scores_gemma":[0.009513122,0.9894796,0.00023989713,0.00045072302,0.000052140407,0.000086752174,0.000093694536,0.0000026776981,0.000081440645],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972306,0.0007633823,0.0011419916,0.00028322346,0.0004237637,0.00015699772],"domain_scores_gemma":[0.99142015,0.0054714535,0.0023298194,0.00011874539,0.00049590436,0.00016392053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030977922,0.0014568134,0.008233422,0.0066430224,0.00041833962,0.0021393604,0.0014611775,0.0017894922,0.007375231],"category_scores_gemma":[0.0099117085,0.0010127231,0.006579335,0.0071620937,0.00070257403,0.002072046,0.0017316121,0.0012721192,0.00037774828],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035485128,0.000028113658,0.00091186207,0.9501283,0.016889218,0.00020406506,0.000115899464,0.00008406341,0.00019417469,0.00013174853,0.0022289676,0.028728807],"study_design_scores_gemma":[0.001523773,0.00037041566,0.010358637,0.67540497,0.27578655,0.0012778273,0.00045102023,0.00012475438,0.00018316385,0.00037431263,0.03405453,0.00009005797],"about_ca_topic_score_codex":0.0058769863,"about_ca_topic_score_gemma":0.027867239,"teacher_disagreement_score":0.008233422,"about_ca_system_score_codex":0.0017851593,"about_ca_system_score_gemma":0.004281379,"threshold_uncertainty_score":0.024672627},"labels":[],"label_agreement":null},{"id":"W3101032247","doi":"10.1007/s40257-020-00564-6","title":"Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Foundation for the National Institutes of Health","keywords":"Acne; Medicine; Psychosocial; Quality of life (healthcare); Dermatology Life Quality Index; Systematic review; MEDLINE; Anxiety; Disease; Patient-reported outcome; Depression (economics); Clinical psychology; Psychiatry; Dermatology; Pathology","score_opus":0.06450156165055514,"score_gpt":0.4056603684713844,"score_spread":0.3411588068208293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101032247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066156033,0.9907137,0.00036315527,0.000399624,0.00014469089,0.00062356336,0.0008277354,0.000007858815,0.00030406605],"genre_scores_gemma":[0.09438606,0.9001571,0.0022461351,0.0012449424,0.0001059047,0.0011972757,0.0005495372,0.000008620043,0.00010446584],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97627854,0.007425697,0.010766303,0.0015593319,0.003496834,0.00047327936],"domain_scores_gemma":[0.90158397,0.07561105,0.015724719,0.0014006095,0.005110678,0.0005689914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023874158,0.0013401539,0.0070500863,0.010352003,0.00069977454,0.0032741495,0.0018162127,0.0026285457,0.0023442807],"category_scores_gemma":[0.10781452,0.0013447604,0.011889108,0.0094929645,0.0013090321,0.003485976,0.002300549,0.0016000491,0.00021125599],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030996997,0.00006001302,0.009214217,0.92258155,0.032630265,0.00011307735,0.00040303596,0.00013863224,0.00012615183,0.00017484592,0.0007291746,0.03351892],"study_design_scores_gemma":[0.0004458554,0.00035018858,0.026354901,0.7673592,0.19524601,0.00047232353,0.0011001187,0.00015976139,0.00020525059,0.00033463942,0.007881995,0.00008969599],"about_ca_topic_score_codex":0.012996027,"about_ca_topic_score_gemma":0.04012526,"teacher_disagreement_score":0.023874158,"about_ca_system_score_codex":0.004049208,"about_ca_system_score_gemma":0.015333242,"threshold_uncertainty_score":0.12626016},"labels":[],"label_agreement":null},{"id":"W3107149649","doi":"10.1007/s40257-020-00575-3","title":"Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"LEO Fondet","keywords":"Adalimumab; Medicine; Interquartile range; Hidradenitis suppurativa; Therapeutic drug monitoring; Internal medicine; Retrospective cohort study; Trough level; Gastroenterology; Surgery; Tumor necrosis factor alpha; Pharmacokinetics; Tacrolimus; Disease; Transplantation","score_opus":0.029982540375932516,"score_gpt":0.3561905999709441,"score_spread":0.3262080595950116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107149649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548787,0.002463817,0.00037395157,0.0001442984,0.000028873197,0.000025481919,0.00005561003,0.000010537146,0.0014096046],"genre_scores_gemma":[0.9989712,0.0004995622,0.00017880296,0.000098501056,0.00006330829,0.000006986113,0.0000766569,0.0000058206783,0.000099129335],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99913836,0.00013448927,0.00016927713,0.00019107887,0.00014050107,0.00022625014],"domain_scores_gemma":[0.99817324,0.00052617263,0.00068364845,0.0001765834,0.00013542708,0.0003050107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045769356,0.0006093784,0.00079854723,0.0015096802,0.0011848926,0.001324719,0.0006239729,0.0015259889,0.0013663787],"category_scores_gemma":[0.002891009,0.00059578597,0.00079054444,0.0011048465,0.0008966509,0.001298687,0.00074818876,0.0009933402,0.0003477515],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021756471,0.00011098688,0.6751969,0.000053421576,0.000044688637,0.3192453,0.00038495514,0.000074689226,0.0009942611,0.0000950168,0.00021573556,0.0033665027],"study_design_scores_gemma":[0.00001748615,0.00021500056,0.14532606,0.000043030963,0.00011170582,0.85112077,0.0011049157,0.00043882412,0.0005839859,0.00010654024,0.0009032546,0.000028434622],"about_ca_topic_score_codex":0.0010961008,"about_ca_topic_score_gemma":0.0010031841,"teacher_disagreement_score":0.0015259889,"about_ca_system_score_codex":0.0005395429,"about_ca_system_score_gemma":0.00059759273,"threshold_uncertainty_score":0.004570961},"labels":[],"label_agreement":null},{"id":"W3115626074","doi":"10.1007/s40257-020-00580-6","title":"The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Mediprobe Research (Canada)","funders":"","keywords":"Terbinafine; Medicine; Dermatophyte; Drug resistance; Itraconazole; Antifungal drugs; Antifungal; Antifungal drug; Intensive care medicine; Flucytosine; Fluconazole; Dermatology; Microbiology; Biology","score_opus":0.038019462035501314,"score_gpt":0.3681311113761409,"score_spread":0.3301116493406396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115626074","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30096364,0.5468373,0.010113683,0.09055544,0.003580684,0.000053160376,0.0004881787,0.00035060264,0.047057386],"genre_scores_gemma":[0.74283105,0.21438469,0.0068990765,0.018280542,0.0128384195,0.000023994598,0.00031807285,0.000094170144,0.004330032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655765,0.0009726343,0.00055663876,0.00033836966,0.0013420017,0.00023269108],"domain_scores_gemma":[0.98018354,0.011169908,0.0048410697,0.00062044064,0.002187961,0.00099706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003012952,0.00040773672,0.0010933003,0.0019743089,0.0005332807,0.0023538712,0.0008193681,0.0031584997,0.0038457466],"category_scores_gemma":[0.010946839,0.00022351822,0.00047958284,0.00233763,0.0015252415,0.0024492096,0.00058708474,0.0024495765,0.0013194197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049222144,0.0003389174,0.11450824,0.0027437652,0.00012349553,0.023643484,0.0007102658,0.00054381107,0.009176223,0.0031915589,0.029147463,0.81538045],"study_design_scores_gemma":[0.00007186181,0.0011684916,0.24012148,0.0026270882,0.00041821453,0.51430017,0.004623751,0.0028575838,0.0052183503,0.008196145,0.22025801,0.0001389234],"about_ca_topic_score_codex":0.0007490873,"about_ca_topic_score_gemma":0.0015499302,"teacher_disagreement_score":0.0038457466,"about_ca_system_score_codex":0.00044856843,"about_ca_system_score_gemma":0.00077732524,"threshold_uncertainty_score":0.015934229},"labels":[],"label_agreement":null},{"id":"W3115765278","doi":"10.1007/s40257-020-00576-2","title":"Correction to: Effects of Diet on Acne and Its Response to Treatment","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"","keywords":"Medicine; Acne; Pharmacotherapy; Dermatology; MEDLINE; Information retrieval; Internal medicine; Computer science","score_opus":0.031674636017969576,"score_gpt":0.392325629300335,"score_spread":0.3606509932823654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115765278","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044606545,0.0013442105,0.0005179063,0.02800181,0.96676254,0.000023638651,0.00053992996,0.00021466527,0.0021492962],"genre_scores_gemma":[0.040085576,0.01277358,0.005883725,0.07360828,0.635493,0.00017926413,0.0022931162,0.0012042384,0.22847919],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977962,0.0003387469,0.0004319614,0.00035293528,0.00081299496,0.00026714097],"domain_scores_gemma":[0.9873009,0.003850989,0.0006303535,0.0007566999,0.0066576544,0.00080336095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014509693,0.001842598,0.0014540525,0.0022616023,0.0015294076,0.0021887491,0.0021885734,0.0056326576,0.039294068],"category_scores_gemma":[0.028424863,0.000730722,0.0015519644,0.0010702224,0.0012289557,0.0014417128,0.0010937263,0.0086578075,0.017484384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011442112,0.000017482422,0.00020935507,0.00026249592,0.00003535914,0.0013070625,0.000042390362,0.00009961778,0.00017657076,0.00055238674,0.9851827,0.012000063],"study_design_scores_gemma":[0.00007789959,0.000052214386,0.0017095377,0.00036288996,0.000069362606,0.004061134,0.00008169585,0.0005530341,0.0006381968,0.0009223588,0.9914232,0.000048520717],"about_ca_topic_score_codex":0.011512088,"about_ca_topic_score_gemma":0.011740534,"teacher_disagreement_score":0.039294068,"about_ca_system_score_codex":0.0028727672,"about_ca_system_score_gemma":0.0024454973,"threshold_uncertainty_score":0.13145173},"labels":[],"label_agreement":null},{"id":"W3118484490","doi":"10.1007/s40257-020-00579-z","title":"Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Pharmacotherapy; Tumor necrosis factor alpha; Drug; Tumor necrosis factor α; Adalimumab; Therapeutic drug monitoring; Dermatology; Pharmacology; Internal medicine; Intensive care medicine; Oncology; Disease","score_opus":0.028422700596694415,"score_gpt":0.35073154960687297,"score_spread":0.32230884901017853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118484490","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16480838,0.5002357,0.0063709337,0.25942904,0.01027211,0.00026209347,0.0004844283,0.00061880786,0.05751856],"genre_scores_gemma":[0.76136816,0.1281018,0.023030365,0.062996484,0.018439883,0.00029600604,0.00056869455,0.00010797851,0.005090684],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988527,0.00048126973,0.00020429555,0.00012027613,0.00022281664,0.00011863364],"domain_scores_gemma":[0.9897746,0.005985418,0.0011310701,0.0003312625,0.0013558713,0.0014218234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022870677,0.0006014778,0.0023042448,0.00060539704,0.00075963326,0.0019686157,0.00091423513,0.002849411,0.0033322496],"category_scores_gemma":[0.013099542,0.00029839197,0.0013918456,0.00069828925,0.0006982523,0.0037254605,0.0004477156,0.003595965,0.00070752733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064087654,0.001448606,0.25151974,0.0021404142,0.00071704946,0.006651065,0.00038648176,0.001001799,0.003978295,0.0035252315,0.040281553,0.681941],"study_design_scores_gemma":[0.006068643,0.00802578,0.44942352,0.022191549,0.0056555863,0.0507,0.0054464787,0.012569069,0.005007378,0.020544732,0.41382504,0.000542187],"about_ca_topic_score_codex":0.0015402444,"about_ca_topic_score_gemma":0.0028299545,"teacher_disagreement_score":0.0033322496,"about_ca_system_score_codex":0.00059467915,"about_ca_system_score_gemma":0.0021176846,"threshold_uncertainty_score":0.012095332},"labels":[],"label_agreement":null},{"id":"W3137117524","doi":"10.1007/s40257-021-00595-7","title":"Rosacea: New Concepts in Classification and Treatment","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Rosacea; Medicine; Dermatology; Erythema; Telangiectasia; Acne","score_opus":0.15782163217570577,"score_gpt":0.5170822609389268,"score_spread":0.35926062876322107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137117524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091570226,0.99775606,0.00015119206,0.0006261707,0.00047519468,0.000006858865,0.000014757291,0.0000070547835,0.0008710777],"genre_scores_gemma":[0.000927087,0.9967439,0.00043938923,0.00061740755,0.00060811447,0.000011682518,0.00004284918,0.0000031540526,0.0006063262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994672,0.00011491919,0.000112098336,0.000080644895,0.000184091,0.000041004976],"domain_scores_gemma":[0.9995042,0.00022894044,0.00007256507,0.000018791125,0.00014117477,0.000034261884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092035794,0.00085096457,0.0015021596,0.0033078133,0.00037886357,0.0015479509,0.00092953106,0.0012343369,0.0034093766],"category_scores_gemma":[0.0015174471,0.00024558458,0.0008273886,0.0022096382,0.0009823182,0.0024948628,0.00087702234,0.0029864444,0.001357841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007152551,0.000071316135,0.0002497386,0.019296514,0.00007727632,0.00020846588,0.00018039704,0.00031003763,0.00070540316,0.008728857,0.039393004,0.9307076],"study_design_scores_gemma":[0.000016009553,0.0000755191,0.0008705722,0.010539351,0.00009654407,0.0016620455,0.0001506487,0.00010375918,0.00013166758,0.0047700712,0.9815661,0.000017847178],"about_ca_topic_score_codex":0.0015569734,"about_ca_topic_score_gemma":0.0020608972,"teacher_disagreement_score":0.0034093766,"about_ca_system_score_codex":0.001009647,"about_ca_system_score_gemma":0.0015927288,"threshold_uncertainty_score":0.011405528},"labels":[],"label_agreement":null},{"id":"W3143775625","doi":"10.1007/s40257-021-00598-4","title":"Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Hamilton Health Sciences; University of Toronto; Lynde Centre for Dermatology; McMaster University","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Ustekinumab; Psoriatic arthritis; Internal medicine; Retrospective cohort study; Psoriasis; Hazard ratio; Proportional hazards model; Oncology; Dermatology; Adalimumab; Confidence interval; Disease","score_opus":0.028362322672536147,"score_gpt":0.32671167242351506,"score_spread":0.29834934975097893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143775625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989065,0.00031356042,0.00008663367,0.000020373402,0.0000066979756,0.000007678572,0.00047106805,0.0000022672434,0.00018532168],"genre_scores_gemma":[0.99907887,0.00013654563,0.000057737216,0.000031539446,0.000008932546,0.000010132601,0.00049580436,0.000003548042,0.0001768947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921155,0.00018361054,0.000067223235,0.0002983868,0.00007190896,0.00016733544],"domain_scores_gemma":[0.99865156,0.00017007504,0.00053541275,0.00025397795,0.00015533553,0.00023364123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007719351,0.00042344915,0.00065759383,0.00060906983,0.0007172378,0.0011808735,0.00041031174,0.0006562099,0.0018788116],"category_scores_gemma":[0.0013582964,0.0006021765,0.0012008952,0.0014027942,0.00035220216,0.00074964826,0.00050395896,0.0009435032,0.00037752002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014392028,0.000098196964,0.99597365,0.000014940976,0.0004285833,0.00020491552,0.00011095215,0.000053347438,0.0004677345,0.000030236282,0.00014280519,0.0010354564],"study_design_scores_gemma":[0.00005867113,0.00045695412,0.9977157,0.0000067513856,0.0002814485,0.0005535521,0.00032039234,0.00015403131,0.000082562285,0.00002621229,0.00033117924,0.000012526853],"about_ca_topic_score_codex":0.004146996,"about_ca_topic_score_gemma":0.003703931,"teacher_disagreement_score":0.004146996,"about_ca_system_score_codex":0.00045293305,"about_ca_system_score_gemma":0.0004553732,"threshold_uncertainty_score":0.008245707},"labels":[],"label_agreement":null},{"id":"W3152146207","doi":"10.1007/s40257-021-00602-x","title":"Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Incyte; National Center for Advancing Translational Sciences; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Randomized controlled trial; Pharmacotherapy; Safety profile; Pooled analysis; Clinical trial; Internal medicine; Meta-analysis; Adverse effect","score_opus":0.0316521412114653,"score_gpt":0.40420677146655387,"score_spread":0.37255463025508856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152146207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79480773,0.1877692,0.0046059703,0.0007131261,0.00031934696,0.004169881,0.0048361593,0.00020631946,0.002572328],"genre_scores_gemma":[0.9775579,0.013886353,0.0024007072,0.00064776087,0.00022241462,0.0014706907,0.0033362752,0.000034668123,0.0004432328],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847247,0.0094557535,0.0024169488,0.0013924165,0.0015642452,0.00044596673],"domain_scores_gemma":[0.97821224,0.010471425,0.007290957,0.0015186814,0.0018488284,0.00065784535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01960841,0.0011927055,0.0052047144,0.0013774224,0.00030822668,0.0019074642,0.00069271494,0.0010835475,0.0021273042],"category_scores_gemma":[0.019995797,0.0005406448,0.011352152,0.0016547816,0.00049527973,0.0012095263,0.00080863823,0.0014658371,0.0002137004],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5939644,0.0009972338,0.040486395,0.014622975,0.2593708,0.00026007177,0.00014204017,0.0022380797,0.005056531,0.00020821246,0.0014244964,0.08122876],"study_design_scores_gemma":[0.30111113,0.06547601,0.1881166,0.0020093934,0.42604458,0.00081957655,0.0001447936,0.0036778436,0.0027843087,0.00096653873,0.008664824,0.00018442028],"about_ca_topic_score_codex":0.00029283407,"about_ca_topic_score_gemma":0.0008718279,"teacher_disagreement_score":0.01960841,"about_ca_system_score_codex":0.0008592956,"about_ca_system_score_gemma":0.0011662357,"threshold_uncertainty_score":0.1037004},"labels":[],"label_agreement":null},{"id":"W3164927049","doi":"10.1007/s40257-021-00607-6","title":"Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Vaccination; Dermatology; Immunology","score_opus":0.02317668804624801,"score_gpt":0.354628461929032,"score_spread":0.331451773882784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164927049","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01114936,0.16739462,0.008602991,0.7605129,0.027619516,0.001106522,0.004826218,0.00040060407,0.018387226],"genre_scores_gemma":[0.1463483,0.26250264,0.14141206,0.37960202,0.019610303,0.00498161,0.02182595,0.0003891341,0.02332806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916786,0.0026007162,0.002504556,0.0005127506,0.0019865711,0.0007169438],"domain_scores_gemma":[0.9851413,0.0030094143,0.0023340648,0.00019065703,0.006465693,0.0028588902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015504703,0.0011651054,0.0017143257,0.0020225884,0.0013376322,0.0022993519,0.002768899,0.007995812,0.003595746],"category_scores_gemma":[0.025353724,0.0008707921,0.003472875,0.0011250784,0.0005804861,0.0023179618,0.0021510515,0.00998752,0.0015589205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050464045,0.00044635363,0.019508453,0.004589907,0.0006255831,0.00077180937,0.00044435065,0.001263665,0.0012885019,0.0016951469,0.6828668,0.28599462],"study_design_scores_gemma":[0.0024395247,0.00049402216,0.07483133,0.045494057,0.0022746539,0.0026670087,0.0018215991,0.0031073017,0.0012792572,0.0042022127,0.8611313,0.0002578157],"about_ca_topic_score_codex":0.022368453,"about_ca_topic_score_gemma":0.036772158,"teacher_disagreement_score":0.022368453,"about_ca_system_score_codex":0.0043388745,"about_ca_system_score_gemma":0.016730987,"threshold_uncertainty_score":0.08199769},"labels":[],"label_agreement":null},{"id":"W3170274915","doi":"10.1007/s40257-021-00614-7","title":"Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Paracelsus Medizinische Privatuniversität; Austrian Science Fund","keywords":"Medicine; Melanoma; Vulva; Dermatology; Disease; Mortality rate; Oncology; Mucosal melanoma; Internal medicine; Cancer research","score_opus":0.04183455519324062,"score_gpt":0.40501753318479955,"score_spread":0.3631829779915589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170274915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001118042,0.9992766,0.0000321518,0.00018972285,0.000061978055,0.0000021039673,0.000008927516,0.0000019105958,0.00031475115],"genre_scores_gemma":[0.0010890745,0.9982938,0.00007765885,0.00015473734,0.00015711595,0.0000031501545,0.000029003168,6.1382195e-7,0.00019491416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997886,0.000040296447,0.0000407753,0.000036662175,0.000076154756,0.000017597215],"domain_scores_gemma":[0.99962246,0.00019289312,0.00007830427,0.0000078718285,0.00007363544,0.000024791327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004889137,0.0006774182,0.0013795214,0.0025099898,0.00022968906,0.0006989807,0.0005861368,0.0006057991,0.0018291249],"category_scores_gemma":[0.0009224227,0.00023018652,0.00055114744,0.0018052282,0.0004193112,0.00084611046,0.00034884844,0.0013733519,0.0005842586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000678377,0.000053097534,0.00094206084,0.015473015,0.00012906572,0.00020888748,0.000046014095,0.00027772898,0.00043936068,0.0010285841,0.021388302,0.959946],"study_design_scores_gemma":[0.00005459465,0.00024473833,0.014792085,0.033688348,0.0007559854,0.012518993,0.00023332037,0.00028602252,0.00042169276,0.0032581356,0.93369156,0.00005462371],"about_ca_topic_score_codex":0.0022539073,"about_ca_topic_score_gemma":0.0046935915,"teacher_disagreement_score":0.0025099898,"about_ca_system_score_codex":0.0006817212,"about_ca_system_score_gemma":0.0009231547,"threshold_uncertainty_score":0.006119013},"labels":[],"label_agreement":null},{"id":"W3183902277","doi":"10.1007/s40257-021-00624-5","title":"The Use of Lasers and Light Devices in Acne Management: An Update","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"","keywords":"Medicine; Acne; Intense pulsed light; Light therapy; Randomized controlled trial; Ablative case; Adverse effect; Dermatology; Intensive care medicine; Surgery; Internal medicine; Radiation therapy","score_opus":0.11084621743028521,"score_gpt":0.45886559661832327,"score_spread":0.34801937918803805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183902277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058673297,0.999524,0.000036388337,0.0000996347,0.00010116685,0.000002516654,0.000015134625,0.0000031674167,0.00015930737],"genre_scores_gemma":[0.00032276622,0.99911994,0.00012153854,0.00019169025,0.00012905116,0.0000027753747,0.000017981265,8.4686616e-7,0.00009343315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944454,0.00009098916,0.00014016198,0.00008234725,0.000205023,0.000036976904],"domain_scores_gemma":[0.9979286,0.0012354506,0.0003810689,0.000030932428,0.00033750132,0.00008647509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014335458,0.00096601405,0.00227836,0.0043697553,0.00028092277,0.0016683168,0.0011935084,0.0017349412,0.004557375],"category_scores_gemma":[0.0022678971,0.0004442495,0.0013119121,0.0035693725,0.000514427,0.0021729884,0.00092503533,0.0018754033,0.0011302254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001686745,0.00010823733,0.00041319994,0.05826864,0.00030750662,0.00023858754,0.00006938488,0.0002136131,0.00091298774,0.0007603075,0.0234056,0.91513324],"study_design_scores_gemma":[0.00018058988,0.00042326725,0.004232135,0.033320233,0.0023893306,0.0041018208,0.00019877698,0.0002625979,0.00050933316,0.0010536005,0.95324606,0.000082254664],"about_ca_topic_score_codex":0.0016677665,"about_ca_topic_score_gemma":0.004156611,"teacher_disagreement_score":0.004557375,"about_ca_system_score_codex":0.0005625002,"about_ca_system_score_gemma":0.001751346,"threshold_uncertainty_score":0.015245914},"labels":[],"label_agreement":null},{"id":"W3206427606","doi":"10.1007/s40257-021-00650-3","title":"Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Adapalene; Tolerability; Medicine; Benzoyl peroxide; Acne; Clindamycin; Adverse effect; Dermatology; Internal medicine; Randomized controlled trial; Antibiotics","score_opus":0.021191720390857805,"score_gpt":0.35778936719485693,"score_spread":0.3365976468039991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206427606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246264,0.0014715422,0.0006663964,0.00019621973,0.0001809196,0.0038205336,0.00045354685,0.00006557756,0.0006826636],"genre_scores_gemma":[0.99142236,0.0010358904,0.0018746258,0.00036268274,0.00024553805,0.003183313,0.00038112674,0.000023498269,0.0014710017],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99891675,0.00051453366,0.000073476935,0.0002423769,0.00011762191,0.00013528184],"domain_scores_gemma":[0.9982254,0.00036377244,0.00046886038,0.00017621176,0.0001524436,0.0006133215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026270347,0.0018083792,0.0028317354,0.0006167978,0.00054668065,0.001175195,0.0011726611,0.0020159523,0.0046793036],"category_scores_gemma":[0.0017153266,0.0011440761,0.0016493716,0.00042933717,0.0014028838,0.0012508658,0.0003987928,0.003194245,0.00094984984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88267064,0.072229944,0.0009907602,0.00052486284,0.0006334696,0.00004270172,0.000102049,0.0003459392,0.023300007,0.00006801989,0.00046478034,0.018626753],"study_design_scores_gemma":[0.577552,0.41656497,0.0022496318,0.000020059213,0.0004202998,0.00005230376,0.000027953527,0.00040171877,0.00221277,0.00005844034,0.000419945,0.000019952216],"about_ca_topic_score_codex":0.00056240504,"about_ca_topic_score_gemma":0.0012977683,"teacher_disagreement_score":0.0046793036,"about_ca_system_score_codex":0.0008276346,"about_ca_system_score_gemma":0.0014018713,"threshold_uncertainty_score":0.015653789},"labels":[],"label_agreement":null},{"id":"W3214446229","doi":"10.1007/s40257-021-00643-2","title":"Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Acne; Medicine; Dermatology; Hyperpigmentation; Melasma; Irritation; Adapalene; Benzoyl peroxide","score_opus":0.0276044791232484,"score_gpt":0.4469005382715478,"score_spread":0.41929605914829937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214446229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006818007,0.99950016,0.000020384772,0.00009919554,0.00006615717,0.0000038606413,0.000011044021,0.0000020042291,0.0002290983],"genre_scores_gemma":[0.00047608378,0.99920976,0.000061684455,0.00009376291,0.000049676673,0.0000043597456,0.000011194218,5.486459e-7,0.00009287331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997056,0.000052072388,0.00008864935,0.00004567623,0.00009132811,0.00001667993],"domain_scores_gemma":[0.9988714,0.00070636737,0.00016681792,0.000020224981,0.00020152329,0.00003367314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007337483,0.0007065221,0.0016203522,0.0029251045,0.0002925567,0.0008740687,0.0007368782,0.0008917034,0.004434782],"category_scores_gemma":[0.0019588396,0.00026687325,0.0011876797,0.0028003317,0.00036188972,0.0010859594,0.00045052273,0.0011075895,0.00084900536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001329215,0.00007938111,0.00033829457,0.10772764,0.00032272108,0.0002426476,0.00011471178,0.00020394157,0.00085838826,0.0009830709,0.02205028,0.8669461],"study_design_scores_gemma":[0.00010848684,0.00030399815,0.0044388096,0.09022172,0.0023098954,0.0056890333,0.00031848947,0.00018255453,0.0007099819,0.0017597511,0.8938988,0.00005849519],"about_ca_topic_score_codex":0.0014816469,"about_ca_topic_score_gemma":0.0030471077,"teacher_disagreement_score":0.004434782,"about_ca_system_score_codex":0.0004826576,"about_ca_system_score_gemma":0.0010049102,"threshold_uncertainty_score":0.014835894},"labels":[],"label_agreement":null},{"id":"W4200583694","doi":"10.1007/s40257-021-00660-1","title":"Efinaconazole in Onychomycosis","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Itraconazole; Terbinafine; Antifungal","score_opus":0.11933609478193363,"score_gpt":0.525844527942879,"score_spread":0.4065084331609453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200583694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012390756,0.9989942,0.000042504926,0.00012277282,0.00015197333,0.000004294094,0.000016144977,0.0000051669276,0.0005391155],"genre_scores_gemma":[0.0013370434,0.9973174,0.00015115931,0.00030998376,0.00021261474,0.0000070162496,0.00003384213,0.0000012871076,0.0006296557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998078,0.00003433199,0.000044192133,0.000028057937,0.000064196356,0.000021348735],"domain_scores_gemma":[0.9996414,0.00014740581,0.00010603826,0.000009557687,0.00006364926,0.0000319574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048429574,0.00095976295,0.001607573,0.0025893003,0.0002218405,0.0009352321,0.00073308405,0.0010205756,0.0055122664],"category_scores_gemma":[0.00072842307,0.00024317374,0.00061048847,0.0021855368,0.00030037915,0.0008327827,0.0005624576,0.0011948826,0.0011959443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017961877,0.00009712696,0.00014630459,0.025566924,0.00017476136,0.00018252184,0.000026058431,0.00015108,0.00097542926,0.00070757803,0.025685813,0.94610673],"study_design_scores_gemma":[0.000293541,0.00042585793,0.0032936134,0.018684406,0.0016293261,0.0026886754,0.00008862341,0.00024346894,0.00081737473,0.0009851761,0.970809,0.000040912335],"about_ca_topic_score_codex":0.0014755003,"about_ca_topic_score_gemma":0.004788809,"teacher_disagreement_score":0.0055122664,"about_ca_system_score_codex":0.00042896098,"about_ca_system_score_gemma":0.0009289604,"threshold_uncertainty_score":0.018440366},"labels":[],"label_agreement":null},{"id":"W4206267503","doi":"10.1007/s40257-021-00652-1","title":"Diagnosis of Generalized Pustular Psoriasis","year":2022,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"Boehringer Ingelheim","keywords":"Medicine; Disease; Generalized pustular psoriasis; Psoriasis; Differential diagnosis; Intensive care medicine; Dermatology; Pathology","score_opus":0.09468950018906415,"score_gpt":0.39441803776924406,"score_spread":0.2997285375801799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206267503","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4172325,0.3061432,0.10118952,0.021914698,0.0034982136,0.0015226844,0.0025838735,0.0023696749,0.14354566],"genre_scores_gemma":[0.87176734,0.08936029,0.023259372,0.005949757,0.0019339791,0.00016147362,0.0020210447,0.000114670016,0.005432013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933976,0.0001505551,0.00007235046,0.0001147984,0.00018878096,0.00013378917],"domain_scores_gemma":[0.999572,0.00012696409,0.000072970346,0.00002281413,0.00012179524,0.00008351416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061273767,0.0007353685,0.00086805463,0.0021948635,0.0007961763,0.0011189294,0.00062590983,0.0012714342,0.003181762],"category_scores_gemma":[0.0022595462,0.00035612544,0.0006599784,0.0007970093,0.0005789528,0.0012448137,0.0009997416,0.0018120627,0.0014590014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076576654,0.00028477306,0.15350163,0.0025048405,0.0001562274,0.26510376,0.001229197,0.00102155,0.035650577,0.008645274,0.05814434,0.472992],"study_design_scores_gemma":[0.00010837932,0.00034180592,0.059898645,0.0029387863,0.00023432045,0.8264826,0.0017293146,0.0035221775,0.009705411,0.009497137,0.08544259,0.00009885626],"about_ca_topic_score_codex":0.002037493,"about_ca_topic_score_gemma":0.0017385276,"teacher_disagreement_score":0.003181762,"about_ca_system_score_codex":0.0005729467,"about_ca_system_score_gemma":0.00070197566,"threshold_uncertainty_score":0.010644019},"labels":[],"label_agreement":null},{"id":"W4211167150","doi":"10.1007/s40257-018-0353-x","title":"Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)","year":2018,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Etanercept; Plaque psoriasis; Psoriasis; Clinical trial; Randomized controlled trial; Internal medicine; Dermatology; Pharmacology; Psoriatic arthritis; Tumor necrosis factor alpha; Secukinumab","score_opus":0.045482967405203044,"score_gpt":0.40517980120416425,"score_spread":0.3596968337989612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211167150","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009189407,0.0010728507,0.00032469412,0.042360805,0.95501715,0.00004373654,0.00050285197,0.000109714405,0.00047634912],"genre_scores_gemma":[0.0059227203,0.005617035,0.0028288814,0.13538593,0.8009606,0.00044878636,0.0012523967,0.00092239893,0.04666117],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9876815,0.003109582,0.0024228608,0.001472187,0.004283622,0.0010302094],"domain_scores_gemma":[0.92895275,0.026645103,0.0060026674,0.0033828176,0.0312856,0.0037311348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012422071,0.003151869,0.004218822,0.0034785497,0.002284084,0.0052848095,0.0039726547,0.008219006,0.02915272],"category_scores_gemma":[0.12067781,0.0021962204,0.0037225077,0.0024954479,0.002863799,0.0020363233,0.0020435853,0.016824963,0.013166261],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015341435,0.000013905143,0.000088548506,0.0002478556,0.00005861356,0.0001096221,0.000014949801,0.000035006233,0.00003695467,0.0001550946,0.995424,0.0036621343],"study_design_scores_gemma":[0.00113776,0.00014476774,0.002501881,0.0014899214,0.00038306095,0.0005773764,0.000097114906,0.00060580095,0.0005338744,0.0013716082,0.9910584,0.000098321914],"about_ca_topic_score_codex":0.011786827,"about_ca_topic_score_gemma":0.013110982,"teacher_disagreement_score":0.02915272,"about_ca_system_score_codex":0.0057205427,"about_ca_system_score_gemma":0.008761259,"threshold_uncertainty_score":0.0975256},"labels":[],"label_agreement":null},{"id":"W4225303623","doi":"10.1007/s40257-022-00685-0","title":"Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Glenmark Pharmaceuticals; LEO Pharma; Galderma; Incyte; Dermira; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Off-label use; Internal medicine","score_opus":0.036607971002882,"score_gpt":0.388442262458741,"score_spread":0.351834291455859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225303623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973003,0.0013312885,0.00016287349,0.000104980965,0.000024221961,0.00021527923,0.00026673588,0.000015957181,0.00057824503],"genre_scores_gemma":[0.9979157,0.00047915705,0.00034922923,0.00016700373,0.000058176036,0.00017300413,0.00038786244,0.0000035879505,0.00046636644],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99921465,0.0004314423,0.00006601772,0.00008916877,0.00010243266,0.00009629258],"domain_scores_gemma":[0.99905044,0.00025485278,0.00025240166,0.00009398948,0.000116758594,0.00023162119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027595074,0.00038542354,0.0008190196,0.00018054285,0.00034979172,0.0004983724,0.00021290887,0.0005204538,0.0014190787],"category_scores_gemma":[0.0015668059,0.0002063538,0.00087355374,0.00018585678,0.00028302884,0.00057922374,0.00021229527,0.0010073814,0.00024354472],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59005994,0.032383114,0.06790812,0.0013160203,0.0028602385,0.0005531516,0.0009525262,0.00087721966,0.06237614,0.00021408686,0.0031822142,0.23731712],"study_design_scores_gemma":[0.11151886,0.6282118,0.24039958,0.00009453824,0.001999508,0.0008123452,0.00025420552,0.0016941564,0.008191554,0.00016946612,0.0065957713,0.000058221663],"about_ca_topic_score_codex":0.0004619199,"about_ca_topic_score_gemma":0.0016912492,"teacher_disagreement_score":0.0027595074,"about_ca_system_score_codex":0.00029901823,"about_ca_system_score_gemma":0.0005012359,"threshold_uncertainty_score":0.01459384},"labels":[],"label_agreement":null},{"id":"W4226034331","doi":"10.1007/s40257-022-00690-3","title":"A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovaderm (Canada)","funders":"Incyte","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Dermatology; Pharmacotherapy; Internal medicine","score_opus":0.022736813773633416,"score_gpt":0.3382440697066223,"score_spread":0.3155072559329889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226034331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997088,0.0014116858,0.00006450342,0.00015426624,0.00002839411,0.00043053887,0.00015447558,0.000009496651,0.0006585846],"genre_scores_gemma":[0.99743503,0.00081392576,0.00024175648,0.00024999914,0.00008422939,0.00045421708,0.00026423004,0.000003023135,0.00045378026],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996007,0.00022642718,0.000024314835,0.00004995584,0.000038392693,0.0000603047],"domain_scores_gemma":[0.9994036,0.00015475845,0.00012723164,0.00002609592,0.000041757434,0.00024659443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012157364,0.0004934707,0.001066162,0.00014705268,0.00030992512,0.00049705047,0.00035180163,0.000687626,0.0028983597],"category_scores_gemma":[0.0009643013,0.00024336691,0.0007547433,0.0001488768,0.00030669218,0.00042064438,0.00027357272,0.0016686321,0.0003496152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7773339,0.052354187,0.045030653,0.001078741,0.0013665687,0.00056023645,0.00048575926,0.0006634899,0.01222593,0.00016096164,0.002663581,0.106076114],"study_design_scores_gemma":[0.525115,0.36524844,0.10143611,0.0001401617,0.0008652172,0.0006055439,0.00019501914,0.0009347318,0.0018303517,0.00009606275,0.003516875,0.00001656775],"about_ca_topic_score_codex":0.00062329444,"about_ca_topic_score_gemma":0.0016856525,"teacher_disagreement_score":0.0028983597,"about_ca_system_score_codex":0.0005072174,"about_ca_system_score_gemma":0.00080294925,"threshold_uncertainty_score":0.009696007},"labels":[],"label_agreement":null},{"id":"W4243004000","doi":"10.1007/s40257-019-00486-y","title":"Acknowledgement to Referees","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Foundation for the Arts","funders":"","keywords":"Medicine; Acknowledgement; Pharmacotherapy; Family medicine; Medical physics; Medical education; Internal medicine; Computer science","score_opus":0.03991488209805869,"score_gpt":0.4170627384689888,"score_spread":0.37714785637093007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243004000","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019723894,0.008974187,0.0041074166,0.32206014,0.58716166,0.0011988649,0.017627656,0.003615666,0.053282075],"genre_scores_gemma":[0.024817964,0.0048213922,0.008546139,0.16627386,0.1651762,0.0025190008,0.012263291,0.0031650222,0.61241716],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98557633,0.004013955,0.0016551401,0.0014768917,0.006350911,0.0009266533],"domain_scores_gemma":[0.7224774,0.033493243,0.006604934,0.011023251,0.2130378,0.013363489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010278075,0.0012772676,0.0022231308,0.0072323806,0.0035886304,0.0048501277,0.0037690145,0.0038316972,0.31630385],"category_scores_gemma":[0.20021553,0.00058649253,0.0016180627,0.003268903,0.0010704906,0.0023470346,0.005086285,0.0062212744,0.12908135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002645482,0.00000872176,0.0001222067,0.000121889614,0.000005728452,0.00017039946,0.000115914234,0.000018762872,0.00016449664,0.0004776536,0.9927644,0.0060034036],"study_design_scores_gemma":[0.000024687475,0.000014577576,0.0014781589,0.00029968936,0.000024947201,0.00064294046,0.0007226968,0.00014464346,0.00019056356,0.0013342507,0.9950858,0.000037065733],"about_ca_topic_score_codex":0.020519013,"about_ca_topic_score_gemma":0.024100976,"teacher_disagreement_score":0.31630385,"about_ca_system_score_codex":0.004988062,"about_ca_system_score_gemma":0.0074621905,"threshold_uncertainty_score":0.9752096},"labels":[],"label_agreement":null},{"id":"W4285992899","doi":"10.1007/s40257-022-00702-2","title":"Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research; BC Children's Hospital; University of Toronto","funders":"LEO Pharma","keywords":"Medicine; Atopic dermatitis; Post-hoc analysis; Pharmacotherapy; Dermatology; Post hoc; Pediatrics; Internal medicine","score_opus":0.013145860085310535,"score_gpt":0.3302098550957344,"score_spread":0.31706399501042387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285992899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949523,0.0012018216,0.00046570384,0.00015905051,0.000104894345,0.0012808846,0.00093908433,0.000043106516,0.00085316],"genre_scores_gemma":[0.9935341,0.0007384222,0.0009406702,0.00023621341,0.00016448763,0.0016587484,0.00087153935,0.00002869581,0.0018272022],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99663323,0.0020355533,0.00021353208,0.00033032525,0.00024678363,0.00054064253],"domain_scores_gemma":[0.99592614,0.0020051287,0.0007843376,0.00041750327,0.00031286018,0.00055411254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008745079,0.0015956433,0.0045652925,0.00045343977,0.00036898075,0.0012352825,0.0012921459,0.001171846,0.005064802],"category_scores_gemma":[0.004041115,0.00051946775,0.006397901,0.00053184817,0.00084520073,0.0012084069,0.0006222975,0.0027771667,0.0006662618],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9785267,0.0045295353,0.0014170458,0.00033167875,0.0025370012,0.000056007204,0.00005886832,0.000848696,0.0038304671,0.000047174533,0.00043919304,0.0073776823],"study_design_scores_gemma":[0.35630247,0.588503,0.033088993,0.000067170244,0.01080508,0.00012733684,0.000111673435,0.0043267985,0.0044220174,0.0001994926,0.001970782,0.00007508799],"about_ca_topic_score_codex":0.0010555324,"about_ca_topic_score_gemma":0.0018750072,"teacher_disagreement_score":0.008745079,"about_ca_system_score_codex":0.0009131978,"about_ca_system_score_gemma":0.0017092834,"threshold_uncertainty_score":0.046248913},"labels":[],"label_agreement":null},{"id":"W4292324125","doi":"10.1007/s40257-022-00722-y","title":"Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Secukinumab; Hazard ratio; Internal medicine; Ixekizumab; Retrospective cohort study; Discontinuation; Proportional hazards model; Psoriasis; Cohort; Confidence interval; Psoriatic arthritis; Immunology; Arthritis","score_opus":0.025827744074120234,"score_gpt":0.3257116528310061,"score_spread":0.29988390875688586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292324125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989365,0.00042014456,0.000077901466,0.000022118313,0.0000073658025,0.000008262622,0.00036123634,0.0000017250114,0.00016474245],"genre_scores_gemma":[0.9992107,0.00016769412,0.00005077147,0.000035496698,0.00001009599,0.000009907516,0.00037617283,0.000002426696,0.00013679071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992055,0.0002086441,0.00007852237,0.00026728876,0.00009223512,0.00014784362],"domain_scores_gemma":[0.9986431,0.00018539405,0.0005685181,0.00022712917,0.00015400254,0.00022181444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007919937,0.00033989217,0.0006154094,0.00047419366,0.0005676984,0.0010481756,0.0003637832,0.0005809762,0.0014656034],"category_scores_gemma":[0.0014427045,0.00053657393,0.0011457916,0.0011750098,0.00030798023,0.0006323508,0.00038712152,0.0008755891,0.00025665187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018342792,0.00011472398,0.99524057,0.000018861081,0.0004992166,0.00020128563,0.000093862516,0.000049395418,0.0004995157,0.000029217877,0.00014527013,0.001273791],"study_design_scores_gemma":[0.0000910611,0.0005895404,0.9975303,0.000007694459,0.0003304322,0.0005496895,0.0002670237,0.0001601802,0.000090628,0.000022842543,0.0003487691,0.000011797129],"about_ca_topic_score_codex":0.0034822626,"about_ca_topic_score_gemma":0.0028604337,"teacher_disagreement_score":0.0034822626,"about_ca_system_score_codex":0.00043904386,"about_ca_system_score_gemma":0.00045022264,"threshold_uncertainty_score":0.0069239736},"labels":[],"label_agreement":null},{"id":"W4308834973","doi":"10.1007/s40257-022-00739-3","title":"Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"","keywords":"Medicine; Roflumilast; Psoriasis; Psoriasis Area and Severity Index; Eczema Area and Severity Index; Erythema; Dermatology; Dermatology Life Quality Index; Severity of illness; Body surface area; Dose-ranging study; Randomized controlled trial; Post-hoc analysis; Physical therapy; Internal medicine; Atopic dermatitis; Placebo; Double blind; Pathology; COPD","score_opus":0.011840739231970945,"score_gpt":0.30982363626329584,"score_spread":0.2979828970313249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308834973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97500414,0.014229495,0.000435866,0.00089644984,0.0002805617,0.0034919414,0.0019286033,0.00013681324,0.003596181],"genre_scores_gemma":[0.98564965,0.0044258293,0.00090664695,0.0013236479,0.0003660339,0.0037883932,0.0016975356,0.000022153848,0.0018200057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994048,0.0003122358,0.000052085717,0.000093570554,0.00006191422,0.000075452466],"domain_scores_gemma":[0.9990816,0.00025724331,0.00027690132,0.000066256536,0.00008980339,0.00022822032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020837807,0.0010594326,0.0019316081,0.00032379746,0.00034968072,0.0007181211,0.0006242918,0.0012977362,0.005334568],"category_scores_gemma":[0.0015686257,0.00038381154,0.0018617858,0.0002824447,0.00047045652,0.0007462363,0.00027037732,0.0019994806,0.0009050459],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9044321,0.013308331,0.003734447,0.0025155211,0.0029851764,0.000087296474,0.00010462997,0.00054504967,0.00776398,0.00012623961,0.002929411,0.061467655],"study_design_scores_gemma":[0.8986009,0.09000378,0.008656763,0.00008889773,0.0008448974,0.00008869475,0.000024613091,0.000328396,0.00040068393,0.000081691906,0.0008628912,0.000017901402],"about_ca_topic_score_codex":0.0007270939,"about_ca_topic_score_gemma":0.0016596382,"teacher_disagreement_score":0.005334568,"about_ca_system_score_codex":0.00043341328,"about_ca_system_score_gemma":0.0006152792,"threshold_uncertainty_score":0.017845869},"labels":[],"label_agreement":null},{"id":"W4321003521","doi":"10.1007/s40257-023-00763-x","title":"Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009–2022)","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Lady Davis Institute for Medical Research; Compute Canada; Fondation de l'Hôpital général juif; Jewish General Hospital; Terry Fox Research Institute; Fonds de Recherche du Québec - Santé","keywords":"Meta-analysis; Medicine; Systematic review; Basal cell carcinoma; Oncology; Sonic hedgehog; Internal medicine; Bioinformatics; MEDLINE; Basal cell; Biology; Genetics","score_opus":0.08804275370804993,"score_gpt":0.4070937080088804,"score_spread":0.31905095430083047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321003521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007944132,0.98989934,0.00039388405,0.00018188845,0.00013443113,0.00011078861,0.0010192257,0.000016175496,0.00030018465],"genre_scores_gemma":[0.21394663,0.78057235,0.0015313908,0.0014283004,0.000266876,0.0002781763,0.0013795735,0.000023995133,0.0005728224],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99675983,0.0011654707,0.0010966454,0.0004583667,0.00037824054,0.00014147557],"domain_scores_gemma":[0.99496573,0.002948486,0.0013844135,0.00019035458,0.000417381,0.00009357298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053893914,0.0012434905,0.009384138,0.0024685992,0.00021621292,0.001396806,0.0010892847,0.0009818391,0.0028385215],"category_scores_gemma":[0.009756076,0.0008337796,0.016536247,0.0036535626,0.0003896202,0.0010510485,0.0009772177,0.0010388097,0.00027127538],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052253455,0.0000351657,0.0072714463,0.3249439,0.616207,0.00020759077,0.000094778945,0.0005328833,0.00085849635,0.00013250555,0.0021994952,0.0422914],"study_design_scores_gemma":[0.0016895739,0.00035299297,0.009761146,0.011604211,0.972013,0.00017017905,0.000047785663,0.00009518279,0.00020474818,0.00015408522,0.0038764256,0.000030710078],"about_ca_topic_score_codex":0.003358835,"about_ca_topic_score_gemma":0.011260461,"teacher_disagreement_score":0.009384138,"about_ca_system_score_codex":0.0010750439,"about_ca_system_score_gemma":0.0014286749,"threshold_uncertainty_score":0.028502166},"labels":[],"label_agreement":null},{"id":"W4321435758","doi":"10.1007/s40257-022-00754-4","title":"Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Placebo; Eczema Area and Severity Index; Atopic dermatitis; Dermatology Life Quality Index; Adverse effect; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Pathology; Disease","score_opus":0.0714840113927091,"score_gpt":0.4185551478489848,"score_spread":0.3470711364562757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321435758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5482591,0.4371661,0.004194709,0.00049873034,0.0004915422,0.002936083,0.0044803047,0.00018420989,0.0017892655],"genre_scores_gemma":[0.9575644,0.03493148,0.0023320518,0.00047098676,0.00029102704,0.0017835457,0.0023294135,0.000030338846,0.0002667074],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9778545,0.013822168,0.0040973183,0.0020895365,0.0016831598,0.00045332315],"domain_scores_gemma":[0.9761662,0.012841676,0.008167415,0.0013139677,0.0010010515,0.00050970435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030944543,0.0020854343,0.0102611855,0.002474369,0.00037351652,0.0024081487,0.00090219866,0.0016157536,0.0014920045],"category_scores_gemma":[0.024591668,0.0010246333,0.018465038,0.002505375,0.0007804359,0.0012552764,0.0010240693,0.0011670726,0.00018198653],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29928124,0.0004140243,0.03148611,0.018764514,0.61267316,0.000110115834,0.00012281182,0.0016425089,0.002051198,0.00009025245,0.00065529655,0.032708734],"study_design_scores_gemma":[0.12343474,0.027451793,0.08154563,0.0018044828,0.7597773,0.00035810337,0.000117103395,0.001316818,0.0012538375,0.00043752044,0.0023927363,0.0001099341],"about_ca_topic_score_codex":0.0006451006,"about_ca_topic_score_gemma":0.0012400174,"teacher_disagreement_score":0.030944543,"about_ca_system_score_codex":0.00077560055,"about_ca_system_score_gemma":0.0010427982,"threshold_uncertainty_score":0.16365236},"labels":[],"label_agreement":null},{"id":"W4367187120","doi":"10.1007/s40257-023-00778-4","title":"Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Monkeypox; Chills; Rash; Outbreak; Transmission (telecommunications); Smallpox; Intensive care medicine; Health care; Adverse effect; Public health; Disease; Dermatology; Virology; Vaccination; Vaccinia; Surgery; Pathology; Internal medicine","score_opus":0.153715069364175,"score_gpt":0.4852617229763247,"score_spread":0.3315466536121497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367187120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044142733,0.9991246,0.00007441123,0.00032681078,0.00025088442,0.0000026750017,0.000009303369,0.0000037357895,0.00016358493],"genre_scores_gemma":[0.0004506733,0.9981982,0.00024100902,0.0004405766,0.00050969276,0.0000042794754,0.000021601963,9.646425e-7,0.00013294749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965227,0.00007022378,0.00007933763,0.00006363381,0.000108400636,0.000026070567],"domain_scores_gemma":[0.9991042,0.00047371478,0.00013214687,0.000015842757,0.00021057605,0.00006347991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082365837,0.0010202699,0.0017972651,0.0026897409,0.00033484696,0.0011082983,0.0010590345,0.0014740301,0.0025902044],"category_scores_gemma":[0.0015970827,0.00033631994,0.0008953157,0.001417242,0.00052900176,0.0018791872,0.0006779391,0.0024887838,0.0010335644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009222758,0.0000824916,0.00066162925,0.019386703,0.00012722952,0.0006261041,0.00006032689,0.00026319863,0.00079897617,0.0010867298,0.056948747,0.91986567],"study_design_scores_gemma":[0.000075105054,0.00027585807,0.0040204576,0.032650217,0.0007888534,0.010771623,0.00036094873,0.00035986223,0.00039987118,0.0033864947,0.9468346,0.00007603212],"about_ca_topic_score_codex":0.0018291232,"about_ca_topic_score_gemma":0.0036759044,"teacher_disagreement_score":0.0026897409,"about_ca_system_score_codex":0.0006568963,"about_ca_system_score_gemma":0.0012482278,"threshold_uncertainty_score":0.008665085},"labels":[],"label_agreement":null},{"id":"W4375852732","doi":"10.1007/s40257-023-00779-3","title":"Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Acute generalized exanthematous pustulosis; Dermatology; Differential diagnosis; Etiology; Disease; Intensive care medicine; Acne; Desquamation; Pathology","score_opus":0.14832034626515395,"score_gpt":0.5024705409521212,"score_spread":0.35415019468696723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375852732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001446633,0.99926025,0.000086126485,0.0001257541,0.00008133601,0.000002999583,0.000008196928,0.0000044668177,0.00028622142],"genre_scores_gemma":[0.0014542936,0.997752,0.00017745847,0.00019892496,0.00025640946,0.0000037344234,0.00002171004,9.0776615e-7,0.00013462054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968684,0.00006178363,0.00006507089,0.000060666913,0.00009959203,0.00002604205],"domain_scores_gemma":[0.999316,0.00035750118,0.00014708558,0.000012994569,0.00011378551,0.00005265577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005601277,0.0010009292,0.0019166296,0.0023003684,0.00027544214,0.0011232856,0.00094405626,0.0010300301,0.0018637637],"category_scores_gemma":[0.0011657814,0.00032164468,0.0006463197,0.0016250621,0.00050442177,0.0012209621,0.00067206006,0.0018936899,0.00086800545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000925724,0.00010905707,0.0012173497,0.015912607,0.00014854764,0.0016797062,0.000061362334,0.0003769791,0.00090095826,0.0008242226,0.021192778,0.95748377],"study_design_scores_gemma":[0.00015385287,0.00038608143,0.012790121,0.028811783,0.0012413918,0.06372042,0.0005601085,0.0009189026,0.000852571,0.004347768,0.8860697,0.0001472362],"about_ca_topic_score_codex":0.00091313553,"about_ca_topic_score_gemma":0.0020998318,"teacher_disagreement_score":0.0023003684,"about_ca_system_score_codex":0.00039241064,"about_ca_system_score_gemma":0.0009424318,"threshold_uncertainty_score":0.006234944},"labels":[],"label_agreement":null},{"id":"W4376609056","doi":"10.1007/s40257-023-00780-w","title":"Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Clinical endpoint; Maintenance therapy; Adverse effect; Eczema Area and Severity Index; Double blind; Incidence (geometry); Randomized controlled trial; Placebo; Surgery; Internal medicine; Dermatology; Chemotherapy","score_opus":0.04220595719627587,"score_gpt":0.3948880800747534,"score_spread":0.35268212287847756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376609056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640733,0.0018971333,0.000114422466,0.00010236682,0.00006648836,0.0006243515,0.00018537315,0.000024512641,0.00057792984],"genre_scores_gemma":[0.994306,0.0021686084,0.00046066183,0.00051824807,0.0002266026,0.000725165,0.00047010413,0.000008304437,0.0011162539],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996748,0.00012422063,0.000027200975,0.00006025599,0.000040105166,0.000073432275],"domain_scores_gemma":[0.9994248,0.00008290927,0.000096943986,0.000048411588,0.0000552971,0.00029160586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012281388,0.00085887156,0.002400132,0.0003994539,0.0004582052,0.0006344314,0.00061516574,0.0009016512,0.0022369728],"category_scores_gemma":[0.000617947,0.000466988,0.0017462291,0.00033999994,0.00055467547,0.00068073504,0.00028230605,0.0019050166,0.00059350417],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7668785,0.10778734,0.009409813,0.0012392036,0.0018191809,0.00038623912,0.00031182764,0.00068165176,0.037324775,0.0000887261,0.0013484386,0.072724275],"study_design_scores_gemma":[0.30537188,0.6590217,0.031798698,0.000040034854,0.0008938791,0.00014922493,0.00006247601,0.0004671035,0.0011182674,0.000031473322,0.0010162794,0.000029080871],"about_ca_topic_score_codex":0.0011431844,"about_ca_topic_score_gemma":0.0027902792,"teacher_disagreement_score":0.002400132,"about_ca_system_score_codex":0.00042472707,"about_ca_system_score_gemma":0.00090111396,"threshold_uncertainty_score":0.007483363},"labels":[],"label_agreement":null},{"id":"W4376871458","doi":"10.1007/s40257-023-00792-6","title":"Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Clinical trial; Pediatrics; Internal medicine","score_opus":0.04778213975216787,"score_gpt":0.41340118672728016,"score_spread":0.36561904697511227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376871458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6865265,0.30028114,0.0016807101,0.0011844302,0.00015587514,0.0024941629,0.00399863,0.00009415013,0.0035843714],"genre_scores_gemma":[0.9508981,0.04158044,0.0019219927,0.0010809497,0.0001821707,0.0008362337,0.003077996,0.000021449354,0.0004007192],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99392635,0.003234323,0.0010427025,0.00057508977,0.00097330334,0.00024826825],"domain_scores_gemma":[0.98917216,0.0050203768,0.003515567,0.00047081878,0.0012205078,0.000600639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012319559,0.0005247199,0.0023852785,0.0008339623,0.0002335706,0.0015435978,0.00042978863,0.00088799867,0.0012832186],"category_scores_gemma":[0.010374045,0.0003114506,0.0044745016,0.0010303152,0.0003832421,0.00076004816,0.0005457347,0.0013158032,0.00016031193],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2627156,0.0018652437,0.18718731,0.023147285,0.105109654,0.00034144678,0.00043252125,0.002094934,0.011367509,0.00044017794,0.0047291624,0.40056905],"study_design_scores_gemma":[0.18360324,0.09119924,0.53034246,0.007927062,0.14345936,0.0020169206,0.00047790026,0.002689479,0.005678722,0.0012470507,0.031208279,0.0001502517],"about_ca_topic_score_codex":0.000419323,"about_ca_topic_score_gemma":0.0015407482,"teacher_disagreement_score":0.012319559,"about_ca_system_score_codex":0.0006992986,"about_ca_system_score_gemma":0.0011867462,"threshold_uncertainty_score":0.06515288},"labels":[],"label_agreement":null},{"id":"W4376872206","doi":"10.1007/s40257-023-00784-6","title":"Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials","year":2023,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Medicine; Dupilumab; Atopic dermatitis; Randomized controlled trial; Dermatology; Pharmacotherapy; Clinical trial; Pooled analysis; Internal medicine; Meta-analysis","score_opus":0.05962794377999545,"score_gpt":0.40276020670482243,"score_spread":0.34313226292482696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376872206","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008186815,0.0012736216,0.00036015737,0.03207875,0.96348345,0.000050226547,0.0012911356,0.0001554075,0.0012254538],"genre_scores_gemma":[0.010736027,0.011277568,0.005794627,0.1773301,0.6594498,0.0006837053,0.0036635413,0.0016935376,0.12937102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905814,0.002313667,0.002110709,0.0010421232,0.003303813,0.00064832874],"domain_scores_gemma":[0.92538464,0.028194238,0.00506501,0.004444233,0.03385187,0.003060031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010829941,0.0031191304,0.004903067,0.005016238,0.0026277807,0.0061449665,0.0049846293,0.0074565555,0.047357127],"category_scores_gemma":[0.120625,0.0025345194,0.003941329,0.0046010604,0.002378918,0.0022851524,0.0014085283,0.014832038,0.022471106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009010109,0.000007953142,0.00006481636,0.0002892563,0.000059424747,0.00012067316,0.000012410157,0.000035212262,0.000021817446,0.0001872137,0.9961165,0.002994531],"study_design_scores_gemma":[0.0010007282,0.000088190856,0.0018219992,0.0017880311,0.0005681576,0.0007019039,0.00008389029,0.00050297176,0.0003655075,0.0015833043,0.99139786,0.00009731471],"about_ca_topic_score_codex":0.018451868,"about_ca_topic_score_gemma":0.02578554,"teacher_disagreement_score":0.047357127,"about_ca_system_score_codex":0.005783451,"about_ca_system_score_gemma":0.009929826,"threshold_uncertainty_score":0.15842533},"labels":[],"label_agreement":null},{"id":"W4385651095","doi":"10.1007/s40257-023-00811-6","title":"Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Itraconazole; Terbinafine; Medicine; Voriconazole; Fluconazole; Griseofulvin; Dermatology; Pharmacology; Antifungal","score_opus":0.09327526366804266,"score_gpt":0.43481238422380614,"score_spread":0.34153712055576346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385651095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000438623,0.999589,0.00003405298,0.00011648735,0.00007592615,0.0000012340154,0.000004383246,0.0000021350402,0.00013302537],"genre_scores_gemma":[0.0004751711,0.9988538,0.00013107313,0.00021904802,0.00019071283,0.0000024050582,0.000013055683,7.757306e-7,0.000113978596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996158,0.00007737303,0.000083580446,0.000060233127,0.00013444513,0.00002862221],"domain_scores_gemma":[0.9991992,0.00041122868,0.00017278183,0.000012761675,0.00015220745,0.00005175285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010030838,0.00091393635,0.0022322852,0.0025922342,0.00023355012,0.0011416216,0.0011146347,0.0013941886,0.002306278],"category_scores_gemma":[0.0014242404,0.0003500419,0.0010044953,0.0018136563,0.00040770328,0.0012626925,0.00055450975,0.002259185,0.00073303055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018879851,0.0001467063,0.0003627904,0.02754291,0.00027536647,0.00036007562,0.00005145521,0.00035574473,0.0010951087,0.0011721298,0.028839555,0.9396093],"study_design_scores_gemma":[0.00022124387,0.00058347866,0.0051105595,0.029038187,0.001788426,0.0062743276,0.00019298687,0.0005773085,0.0006970457,0.0023599332,0.95306677,0.00008960902],"about_ca_topic_score_codex":0.001446051,"about_ca_topic_score_gemma":0.003906944,"teacher_disagreement_score":0.0025922342,"about_ca_system_score_codex":0.00045587332,"about_ca_system_score_gemma":0.00092733686,"threshold_uncertainty_score":0.007715285},"labels":[],"label_agreement":null},{"id":"W4386153609","doi":"10.1007/s40257-023-00810-7","title":"Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Post-hoc analysis; JADE (particle detector); Dermatology; Post hoc; Sleep (system call); Work productivity; Productivity; Internal medicine","score_opus":0.018667143190910195,"score_gpt":0.3217709866784355,"score_spread":0.30310384348752534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386153609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980914,0.0005466239,0.00040750753,0.000065362234,0.00005694963,0.000109095956,0.00038247797,0.000012384889,0.0003280605],"genre_scores_gemma":[0.99830353,0.00007170424,0.00025475433,0.000054789856,0.000047939975,0.00016762338,0.0005123592,0.000007105771,0.0005801647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958566,0.0024245095,0.00027245938,0.00062400394,0.00040273456,0.00041974187],"domain_scores_gemma":[0.99549484,0.0026217112,0.00054630055,0.0007177267,0.00027933,0.0003400709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059597464,0.00080045575,0.0021521356,0.0004122863,0.00038190561,0.00087504904,0.00089738553,0.00061517366,0.0031569176],"category_scores_gemma":[0.0047160992,0.00034703367,0.0054297624,0.00041179097,0.00038381648,0.0007158585,0.00075971044,0.00119144,0.00030862275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25284204,0.0034210894,0.6753073,0.0006841591,0.025770063,0.00056907337,0.0004333259,0.0027406532,0.008913222,0.0002325003,0.0017488351,0.027337776],"study_design_scores_gemma":[0.0071655153,0.040488813,0.92881477,0.00003797638,0.009854637,0.00026168942,0.0003156187,0.008675968,0.00214893,0.0001654241,0.0020194752,0.000051130544],"about_ca_topic_score_codex":0.0014832132,"about_ca_topic_score_gemma":0.0019592543,"teacher_disagreement_score":0.0059597464,"about_ca_system_score_codex":0.0004956271,"about_ca_system_score_gemma":0.0008803638,"threshold_uncertainty_score":0.03151852},"labels":[],"label_agreement":null},{"id":"W4386529783","doi":"10.1007/s40257-023-00806-3","title":"Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"LEO Pharma; Ludwig-Maximilians-Universität München","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Post-hoc analysis; Atopic dermatitis; Regimen; Randomized controlled trial; Internal medicine; Clinical trial; Dermatology","score_opus":0.07569444120710184,"score_gpt":0.43786725018776146,"score_spread":0.3621728089806596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386529783","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47995153,0.50527716,0.002399566,0.0010444,0.0007136926,0.0017511671,0.0052032587,0.00027236773,0.0033868554],"genre_scores_gemma":[0.91745913,0.07112078,0.0016994932,0.0016466493,0.0007083653,0.0013501821,0.0050510988,0.000048146307,0.00091602956],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99573684,0.001925221,0.0007849891,0.000735782,0.00054399687,0.0002732035],"domain_scores_gemma":[0.99408215,0.0023029095,0.0022152343,0.00042966483,0.0005547972,0.00041529626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0150828045,0.0015793842,0.0067308876,0.0008938978,0.00044536867,0.0018334106,0.00081357785,0.0014894755,0.0016135974],"category_scores_gemma":[0.008378805,0.00069934945,0.011345026,0.0015083619,0.0003975298,0.0012165398,0.0005968784,0.0021728354,0.0002545534],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50087076,0.001352723,0.032849383,0.02620487,0.28416166,0.00023631459,0.00027734204,0.0024074614,0.008607645,0.0001712036,0.005610229,0.13725042],"study_design_scores_gemma":[0.21643193,0.08458729,0.24735908,0.0032041892,0.4309166,0.0009691273,0.00018135604,0.0015321746,0.0029981735,0.000534419,0.011095136,0.00019053179],"about_ca_topic_score_codex":0.0010565545,"about_ca_topic_score_gemma":0.0034453084,"teacher_disagreement_score":0.0150828045,"about_ca_system_score_codex":0.0008200727,"about_ca_system_score_gemma":0.0011872081,"threshold_uncertainty_score":0.07976645},"labels":[],"label_agreement":null},{"id":"W4390815344","doi":"10.1007/s40257-023-00837-w","title":"Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Dupilumab; Janus kinase; Clinical trial; Intensive care medicine; Dermatology; Immunology; Internal medicine","score_opus":0.01717014091111071,"score_gpt":0.33215766984991213,"score_spread":0.31498752893880144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390815344","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7638408,0.15561289,0.005141572,0.028822012,0.002088076,0.0002645283,0.00040685848,0.00013697005,0.04368632],"genre_scores_gemma":[0.93202466,0.039378766,0.0071540377,0.013913856,0.0028941801,0.00013063897,0.0004437652,0.000054701195,0.0040054265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996406,0.00007491925,0.000052456064,0.0000502415,0.000113704744,0.00006818125],"domain_scores_gemma":[0.99929774,0.00028531207,0.00012306408,0.000023021574,0.000099222845,0.00017164949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055501075,0.00022144764,0.0006963295,0.00029672077,0.00046041296,0.0007994495,0.00016549995,0.00045977332,0.0021063758],"category_scores_gemma":[0.0014646783,0.00009252404,0.0004615909,0.00028718958,0.00019725855,0.0006332042,0.00028807012,0.00097537594,0.0005710163],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029022885,0.0006570924,0.15837252,0.00040894668,0.00018937826,0.0019136353,0.0001948732,0.00041229872,0.0062242583,0.0011400698,0.025684293,0.8019004],"study_design_scores_gemma":[0.0025933757,0.010255882,0.62695193,0.0043072863,0.0023010278,0.055400036,0.0023478698,0.0040568444,0.01138164,0.0094866995,0.2707878,0.0001296453],"about_ca_topic_score_codex":0.0004499652,"about_ca_topic_score_gemma":0.002280261,"teacher_disagreement_score":0.0021063758,"about_ca_system_score_codex":0.00029211605,"about_ca_system_score_gemma":0.0005590301,"threshold_uncertainty_score":0.0070465207},"labels":[],"label_agreement":null},{"id":"W4391130620","doi":"10.1007/s40257-024-00846-3","title":"Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"National Center for Advancing Translational Sciences; Pfizer","keywords":"Medicine; Placebo; Internal medicine; Alopecia areata; Adverse effect; Cohort; Gastroenterology; Incidence (geometry); Surgery; Dermatology; Pathology","score_opus":0.11009822980209649,"score_gpt":0.46786878886518185,"score_spread":0.35777055906308536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391130620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728968,0.016011408,0.0022256663,0.0003629292,0.00004821362,0.0029258549,0.0031326727,0.00007841471,0.002318021],"genre_scores_gemma":[0.98960274,0.0025357355,0.001647994,0.00031316528,0.000119930264,0.0011932214,0.004021199,0.0000126881905,0.00055331044],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9935796,0.0040134266,0.0003992855,0.00056237204,0.0011828335,0.00026248075],"domain_scores_gemma":[0.9907115,0.002823849,0.0040074196,0.00059230305,0.0011693181,0.0006955593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014952696,0.000656239,0.0016915158,0.00089210167,0.0003547122,0.0012252966,0.00065843726,0.0006681644,0.002446683],"category_scores_gemma":[0.007364588,0.00031100342,0.0031266552,0.00073521194,0.0004169136,0.00067966146,0.00070720114,0.0009440167,0.00019794889],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5210551,0.005626989,0.15216883,0.0060458486,0.05291517,0.00047267668,0.0003974537,0.0052846936,0.021951493,0.00042758483,0.0040647085,0.22958942],"study_design_scores_gemma":[0.19483307,0.22779013,0.4926742,0.000771603,0.049882416,0.0016677165,0.00013339423,0.005045002,0.010065446,0.0006087703,0.016405717,0.00012261762],"about_ca_topic_score_codex":0.00051142945,"about_ca_topic_score_gemma":0.0015763186,"teacher_disagreement_score":0.014952696,"about_ca_system_score_codex":0.0009651253,"about_ca_system_score_gemma":0.00218338,"threshold_uncertainty_score":0.07907832},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4392926834","doi":"10.1007/s40257-024-00854-3","title":"Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; Memorial University of Newfoundland; Centre de Recherche Dermatologique du Québec Métropolitain; McGill University Health Centre; McGill University; University of Toronto","funders":"","keywords":"Psoriasis; Medicine; Incidence (geometry); Demography; Context (archaeology); Socioeconomic status; Environmental health; Gerontology; Population; Geography; Dermatology","score_opus":0.03423073616569131,"score_gpt":0.3359677600582995,"score_spread":0.30173702389260815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392926834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940222,0.0007456658,0.0004686706,0.00045387502,0.000024750952,0.000070824295,0.0027205416,0.000015863225,0.0014775044],"genre_scores_gemma":[0.99532855,0.0004721008,0.00050157384,0.00016099664,0.0000117508125,0.0000407898,0.0012808082,0.000014571513,0.0021888926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991036,0.00015641362,0.000053802218,0.0001712192,0.00023002214,0.00028490674],"domain_scores_gemma":[0.9970392,0.00029617597,0.00031456855,0.00013315798,0.0016626654,0.0005541697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011462959,0.00052664924,0.00069029507,0.0013577905,0.0046700384,0.0016904676,0.0014949512,0.0007481987,0.0025761754],"category_scores_gemma":[0.002772385,0.00036657366,0.0008127402,0.0041844845,0.0008471661,0.00045734885,0.00064322626,0.0014505569,0.00039083368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001827929,0.00015885655,0.98716474,0.00003040024,0.00015646248,0.00020626356,0.0013993076,0.00036473488,0.0003552469,0.00022600645,0.0026957225,0.0070595033],"study_design_scores_gemma":[0.000034399767,0.00004826843,0.9956696,0.00003768115,0.00006382173,0.00010300575,0.0016265579,0.0010781798,0.000048515056,0.000058830163,0.001212563,0.000018544297],"about_ca_topic_score_codex":0.9962728,"about_ca_topic_score_gemma":0.9978077,"teacher_disagreement_score":0.021546816,"about_ca_system_score_codex":0.021546816,"about_ca_system_score_gemma":0.018473702,"threshold_uncertainty_score":0.15633386},"labels":[],"label_agreement":null},{"id":"W4393164331","doi":"10.1007/s40257-024-00853-4","title":"Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"National Center for Advancing Translational Sciences; AbbVie","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Quality of life (healthcare); Clinical trial; Pharmacotherapy; Pediatrics; Internal medicine; Dermatology","score_opus":0.05139782894144093,"score_gpt":0.4066843368383661,"score_spread":0.3552865078969252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393164331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924522,0.0054002726,0.0001927814,0.00016624089,0.00003906825,0.00070916355,0.00043104848,0.000025062169,0.00058422226],"genre_scores_gemma":[0.9950229,0.0023619172,0.0006184444,0.0003443867,0.000052302265,0.00073676533,0.0005584817,0.0000053085664,0.00029956157],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993673,0.00028149507,0.00006455901,0.00008340188,0.000098357596,0.0001048441],"domain_scores_gemma":[0.9994087,0.00011503407,0.00020186913,0.000034660326,0.000054656834,0.00018508712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017947671,0.0004987652,0.0016506542,0.00023455746,0.00024146473,0.00066465477,0.0003123066,0.0006205687,0.0011272873],"category_scores_gemma":[0.0011488847,0.00027003494,0.0013823122,0.00031786738,0.00032751495,0.00046798645,0.00028281088,0.0014629505,0.00013126979],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6331574,0.03392443,0.03773599,0.003010655,0.005108263,0.00024519966,0.0003660837,0.0014366297,0.027239542,0.00017326808,0.002907396,0.25469518],"study_design_scores_gemma":[0.37825233,0.41300446,0.19485222,0.00027859592,0.0036266036,0.00041951844,0.0001683148,0.001309444,0.004794678,0.00013512916,0.003103457,0.00005530943],"about_ca_topic_score_codex":0.0006804554,"about_ca_topic_score_gemma":0.0026864351,"teacher_disagreement_score":0.0017947671,"about_ca_system_score_codex":0.00046822784,"about_ca_system_score_gemma":0.0007644224,"threshold_uncertainty_score":0.009491742},"labels":[],"label_agreement":null},{"id":"W4396573295","doi":"10.1007/s40257-024-00855-2","title":"Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Incyte","keywords":"Medicine; Ruxolitinib; Atopic dermatitis; Dermatology; Randomized controlled trial; Pharmacotherapy; Term (time); Dupilumab; Internal medicine; Disease; Disease control; Myelofibrosis; Environmental health","score_opus":0.021750270050277888,"score_gpt":0.38418697223797615,"score_spread":0.36243670218769825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396573295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80861884,0.17394018,0.0032412296,0.00062989164,0.0005547311,0.0056619872,0.0045426325,0.0002158094,0.002594616],"genre_scores_gemma":[0.96979874,0.021551574,0.0017763312,0.00081069244,0.00041493832,0.0028293852,0.0023512216,0.00003998455,0.0004270912],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9918576,0.0050824136,0.0013084747,0.0007365433,0.0006982046,0.00031680163],"domain_scores_gemma":[0.99070275,0.003918908,0.0034978231,0.00067930564,0.0007221733,0.00047911768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014013651,0.0016404432,0.0062943595,0.00086583087,0.00040615414,0.0019269135,0.0009234221,0.0018242213,0.0024276196],"category_scores_gemma":[0.01254537,0.00086997106,0.01207801,0.001196391,0.0008032179,0.0011788151,0.00072575716,0.0017072983,0.0003151793],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7699374,0.0016958462,0.011712698,0.009494214,0.15512525,0.00011079379,0.00013536603,0.0010001032,0.0028858415,0.00007899612,0.0010298115,0.046793602],"study_design_scores_gemma":[0.62252724,0.07272602,0.05759205,0.0014595804,0.23944667,0.0003061843,0.00011911481,0.000947913,0.0015875841,0.00033752946,0.002849774,0.000100289326],"about_ca_topic_score_codex":0.0008099149,"about_ca_topic_score_gemma":0.0022485447,"teacher_disagreement_score":0.014013651,"about_ca_system_score_codex":0.0009625633,"about_ca_system_score_gemma":0.0012309297,"threshold_uncertainty_score":0.07411212},"labels":[],"label_agreement":null},{"id":"W4396948193","doi":"10.1007/s40257-024-00867-y","title":"Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Alberta; Stollery Children's Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Pediatrics; Population; MEDLINE; Pathology","score_opus":0.04453943385293979,"score_gpt":0.4296405962073905,"score_spread":0.3851011623544507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396948193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024805978,0.9995796,0.000017396958,0.00003314824,0.000027137938,0.000009730307,0.000028717139,0.0000010640192,0.000055071872],"genre_scores_gemma":[0.0026758602,0.9970072,0.00010639321,0.000096007774,0.000029058614,0.000015521993,0.000034274795,7.4659334e-7,0.000034980152],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986314,0.0002709967,0.000582284,0.00015802833,0.00028958617,0.000067619374],"domain_scores_gemma":[0.9946439,0.0037275993,0.0011843321,0.00004858628,0.00032205318,0.000073608375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030873765,0.00081194943,0.0048190895,0.0028922148,0.00030656735,0.0019481065,0.0011975807,0.001505484,0.0026917844],"category_scores_gemma":[0.008181353,0.00054369814,0.0049168523,0.0030909628,0.00042225802,0.0012784055,0.0008370708,0.0012257227,0.00022205719],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045966057,0.000100979414,0.0029178846,0.64059484,0.010886449,0.00025370298,0.00022690314,0.0003304491,0.00033000112,0.00042373588,0.004747975,0.33872747],"study_design_scores_gemma":[0.00037507465,0.00049876183,0.015320674,0.8238882,0.06688106,0.0019871918,0.00058196473,0.00021660155,0.00036399256,0.0005717733,0.08922177,0.00009298484],"about_ca_topic_score_codex":0.004299876,"about_ca_topic_score_gemma":0.011747645,"teacher_disagreement_score":0.0048190895,"about_ca_system_score_codex":0.0009671518,"about_ca_system_score_gemma":0.002667722,"threshold_uncertainty_score":0.016327798},"labels":[],"label_agreement":null},{"id":"W4398775198","doi":"10.1007/s40257-024-00864-1","title":"Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2024,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"National Center for Advancing Translational Sciences","keywords":"Alopecia areata; Medicine; TEC; Dermatology; Clinical trial; Pharmacotherapy; Family medicine; Internal medicine","score_opus":0.10880036531010523,"score_gpt":0.4783574250397168,"score_spread":0.36955705972961156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398775198","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088506046,0.0020519109,0.005046208,0.17626332,0.7110963,0.0004596553,0.05668783,0.0047205696,0.042789105],"genre_scores_gemma":[0.026159171,0.008509981,0.016265513,0.19377346,0.18706468,0.0015586078,0.058216732,0.009382605,0.49906927],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99467963,0.0009819821,0.00071969046,0.00048442557,0.0026976545,0.00043663883],"domain_scores_gemma":[0.9556067,0.01644309,0.0028867072,0.0018847685,0.021661788,0.0015169156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006010654,0.0009267998,0.0010098582,0.0018697841,0.0012939626,0.00292914,0.0018916155,0.0044790646,0.23411661],"category_scores_gemma":[0.08102264,0.0006898725,0.0014969668,0.0016651271,0.0010496465,0.0017253179,0.0011933134,0.006422422,0.07043205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003888025,0.0000029898456,0.000030385236,0.000049849295,0.0000040347427,0.000042110234,0.000008151011,0.000020411204,0.000020631665,0.0002154263,0.9959831,0.003583961],"study_design_scores_gemma":[0.00012916411,0.000027805008,0.00052566465,0.00034406123,0.000022642205,0.00023828528,0.000025038316,0.00016931913,0.00017586535,0.0006599826,0.9976654,0.00001675604],"about_ca_topic_score_codex":0.015937764,"about_ca_topic_score_gemma":0.018406902,"teacher_disagreement_score":0.23411661,"about_ca_system_score_codex":0.003774235,"about_ca_system_score_gemma":0.0065914886,"threshold_uncertainty_score":0.7831981},"labels":[],"label_agreement":null},{"id":"W4401346421","doi":"10.1007/s40257-024-00881-0","title":"Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Chronic urticaria; Disease; Pharmacotherapy; Association (psychology); Internal medicine; Dermatology","score_opus":0.013461216021379003,"score_gpt":0.313283677923859,"score_spread":0.29982246190248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401346421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978017,0.00043618312,0.00025217969,0.00031439663,0.00008648448,0.000035899142,0.0002471286,0.000010774817,0.00081518304],"genre_scores_gemma":[0.99809057,0.00023326291,0.00023467441,0.00035008462,0.00021240309,0.000042534328,0.00021370774,0.0000051327506,0.0006177313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789524,0.00095501594,0.00025445814,0.00040391015,0.00027679364,0.00021450136],"domain_scores_gemma":[0.99522686,0.0017891108,0.000919204,0.00083122787,0.0005707516,0.0006627638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020132526,0.0008118164,0.000953474,0.0013174477,0.0016023954,0.0012685081,0.0011134847,0.0030080543,0.0040902076],"category_scores_gemma":[0.005963183,0.0013300395,0.0011584377,0.0017409979,0.0009078143,0.0011119049,0.0005775878,0.0017202245,0.0005392452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018220162,0.00094269967,0.9874379,0.000047605507,0.0008010555,0.005171219,0.00036506882,0.000026485186,0.00095100707,0.00010941807,0.00068497297,0.0016405795],"study_design_scores_gemma":[0.0005038246,0.0014048618,0.98636335,0.000020138728,0.00051455485,0.009395523,0.00045554718,0.000499409,0.00010905131,0.000096105556,0.0006111006,0.000026633774],"about_ca_topic_score_codex":0.0051280768,"about_ca_topic_score_gemma":0.0046494617,"teacher_disagreement_score":0.0051280768,"about_ca_system_score_codex":0.00046673973,"about_ca_system_score_gemma":0.00047110853,"threshold_uncertainty_score":0.01368314},"labels":[],"label_agreement":null},{"id":"W4402549751","doi":"10.1007/s40257-024-00889-6","title":"Update on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; Medical Research Council; National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; National Health and Medical Research Council; National Institutes of Health","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Pharmacotherapy; Erythroderma; Intensive care medicine; Psychiatry","score_opus":0.07949413642189881,"score_gpt":0.4421618073581992,"score_spread":0.36266767093630037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402549751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014139633,0.9973851,0.000109180124,0.00060676195,0.00065608864,0.000007438216,0.00004101473,0.000011946216,0.0010410051],"genre_scores_gemma":[0.0006307896,0.99726224,0.00028126343,0.0004974834,0.0007983024,0.000006674985,0.000080653444,0.0000021522746,0.00044046817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996512,0.00006917701,0.00009054836,0.000038041602,0.00012984364,0.000021173239],"domain_scores_gemma":[0.99884737,0.0005637465,0.00021307093,0.000021065194,0.00028676257,0.00006806935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005841528,0.0007108055,0.0012046151,0.003550194,0.00030711733,0.0010385539,0.0008732204,0.0010075661,0.0051225186],"category_scores_gemma":[0.0018667697,0.00026411845,0.00072282227,0.0027763995,0.000305344,0.0015282109,0.0005483561,0.00170347,0.0018239174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006051132,0.000082872364,0.00052660535,0.033904202,0.00014630627,0.0005745761,0.00012612893,0.000333166,0.0007427374,0.0015878093,0.120802894,0.8411123],"study_design_scores_gemma":[0.000016890357,0.00008873189,0.0015092075,0.015493096,0.00032634498,0.006252167,0.00009621518,0.00010005236,0.00013965824,0.0011489113,0.9748054,0.00002331881],"about_ca_topic_score_codex":0.0013158695,"about_ca_topic_score_gemma":0.0028171595,"teacher_disagreement_score":0.0051225186,"about_ca_system_score_codex":0.000539778,"about_ca_system_score_gemma":0.0012243015,"threshold_uncertainty_score":0.017136514},"labels":[],"label_agreement":null},{"id":"W4403223396","doi":"10.1007/s40257-024-00885-w","title":"Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Merkel cell carcinoma; Oncology; Dermatology; Internal medicine; Carcinoma; Cancer; Immunotherapy","score_opus":0.13686947256272802,"score_gpt":0.45425315595615123,"score_spread":0.3173836833934232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403223396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820926,0.012414977,0.00077449746,0.0004692845,0.00006477655,0.0011269205,0.0014054998,0.000085754196,0.001565677],"genre_scores_gemma":[0.98974484,0.0042411205,0.0008960369,0.0008213684,0.00008962411,0.0005736925,0.0027195953,0.00002335923,0.00089028955],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999338,0.0003486342,0.0000601847,0.000071793125,0.00010091842,0.00008049026],"domain_scores_gemma":[0.99869245,0.00027669346,0.00039332107,0.000107619315,0.00014734006,0.00038246418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043305396,0.00080975663,0.0013621463,0.0002069019,0.00030207785,0.00080527907,0.0006023168,0.0008989058,0.0018935195],"category_scores_gemma":[0.0013099164,0.00025328094,0.0014654868,0.0002741994,0.0003993054,0.0006223171,0.0002601527,0.0017791172,0.00055093237],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5430976,0.03939883,0.033521853,0.004101854,0.0076883803,0.0006118734,0.00062595983,0.003685061,0.09626843,0.00027709952,0.010457568,0.26026547],"study_design_scores_gemma":[0.36534035,0.445371,0.1568757,0.0003369885,0.005667237,0.0018787447,0.0001888048,0.002265289,0.011313233,0.00026161838,0.010401431,0.0000996615],"about_ca_topic_score_codex":0.0006000137,"about_ca_topic_score_gemma":0.0017666498,"teacher_disagreement_score":0.0043305396,"about_ca_system_score_codex":0.0006995305,"about_ca_system_score_gemma":0.00091083115,"threshold_uncertainty_score":0.02290237},"labels":[],"label_agreement":null},{"id":"W4404399925","doi":"10.1007/s40257-024-00901-z","title":"Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Incyte","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Quality of life (healthcare); Pharmacotherapy; Dermatology; Pediatrics; Internal medicine","score_opus":0.04186626408346513,"score_gpt":0.4118241197351304,"score_spread":0.3699578556516653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404399925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875793,0.010758374,0.00012642646,0.00011498126,0.000028680583,0.0002573937,0.0005875158,0.000008979442,0.0005383942],"genre_scores_gemma":[0.9955472,0.0029196988,0.00022096993,0.00023806888,0.000045254445,0.00021297783,0.00067068916,0.0000020324132,0.00014326486],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991534,0.00041166245,0.00013562718,0.00011302836,0.00011583937,0.000070380236],"domain_scores_gemma":[0.99889994,0.00033252168,0.00043917567,0.00005658405,0.00010670473,0.00016511422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024971957,0.0005124359,0.0017665875,0.00023500045,0.00020057552,0.00062279386,0.0002644551,0.00060707587,0.0009070591],"category_scores_gemma":[0.0015083604,0.00021977122,0.0022072932,0.00032269853,0.00023161816,0.00038516,0.0002717258,0.00076976116,0.00012297324],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47458416,0.015719762,0.23149431,0.0065231924,0.028117113,0.00055686757,0.0005620638,0.00143545,0.01696891,0.00018004052,0.0029453747,0.22091278],"study_design_scores_gemma":[0.1409022,0.19974937,0.63130426,0.00058343366,0.017729167,0.0010265647,0.00026608014,0.0014735324,0.0033438136,0.00014766406,0.0033936894,0.000080320315],"about_ca_topic_score_codex":0.00047377593,"about_ca_topic_score_gemma":0.0013888585,"teacher_disagreement_score":0.0024971957,"about_ca_system_score_codex":0.00034704973,"about_ca_system_score_gemma":0.0004229828,"threshold_uncertainty_score":0.013206601},"labels":[],"label_agreement":null},{"id":"W4404798340","doi":"10.1007/s40257-024-00906-8","title":"Real-World Experience of Spesolimab for Generalized Pustular Psoriasis Flares in Adult Patients: A Multicenter Retrospective Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Retrospective cohort study; Multicenter study; Psoriasis; Dermatology; Pharmacotherapy; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.03851048109186108,"score_gpt":0.40787636072416705,"score_spread":0.369365879632306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404798340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792224,0.0006433175,0.00017956928,0.00023328919,0.000013584746,0.000028456212,0.00022646318,0.000004404596,0.0007487296],"genre_scores_gemma":[0.99906224,0.00017683979,0.00011462148,0.00030285204,0.000050844403,0.000014034191,0.00019470401,0.000002882499,0.000080982856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839944,0.00070156617,0.0002643942,0.00026520714,0.00019115218,0.00017824651],"domain_scores_gemma":[0.9957623,0.0012469024,0.0016883996,0.0003602551,0.0004424489,0.0004997506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016220857,0.00028125185,0.00053751096,0.00037599646,0.0005334645,0.000989584,0.00031572575,0.0007902477,0.0013808458],"category_scores_gemma":[0.0043230336,0.00025065904,0.0005525471,0.0007708439,0.00045032223,0.00077826245,0.00040984713,0.0004892971,0.00028674962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065971527,0.00017090207,0.99096745,0.00004155139,0.00014102655,0.003424118,0.00034048944,0.000052271876,0.00032537806,0.000051072784,0.0005219919,0.0033039758],"study_design_scores_gemma":[0.00030118893,0.0022564935,0.9667574,0.00005357363,0.00035586403,0.024903042,0.0020260978,0.00051284145,0.0002463609,0.00010840764,0.0024435434,0.000035100355],"about_ca_topic_score_codex":0.0012439472,"about_ca_topic_score_gemma":0.0013529074,"teacher_disagreement_score":0.0016220857,"about_ca_system_score_codex":0.0005672819,"about_ca_system_score_gemma":0.00041943954,"threshold_uncertainty_score":0.008578479},"labels":[],"label_agreement":null},{"id":"W4406087364","doi":"10.1007/s40257-024-00909-5","title":"A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Incyte","keywords":"Medicine; Ruxolitinib; Adverse effect; Atopic dermatitis; Tolerability; Janus kinase inhibitor; Eczema Area and Severity Index; Internal medicine; Clinical endpoint; Quality of life (healthcare); Pharmacokinetics; Body surface area; Clinical trial; Tofacitinib; Dermatology; Bone marrow","score_opus":0.01936643116546527,"score_gpt":0.3473711334280457,"score_spread":0.32800470226258044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406087364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997612,0.0015223133,0.00006712042,0.00006550589,0.000021009486,0.0001813498,0.00011085373,0.00000639728,0.00041340358],"genre_scores_gemma":[0.9975005,0.0011576067,0.00028729363,0.00015646004,0.000052187053,0.00022470184,0.0002617438,0.0000034622183,0.00035597966],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995975,0.00020983843,0.0000279391,0.000048893206,0.000044834247,0.000071104674],"domain_scores_gemma":[0.99959296,0.00012528307,0.00010309288,0.000019530904,0.000025627489,0.00013354947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010702382,0.00052525953,0.0012009649,0.00014827837,0.00030484048,0.00037432145,0.00031990092,0.00053844426,0.001349818],"category_scores_gemma":[0.00067930087,0.00025458663,0.0009784101,0.00018168798,0.00027879066,0.00036693728,0.00026371487,0.0013137695,0.00018794807],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6641226,0.04397834,0.06927833,0.0023381447,0.0024595063,0.0029412163,0.0008209711,0.0018531826,0.050428703,0.00030262413,0.0027960292,0.15868035],"study_design_scores_gemma":[0.2356044,0.5009991,0.24449039,0.00017258333,0.0011496879,0.002565499,0.00027807293,0.0012666967,0.0069482997,0.00008195625,0.0064000636,0.000043265325],"about_ca_topic_score_codex":0.00066077674,"about_ca_topic_score_gemma":0.0019614953,"teacher_disagreement_score":0.001349818,"about_ca_system_score_codex":0.00044949126,"about_ca_system_score_gemma":0.00056335254,"threshold_uncertainty_score":0.0056599975},"labels":[],"label_agreement":null},{"id":"W4407095389","doi":"10.1007/s40257-025-00922-2","title":"Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study","year":2025,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; Dermatrials Research; Probity Medical Research; SKiN Health; University of Calgary; Nova Chemicals (Canada); University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Plaque psoriasis; Retrospective cohort study; Multicenter study; Pharmacotherapy; Interleukin; Dermatology; Internal medicine; Cytokine; Randomized controlled trial","score_opus":0.014459903883459971,"score_gpt":0.3520595910678784,"score_spread":0.3375996871844184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407095389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983687,0.00047619137,0.00011951436,0.00024842078,0.000013806032,0.000012590343,0.00014909079,0.0000024300193,0.00060926145],"genre_scores_gemma":[0.9992072,0.00017855004,0.000083586056,0.000258391,0.000055219036,0.0000075204707,0.00013434007,0.0000019411702,0.00007314859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890184,0.00043318904,0.00015916495,0.00021350727,0.00014598988,0.00014621727],"domain_scores_gemma":[0.99680054,0.0009349951,0.0012177052,0.000267747,0.00029554954,0.00048342967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010188271,0.00023638135,0.0004920123,0.00032777234,0.0005419886,0.0010219855,0.00029791586,0.00081153604,0.0012433254],"category_scores_gemma":[0.003430243,0.00027617766,0.00049058726,0.0006644476,0.0004492872,0.0007021831,0.0003888343,0.00059799163,0.00027204514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033382955,0.00013273688,0.9926017,0.000020924952,0.000082999766,0.0038764959,0.00023792703,0.000039750037,0.00025775086,0.000036088004,0.00034627013,0.0020334902],"study_design_scores_gemma":[0.00017408283,0.0014769337,0.955291,0.00004105701,0.00026415288,0.03725005,0.0022580507,0.0005713767,0.00024939186,0.00009972112,0.0022937632,0.000030472798],"about_ca_topic_score_codex":0.0017124024,"about_ca_topic_score_gemma":0.0015868986,"teacher_disagreement_score":0.0017124024,"about_ca_system_score_codex":0.0005341323,"about_ca_system_score_gemma":0.00044923447,"threshold_uncertainty_score":0.0053881407},"labels":[],"label_agreement":null},{"id":"W4408445833","doi":"10.1007/s40257-025-00931-1","title":"Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"LEO Pharma","keywords":"Medicine; Atopic dermatitis; Dupilumab; Pharmacotherapy; Dermatology; Pediatrics; Disease; Head and neck; Disease control; Internal medicine; Surgery","score_opus":0.011971134804463901,"score_gpt":0.33388276177344606,"score_spread":0.3219116269689822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408445833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981018,0.0010533752,0.000042939075,0.000017042381,0.000007286764,0.000018133598,0.00013114506,0.0000031455952,0.00062527665],"genre_scores_gemma":[0.99932766,0.00011577122,0.00003810197,0.00002620616,0.000011788837,0.000011864936,0.00027703375,8.84011e-7,0.00019075473],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99922574,0.00019523589,0.00007846438,0.00017220931,0.0001666918,0.00016168131],"domain_scores_gemma":[0.9981316,0.0004657339,0.00076141045,0.0001309032,0.00016827066,0.00034213738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001360534,0.00029151037,0.00071267923,0.00058373867,0.00046519376,0.00077198877,0.00028340417,0.00040497555,0.000802084],"category_scores_gemma":[0.0020610872,0.00015292998,0.00091672456,0.00047668052,0.0003585443,0.0007114751,0.00036866305,0.00075611577,0.00010934122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011938032,0.00051681156,0.9696278,0.00008523451,0.0006817262,0.0003390353,0.0001711851,0.00041349733,0.0034979724,0.000045559787,0.00012895458,0.012554186],"study_design_scores_gemma":[0.00015024754,0.0023965214,0.99608165,0.000009472555,0.00025704707,0.000298503,0.000051368585,0.00023052472,0.00023932906,0.00002629873,0.00024727423,0.000011761139],"about_ca_topic_score_codex":0.0028717334,"about_ca_topic_score_gemma":0.004725186,"teacher_disagreement_score":0.0028717334,"about_ca_system_score_codex":0.0006411661,"about_ca_system_score_gemma":0.00047004528,"threshold_uncertainty_score":0.007195294},"labels":[],"label_agreement":null},{"id":"W4409448141","doi":"10.1007/s40257-025-00944-w","title":"Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Pharmacotherapy; Dermatology; MEDLINE; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.02826216597991016,"score_gpt":0.35803172884862633,"score_spread":0.32976956286871617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409448141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679935,0.00053865305,0.000055510234,0.00014858214,0.000010195168,0.00004067355,0.0013098567,0.0000026672446,0.0010944962],"genre_scores_gemma":[0.9985525,0.00032814543,0.000056765934,0.000055900895,0.0000086915425,0.00003846386,0.00076840975,0.0000024684089,0.00018868333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990864,0.0004005712,0.00009974886,0.00012164717,0.00016784554,0.00012381868],"domain_scores_gemma":[0.9968772,0.0005890031,0.0013067642,0.00018896305,0.00033738904,0.0007006752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016938548,0.00030835747,0.00039530997,0.00095129857,0.00071152457,0.0008297968,0.000332519,0.00036651077,0.0019516309],"category_scores_gemma":[0.005879767,0.0002282184,0.00079648325,0.0014351528,0.0002612491,0.0007127468,0.0012938178,0.0006730744,0.00023378027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016491748,0.00006624693,0.9954847,0.00003309068,0.00008206018,0.00009760755,0.00092567026,0.00004002598,0.000027799957,0.000022095131,0.0004167358,0.0026391328],"study_design_scores_gemma":[0.000026137262,0.000115834235,0.99576926,0.000035833775,0.00005355888,0.00022099899,0.0029766883,0.000099155026,0.000024374784,0.000033791566,0.00063500134,0.000009503575],"about_ca_topic_score_codex":0.01098759,"about_ca_topic_score_gemma":0.01055757,"teacher_disagreement_score":0.01098759,"about_ca_system_score_codex":0.0004506372,"about_ca_system_score_gemma":0.00040589037,"threshold_uncertainty_score":0.021847248},"labels":[],"label_agreement":null},{"id":"W4411964459","doi":"10.1007/s40257-025-00959-3","title":"Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Psoriasis; Disease; Pharmacotherapy; Systematic review; Duration (music); MEDLINE; Clinical trial; Internal medicine; Dermatology","score_opus":0.10144247819161838,"score_gpt":0.45203061981818654,"score_spread":0.35058814162656815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411964459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017560263,0.99746704,0.0000835471,0.00011245044,0.00007101304,0.000105075946,0.0002874989,0.0000056167605,0.00011173262],"genre_scores_gemma":[0.058348812,0.93907243,0.00063947804,0.0010884803,0.0001138056,0.0002797796,0.00030965087,0.000008844305,0.00013877926],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99487126,0.0016975416,0.0020703902,0.0005895245,0.0005856348,0.00018568459],"domain_scores_gemma":[0.982498,0.01170377,0.004581101,0.0002914681,0.0006469139,0.00027871877],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0064042457,0.0011555677,0.010506462,0.003129192,0.0003624755,0.0019309656,0.0015256229,0.0017098514,0.005140174],"category_scores_gemma":[0.02014515,0.0009816563,0.009621185,0.0041053453,0.0007166861,0.0015988833,0.0013384178,0.0015810949,0.00023909159],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027137646,0.00004495003,0.0033712203,0.8563739,0.1001671,0.00011359984,0.00014539594,0.0001506214,0.00027100477,0.00013113148,0.0019438914,0.034573477],"study_design_scores_gemma":[0.0057099275,0.000846623,0.021512652,0.2845007,0.6704315,0.00042246314,0.000283213,0.00014446267,0.00021094158,0.00045712708,0.015387545,0.000092869326],"about_ca_topic_score_codex":0.0042385813,"about_ca_topic_score_gemma":0.018293727,"teacher_disagreement_score":0.98949355,"about_ca_system_score_codex":0.0019001692,"about_ca_system_score_gemma":0.003565935,"threshold_uncertainty_score":0.033869326},"labels":[],"label_agreement":null},{"id":"W4412727529","doi":"10.1007/s40257-025-00964-6","title":"Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; University of Toronto","funders":"AbbVie","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Discontinuation; Adverse effect; Internal medicine; Dermatology Life Quality Index; Randomized controlled trial; Severity of illness; Dermatology","score_opus":0.07167977802277621,"score_gpt":0.40167062400092113,"score_spread":0.32999084597814493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412727529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98131955,0.0074762427,0.0010846446,0.0012833175,0.0004124065,0.0012918053,0.002769128,0.00024531665,0.0041176868],"genre_scores_gemma":[0.9864179,0.0023541148,0.0015991714,0.0017315703,0.00036247692,0.0010532329,0.003090397,0.00006246466,0.0033286044],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99912745,0.00038136297,0.000047046142,0.00013791335,0.00011052941,0.00019576817],"domain_scores_gemma":[0.9987488,0.00032959192,0.00024429176,0.00014588541,0.00010780463,0.00042360535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035552226,0.0014012861,0.0021529787,0.0002655114,0.00048897514,0.0017354179,0.00092450273,0.0016944185,0.004928063],"category_scores_gemma":[0.001962752,0.00048137296,0.0030008985,0.00024864983,0.00115477,0.0013156177,0.0004042957,0.0046573333,0.0016042831],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89183784,0.012766697,0.002778527,0.0010733877,0.0026664804,0.00014254433,0.00021388708,0.0012408176,0.014236013,0.00034811653,0.0062319916,0.06646361],"study_design_scores_gemma":[0.8529768,0.12807402,0.010886161,0.00008737399,0.00151586,0.00025379064,0.00008005885,0.000898843,0.0016859665,0.0006212972,0.0028712782,0.00004843725],"about_ca_topic_score_codex":0.000723458,"about_ca_topic_score_gemma":0.0016027632,"teacher_disagreement_score":0.004928063,"about_ca_system_score_codex":0.0007691614,"about_ca_system_score_gemma":0.0011873144,"threshold_uncertainty_score":0.018802047},"labels":[],"label_agreement":null},{"id":"W4413569229","doi":"10.1007/s40257-025-00979-z","title":"Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Quality of life (healthcare); Psychosocial; Botulinum toxin; Apremilast; Dermatology; Psoriasis; Bioinformatics; Psoriatic arthritis; Psychiatry; Pathology; Surgery","score_opus":0.07866549000410561,"score_gpt":0.5097149119420339,"score_spread":0.4310494219379283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413569229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031225124,0.99581796,0.00024806533,0.0021495472,0.00037611707,0.000006974217,0.000016566724,0.000010206191,0.0010623642],"genre_scores_gemma":[0.0023152553,0.99447846,0.00055910076,0.0012124836,0.00092721207,0.000019238836,0.000045568933,0.00000305913,0.00043969337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966156,0.00009579887,0.000053786644,0.0000565299,0.00008896821,0.00004332517],"domain_scores_gemma":[0.9995314,0.00022985107,0.000057061166,0.0000096504555,0.000117398784,0.000054651977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095681474,0.0006782719,0.0012554892,0.0015050469,0.00034554067,0.0017096602,0.00078808266,0.0013066441,0.0035062516],"category_scores_gemma":[0.0011119064,0.0002179152,0.0006084449,0.0008422583,0.0005644923,0.0018316304,0.000893802,0.0027440262,0.0010744863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018810811,0.000144304,0.00044401604,0.015328907,0.00009230753,0.0009128002,0.00017723272,0.0004610056,0.0020643356,0.0085783135,0.03805475,0.9335539],"study_design_scores_gemma":[0.000093478106,0.0003565431,0.0010164062,0.011937923,0.00021379626,0.005343105,0.00035246002,0.00044200066,0.0005966255,0.009675908,0.9699158,0.000055912576],"about_ca_topic_score_codex":0.00070940435,"about_ca_topic_score_gemma":0.0020003982,"teacher_disagreement_score":0.0035062516,"about_ca_system_score_codex":0.00067895127,"about_ca_system_score_gemma":0.0012310364,"threshold_uncertainty_score":0.011729538},"labels":[],"label_agreement":null},{"id":"W4413938704","doi":"10.1007/s40257-025-00975-3","title":"Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; Probity Medical Research; SKiN Health; University of Calgary","funders":"AbbVie","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Pharmacotherapy; Dermatology; Clinical trial; Internal medicine","score_opus":0.027768150268074828,"score_gpt":0.4017457693328107,"score_spread":0.37397761906473587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413938704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708447,0.008305381,0.0011950039,0.0009816587,0.0003975841,0.00996571,0.0033378957,0.0002819729,0.004690079],"genre_scores_gemma":[0.9779779,0.0030883036,0.0020374856,0.0017082695,0.00028857085,0.0094246715,0.0023732313,0.000041243227,0.0030603656],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992619,0.00032732863,0.000054896558,0.00013810961,0.00007914111,0.00013858512],"domain_scores_gemma":[0.9989737,0.00020143787,0.0002680862,0.00010026195,0.000106178646,0.0003503518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026677244,0.0011415754,0.0023992565,0.00029168525,0.000537921,0.0011855401,0.00085730903,0.0014392087,0.007273305],"category_scores_gemma":[0.0017553121,0.00051702326,0.0025083846,0.0004365911,0.0006779107,0.0011055535,0.00039386944,0.00297692,0.0010298878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9437095,0.013166886,0.0017815218,0.0009947692,0.0019259886,0.0000690659,0.00007593997,0.00046221874,0.004692439,0.00014010536,0.0028413036,0.03014036],"study_design_scores_gemma":[0.90485466,0.08498279,0.0059289373,0.00007553394,0.0010874674,0.000117181546,0.000027164928,0.00052686856,0.0007197544,0.00026267368,0.0013922536,0.000024622603],"about_ca_topic_score_codex":0.0005211738,"about_ca_topic_score_gemma":0.0019413603,"teacher_disagreement_score":0.007273305,"about_ca_system_score_codex":0.0007540718,"about_ca_system_score_gemma":0.0015372987,"threshold_uncertainty_score":0.024331689},"labels":[],"label_agreement":null},{"id":"W4414167313","doi":"10.1007/s40257-025-00976-2","title":"Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2025,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Alopecia areata; Clinical trial; Pharmacotherapy; Safety profile; MEDLINE","score_opus":0.0974651543288489,"score_gpt":0.47585318935152604,"score_spread":0.37838803502267715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414167313","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019606658,0.00076959876,0.000723256,0.12150226,0.8700711,0.00006711292,0.0024696542,0.00028903157,0.003911858],"genre_scores_gemma":[0.0115814945,0.0063662967,0.005961523,0.3230432,0.4677159,0.00043239997,0.0036659164,0.0012576568,0.17997567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99224323,0.0015290001,0.001382719,0.00077250804,0.003434897,0.00063765683],"domain_scores_gemma":[0.95439184,0.018407585,0.003031204,0.002055272,0.020028457,0.002085619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007987289,0.001738462,0.0019294719,0.0029308884,0.0022264037,0.0039462033,0.0030047086,0.010389255,0.03424167],"category_scores_gemma":[0.088645495,0.0011266174,0.0020455234,0.0018995572,0.001993072,0.0015599144,0.0013060265,0.016238932,0.018571086],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045729787,0.000009046208,0.000058332305,0.00007347704,0.000014890953,0.00019065093,0.000013692363,0.000034235756,0.000020004707,0.00040693572,0.99583447,0.0032986372],"study_design_scores_gemma":[0.00018356596,0.000031861917,0.0009554953,0.00044250512,0.000072767725,0.0006320629,0.00004820922,0.00029046886,0.00023512299,0.0015932897,0.9954787,0.00003603246],"about_ca_topic_score_codex":0.019356355,"about_ca_topic_score_gemma":0.027545718,"teacher_disagreement_score":0.03424167,"about_ca_system_score_codex":0.0049071284,"about_ca_system_score_gemma":0.008587503,"threshold_uncertainty_score":0.114549816},"labels":[],"label_agreement":null},{"id":"W4414358590","doi":"10.1007/s40257-025-00962-8","title":"Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Atopic dermatitis; Pharmacotherapy; MEDLINE; Young adult; Clinical trial; Systemic therapy","score_opus":0.02782264573178088,"score_gpt":0.36507156720074485,"score_spread":0.33724892146896396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414358590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890702,0.0012043203,0.00008862703,0.00013265813,0.000010589341,0.000014229675,0.008124505,0.000010201779,0.0013445785],"genre_scores_gemma":[0.9926185,0.0009748941,0.00011484458,0.000069846545,0.0000168849,0.000023230936,0.0059910263,0.0000066683037,0.00018395815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990025,0.00025073226,0.00016806964,0.00019272495,0.00019268619,0.00019335936],"domain_scores_gemma":[0.99695325,0.00045391696,0.0019925593,0.00011979489,0.00023494504,0.0002454801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066345226,0.00022750406,0.00047235147,0.0008527454,0.00030010176,0.00077460444,0.0003491905,0.000383627,0.001500457],"category_scores_gemma":[0.002862937,0.00017985626,0.00080796774,0.0020673098,0.00021211217,0.00082550215,0.00067550124,0.00059227203,0.0002755806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011575075,0.000026713771,0.9969266,0.00002799742,0.0000622169,0.00007711751,0.000055901815,0.00007064172,0.000028331928,0.000028145303,0.0005357748,0.0020448277],"study_design_scores_gemma":[0.000010711262,0.000057030295,0.99854004,0.000029690664,0.000048314192,0.00034507972,0.0003251812,0.00008271573,0.000036879374,0.000017420101,0.0005029993,0.0000037824523],"about_ca_topic_score_codex":0.008475232,"about_ca_topic_score_gemma":0.012208104,"teacher_disagreement_score":0.008475232,"about_ca_system_score_codex":0.0005778551,"about_ca_system_score_gemma":0.00064108544,"threshold_uncertainty_score":0.016851842},"labels":[],"label_agreement":null},{"id":"W4414459865","doi":"10.1007/s40257-025-00952-w","title":"The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Atopic dermatitis; Clinical trial; Pharmacotherapy; Safety profile; Rescue therapy","score_opus":0.02295494221768726,"score_gpt":0.36751946206121494,"score_spread":0.3445645198435277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414459865","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45218807,0.4599414,0.005540842,0.006858483,0.0009711153,0.003428357,0.03262835,0.00029138933,0.038152065],"genre_scores_gemma":[0.88829315,0.08177515,0.0048613367,0.0050784615,0.0010161017,0.0021761437,0.013639665,0.00006878994,0.0030912473],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99064976,0.004918124,0.001601504,0.00060497713,0.0019794994,0.0002462278],"domain_scores_gemma":[0.97407305,0.01166758,0.006953983,0.0015358165,0.0049019274,0.0008676772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010602979,0.00047834514,0.0011085506,0.00069448084,0.00051331194,0.00095054257,0.00048581598,0.0010655466,0.00489139],"category_scores_gemma":[0.018950172,0.00025978487,0.0030162195,0.0008511778,0.0004984589,0.000760746,0.00044947138,0.0017012715,0.00093849417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.092723556,0.0014497772,0.06418476,0.033110972,0.010179175,0.0011726487,0.00079887355,0.001427698,0.032315694,0.0017586241,0.03501885,0.7258593],"study_design_scores_gemma":[0.03556969,0.11634918,0.3908795,0.016408473,0.023332778,0.017731017,0.0005830241,0.0019139173,0.04406344,0.0017497649,0.3511002,0.00031903211],"about_ca_topic_score_codex":0.0013141449,"about_ca_topic_score_gemma":0.0036198895,"teacher_disagreement_score":0.010602979,"about_ca_system_score_codex":0.0007876176,"about_ca_system_score_gemma":0.0014683931,"threshold_uncertainty_score":0.05607462},"labels":[],"label_agreement":null},{"id":"W4414537613","doi":"10.1007/s40257-025-00974-4","title":"Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"LEO Pharma","keywords":"Hand eczema; Quality of life (healthcare); Clinical trial; Safety profile; Pharmacotherapy; Chronic disease","score_opus":0.1267621694134489,"score_gpt":0.4697093432548251,"score_spread":0.3429471738413762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414537613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018396907,0.94532245,0.0015607261,0.011136282,0.0028950167,0.0050836075,0.0066179615,0.00027815133,0.008708958],"genre_scores_gemma":[0.15376414,0.78104854,0.0056998706,0.030276876,0.007898299,0.006145171,0.009403254,0.00013724228,0.0056266976],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99666554,0.0012521811,0.0008663858,0.00037410948,0.00062160793,0.00022014629],"domain_scores_gemma":[0.9902856,0.003865485,0.0030278899,0.00021436317,0.0019886296,0.0006180961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0102782985,0.0014458706,0.004203509,0.0011599145,0.00048098445,0.0030558666,0.0016834756,0.002948629,0.00859082],"category_scores_gemma":[0.010404783,0.00076321047,0.006014681,0.0012453479,0.0005582149,0.0013759335,0.00068591314,0.002519379,0.0023533257],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07654524,0.0014405353,0.0029603424,0.31219435,0.01883527,0.00033573527,0.0003230894,0.0007569877,0.010286176,0.0012687106,0.06462931,0.51042426],"study_design_scores_gemma":[0.23810166,0.10567217,0.028196152,0.16346909,0.11451175,0.0015122562,0.00056341855,0.001010217,0.01000783,0.003655452,0.33295783,0.00034221364],"about_ca_topic_score_codex":0.0012344286,"about_ca_topic_score_gemma":0.0026285495,"teacher_disagreement_score":0.0102782985,"about_ca_system_score_codex":0.0012898999,"about_ca_system_score_gemma":0.0029297112,"threshold_uncertainty_score":0.05435747},"labels":[],"label_agreement":null},{"id":"W4415285914","doi":"10.1007/s40257-025-00988-y","title":"Understanding Enthesitis in Psoriatic Disease: Insights and Implications","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Enthesitis; Psoriatic arthritis; Psoriasis; Referral; Psychological intervention; Multidisciplinary approach; Rheumatology","score_opus":0.1503657843594049,"score_gpt":0.4546404194953279,"score_spread":0.304274635135923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415285914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000257833,0.99966526,0.000015974181,0.00017255802,0.00003760661,0.0000011328704,0.0000050002845,6.8103515e-7,0.00007596744],"genre_scores_gemma":[0.0003094661,0.9993954,0.000057320918,0.00013598683,0.00005844428,0.0000021287087,0.00000571381,1.6909466e-7,0.00003533794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951625,0.00012389512,0.000089137524,0.00007719596,0.00016125473,0.00003234976],"domain_scores_gemma":[0.9978352,0.0015758395,0.0002714938,0.00002621873,0.00023618044,0.00005509906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018084035,0.0008948765,0.0026086955,0.0026591239,0.0002921347,0.0020105469,0.0010271065,0.0018035552,0.0032726373],"category_scores_gemma":[0.0032915918,0.00036635043,0.0010707557,0.00308225,0.00076497404,0.0017797346,0.0009827141,0.0019507256,0.0006143791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014491545,0.00008630492,0.0004693535,0.10107816,0.0006367013,0.00015490931,0.00011316236,0.00029625942,0.00059935893,0.0033694832,0.014267962,0.8787833],"study_design_scores_gemma":[0.00019255916,0.00030197322,0.0051932307,0.12924968,0.003260271,0.0021115467,0.0005775563,0.00031621876,0.00041693356,0.008034309,0.85025746,0.00008829043],"about_ca_topic_score_codex":0.002945569,"about_ca_topic_score_gemma":0.0062309373,"teacher_disagreement_score":0.0032726373,"about_ca_system_score_codex":0.00091147015,"about_ca_system_score_gemma":0.0027394902,"threshold_uncertainty_score":0.010948002},"labels":[],"label_agreement":null},{"id":"W4415376342","doi":"10.1007/s40257-025-00985-1","title":"Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"LEO Pharma","keywords":"Post-hoc analysis; Post hoc; Clinical trial; Phase (matter); Pharmacotherapy; MEDLINE","score_opus":0.022060589844944738,"score_gpt":0.4044911377009969,"score_spread":0.3824305478560521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415376342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659178,0.017499117,0.002201114,0.0006365992,0.00049360533,0.0062908423,0.003264846,0.00014598545,0.003549983],"genre_scores_gemma":[0.9857883,0.0030164511,0.0018751097,0.0008483692,0.0002604478,0.00497888,0.0018447251,0.000050920287,0.0013368077],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9940608,0.003686755,0.000677788,0.00068996317,0.00036323897,0.0005213763],"domain_scores_gemma":[0.99390346,0.0026598258,0.001420716,0.000836899,0.0005902207,0.00058882014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013493789,0.0017570056,0.004675434,0.0004954044,0.00058346725,0.0020537095,0.00084846665,0.0011779678,0.003462691],"category_scores_gemma":[0.008569521,0.00062584964,0.009086127,0.0007237628,0.0008084352,0.0015192905,0.0006460235,0.0027803513,0.000567746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95286113,0.0020535241,0.0047487095,0.0010097711,0.016419398,0.000039129358,0.000103752565,0.00088033505,0.004310428,0.000095165764,0.0009576866,0.01652108],"study_design_scores_gemma":[0.66031575,0.21008511,0.07406782,0.00034126686,0.041414913,0.00019631341,0.0002218679,0.0029664044,0.004345396,0.00072614325,0.005198049,0.000120889476],"about_ca_topic_score_codex":0.00065686466,"about_ca_topic_score_gemma":0.0018848545,"teacher_disagreement_score":0.013493789,"about_ca_system_score_codex":0.0009428365,"about_ca_system_score_gemma":0.0016989261,"threshold_uncertainty_score":0.07136285},"labels":[],"label_agreement":null},{"id":"W4415503732","doi":"10.1007/s40257-025-00983-3","title":"The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"Sanofi","keywords":"Psychosocial; Acne; Quality of life (healthcare); Pharmacotherapy; MEDLINE; Systematic review","score_opus":0.02698976605609848,"score_gpt":0.4267974220270276,"score_spread":0.3998076559709291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415503732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016018458,0.99723166,0.000099748155,0.00018001579,0.00007402023,0.00023964993,0.00035075442,0.000005992862,0.00021622855],"genre_scores_gemma":[0.020787753,0.97754556,0.00043137887,0.00039617554,0.0000653935,0.00048208152,0.0002080716,0.000004820534,0.00007868142],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9919463,0.0028103837,0.0028368908,0.0005906969,0.0015479578,0.000267734],"domain_scores_gemma":[0.9714216,0.020689962,0.0049096467,0.00040531726,0.0022899061,0.0002836191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008171762,0.0016308095,0.009463977,0.011039758,0.000787833,0.0030193096,0.00164837,0.0018448936,0.0033342915],"category_scores_gemma":[0.038975712,0.0011499773,0.009447461,0.010100027,0.000930539,0.002138541,0.0019124128,0.0011875423,0.00020869655],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014452326,0.000011308295,0.0010282156,0.9646287,0.0105977515,0.000078868055,0.00019849959,0.00008325186,0.00010409452,0.000121778816,0.00081481086,0.022188207],"study_design_scores_gemma":[0.00018050674,0.0001796551,0.0060780365,0.8864048,0.09472318,0.000380531,0.0003372669,0.000087535525,0.00011985576,0.00024855448,0.011216239,0.000043864562],"about_ca_topic_score_codex":0.008689707,"about_ca_topic_score_gemma":0.025155695,"teacher_disagreement_score":0.011039758,"about_ca_system_score_codex":0.0038522661,"about_ca_system_score_gemma":0.010761117,"threshold_uncertainty_score":0.043216944},"labels":[],"label_agreement":null},{"id":"W4415761490","doi":"10.1007/s40257-025-00989-x","title":"Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials","year":2025,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Pharmacotherapy; Hand eczema; Delta; Phase (matter)","score_opus":0.06400379933982515,"score_gpt":0.42056833524607884,"score_spread":0.3565645359062537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415761490","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060701175,0.0024267128,0.00028905852,0.053563073,0.94042027,0.00008658864,0.0015080258,0.00016957016,0.0014760715],"genre_scores_gemma":[0.0048547206,0.013858676,0.0031743338,0.18688737,0.7016356,0.0007685573,0.0027932404,0.0010239694,0.085003525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905663,0.002502526,0.0017309117,0.0009189454,0.0033208807,0.0009603941],"domain_scores_gemma":[0.9486916,0.01606969,0.004806217,0.0018105386,0.02531925,0.0033026962],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01047421,0.0035453138,0.0049408847,0.004314807,0.0021995364,0.00544368,0.0053768,0.00958649,0.07606767],"category_scores_gemma":[0.088731706,0.002035498,0.004196567,0.0029831806,0.0026066047,0.002636507,0.0018108074,0.016138654,0.033455726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015048527,0.000008484869,0.000032707077,0.0005045844,0.000047394216,0.00007579536,0.000009050712,0.000021935177,0.000025791023,0.0001207282,0.9955715,0.0034314077],"study_design_scores_gemma":[0.0018171571,0.00011363294,0.0012779556,0.0029613567,0.00045079092,0.00035228406,0.00005995446,0.00027772834,0.0002932291,0.0010390489,0.99128026,0.00007655154],"about_ca_topic_score_codex":0.024795104,"about_ca_topic_score_gemma":0.031558882,"teacher_disagreement_score":0.9904135,"about_ca_system_score_codex":0.0069032335,"about_ca_system_score_gemma":0.011555982,"threshold_uncertainty_score":0.25447172},"labels":[],"label_agreement":null},{"id":"W48128272","doi":"10.2165/00128071-200607040-00006","title":"The Role of Antimalarials in the Exacerbation of Psoriasis","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Psoriasis; Exacerbation; Pharmacotherapy; Dermatology; Intensive care medicine; Immunology; Internal medicine","score_opus":0.04442707188023524,"score_gpt":0.37156793728451737,"score_spread":0.3271408654042821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48128272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010545376,0.99901164,0.000121280726,0.00020068885,0.00014338456,0.000002983689,0.0000074775667,0.0000048294733,0.0004022514],"genre_scores_gemma":[0.0010291263,0.9978703,0.0002562433,0.00019245165,0.00032562666,0.0000049164923,0.000017882552,0.0000011097753,0.0003023336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997329,0.000046632384,0.000051882173,0.000039793213,0.00010716088,0.00002161216],"domain_scores_gemma":[0.9994599,0.0002752936,0.000093953786,0.000016988324,0.000116540185,0.000037233356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072930276,0.0008175572,0.002010945,0.0019063124,0.0002966492,0.0008514934,0.00108589,0.0012934173,0.0017969299],"category_scores_gemma":[0.0009012372,0.00031617907,0.0005549203,0.0017297659,0.0005558046,0.0010643237,0.0005562145,0.0020613591,0.0014348611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014590085,0.00009347188,0.00026574894,0.0072286944,0.00009618594,0.00036739057,0.00003335717,0.00029611058,0.0015909355,0.0015354875,0.0157882,0.9725585],"study_design_scores_gemma":[0.00010827845,0.0002554543,0.0022575604,0.0021223743,0.00028308458,0.004648297,0.000057879508,0.00025843375,0.0010073397,0.0018984849,0.987074,0.000028791199],"about_ca_topic_score_codex":0.0010287836,"about_ca_topic_score_gemma":0.0022410792,"teacher_disagreement_score":0.002010945,"about_ca_system_score_codex":0.0004891176,"about_ca_system_score_gemma":0.0007401299,"threshold_uncertainty_score":0.0060113072},"labels":[],"label_agreement":null},{"id":"W83713607","doi":"10.2165/11587890-000000000-00000","title":"The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Western University","funders":"Allergan; Genentech; LEO Pharma; Medac; Mitsubishi Tanabe Pharma Corporation; Cilag; Astellas Pharma; Novo Nordisk; Incyte; University of Connecticut; Abbott Laboratories; Zalicus; Biogen; Celgene; Amgen; Pfizer; Galderma; Eli Lilly and Company; GlaxoSmithKline; Eisai","keywords":"Adalimumab; Medicine; Adverse effect; Psoriasis; Placebo; Population; Clinical trial; Internal medicine; Dosing; Incidence (geometry); Dermatology; Pathology; Disease","score_opus":0.07252126911291348,"score_gpt":0.3763919246789039,"score_spread":0.30387065556599047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W83713607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037411618,0.99882954,0.00009825133,0.00018551781,0.00010858259,0.0000020765895,0.000013264171,0.0000035089954,0.00038513425],"genre_scores_gemma":[0.006383917,0.99196327,0.00024065528,0.0004520352,0.0004088503,0.000006588671,0.000054885208,0.0000023735804,0.0004872884],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99970216,0.000057615267,0.00006398977,0.000042332947,0.00010970786,0.000024137225],"domain_scores_gemma":[0.9992951,0.00038385772,0.0001368884,0.000016021077,0.00013292476,0.00003511383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010691768,0.00050363404,0.0019774183,0.0006974476,0.0001646236,0.0008650413,0.0009240914,0.00087935186,0.0016304556],"category_scores_gemma":[0.0010637763,0.00019393447,0.00071439246,0.0007457756,0.00034529698,0.0006333774,0.00027841877,0.0014551751,0.0008112705],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003938081,0.00006529832,0.000394204,0.0073367814,0.00020785198,0.00018233899,0.000020774902,0.0001513598,0.0011018836,0.00065323454,0.009984819,0.97950774],"study_design_scores_gemma":[0.0005922873,0.0011398512,0.010167206,0.0065473323,0.0018154801,0.0068337326,0.00010920548,0.0004872078,0.0025419153,0.0025489756,0.9671492,0.000067659814],"about_ca_topic_score_codex":0.00055609155,"about_ca_topic_score_gemma":0.0013665785,"teacher_disagreement_score":0.0019774183,"about_ca_system_score_codex":0.00038778636,"about_ca_system_score_gemma":0.000653048,"threshold_uncertainty_score":0.0056543946},"labels":[],"label_agreement":null},{"id":"W839775831","doi":"10.1007/s40257-015-0141-9","title":"23rd World Congress of Dermatology: Vancouver, Canada, June 8–13, 2015","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Pharmacotherapy; Family medicine; Internal medicine","score_opus":0.03432645344616939,"score_gpt":0.3251040620749621,"score_spread":0.2907776086287927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W839775831","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009451513,0.124699764,0.0022934258,0.031141214,0.10767429,0.0005905323,0.0074615614,0.001310235,0.71537745],"genre_scores_gemma":[0.009374113,0.019800691,0.0007604264,0.0011530295,0.0031841025,0.0000353651,0.0027302073,0.00013782115,0.96282434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991763,0.00005163931,0.000024975854,0.000081132726,0.0004274149,0.00023846347],"domain_scores_gemma":[0.9989699,0.000029386325,0.000034123994,0.00003002559,0.0006116823,0.00032490943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001134457,0.00130168,0.0008304746,0.00202892,0.0024334153,0.0038208466,0.0012361535,0.002088323,0.18014652],"category_scores_gemma":[0.0010299463,0.00038689663,0.0007624748,0.0012135544,0.0007017202,0.00072109676,0.0014509204,0.0024109914,0.06967778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014201825,0.00006973314,0.00052092585,0.0001568173,0.000022363061,0.00014226782,0.000025506923,0.00017929674,0.00096895016,0.00032570458,0.93259543,0.06485106],"study_design_scores_gemma":[0.000013440314,0.000025746249,0.0031699413,0.00012998871,0.000009371816,0.00009690639,0.00006615429,0.00007512315,0.00026518633,0.00014354188,0.995996,0.000008651879],"about_ca_topic_score_codex":0.13980488,"about_ca_topic_score_gemma":0.56714433,"teacher_disagreement_score":0.18014652,"about_ca_system_score_codex":0.0049265437,"about_ca_system_score_gemma":0.005584269,"threshold_uncertainty_score":0.60265017},"labels":[],"label_agreement":null},{"id":"W98489906","doi":"10.2165/00128071-200304100-00004","title":"Photodynamic Therapy and Topical Aminolevulinic Acid","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Photodynamic therapy; Medicine; Actinic keratosis; Phototoxicity; Dermatology; Mycosis fungoides; Actinic keratoses; Acne; Prodrug; Protoporphyrin IX; Psoriasis; Skin cancer; Cancer; Cancer research; Pathology; Basal cell; Pharmacology; Internal medicine; Lymphoma; Chemistry","score_opus":0.11317456751194192,"score_gpt":0.47996568885444374,"score_spread":0.3667911213425018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W98489906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009934837,0.999469,0.00002100632,0.00004274583,0.000047536494,0.0000021858089,0.0000050813096,0.0000019313147,0.00031128176],"genre_scores_gemma":[0.00067515124,0.9988354,0.00006836232,0.000070044785,0.00006289886,0.000003342794,0.000009699335,4.1124733e-7,0.0002746337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997392,0.00004542264,0.00006135394,0.000041344065,0.00009701407,0.000015587239],"domain_scores_gemma":[0.9994055,0.00029784619,0.00014703929,0.000017177501,0.00010593986,0.000026508338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006990876,0.00091496017,0.0022339318,0.003955689,0.0002933446,0.0009530117,0.00078946527,0.0009810639,0.0036521885],"category_scores_gemma":[0.0010079517,0.00030042295,0.00054469146,0.0046393415,0.0004964905,0.0011336327,0.00043128518,0.0007216684,0.0011323786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022416892,0.00014547814,0.0004499958,0.045038406,0.00021802251,0.00047039182,0.000066145694,0.00016194704,0.0029406934,0.0009364972,0.016447196,0.932901],"study_design_scores_gemma":[0.00009669968,0.00031412017,0.0036385274,0.011849351,0.0012173589,0.0046913945,0.00020396219,0.00008391245,0.0023562755,0.0008530946,0.97466123,0.00003410228],"about_ca_topic_score_codex":0.0017502317,"about_ca_topic_score_gemma":0.004134924,"teacher_disagreement_score":0.003955689,"about_ca_system_score_codex":0.00063353195,"about_ca_system_score_gemma":0.0011627793,"threshold_uncertainty_score":0.01221776},"labels":[],"label_agreement":null}]}